id	sid	tid	token	lemma	pos
iajs-3148	1	1	75	75	NUM
iajs-3148	1	2	this	this	DET
iajs-3148	1	3	work	work	NOUN
iajs-3148	1	4	is	be	AUX
iajs-3148	1	5	licensed	license	VERB
iajs-3148	1	6	under	under	ADP
iajs-3148	1	7	a	a	DET
iajs-3148	1	8	creative	creative	ADJ
iajs-3148	1	9	commons	common	NOUN
iajs-3148	1	10	attribution	attribution	NOUN
iajs-3148	1	11	4.0	4.0	NUM
iajs-3148	1	12	international	international	ADJ
iajs-3148	1	13	license	license	NOUN
iajs-3148	1	14	1samara	1samara	NUM
iajs-3148	1	15	ammar	ammar	PROPN
iajs-3148	1	16	sabri	sabri	PROPN
iajs-3148	1	17	*	*	PROPN
iajs-3148	1	18	2shaima	2shaima	PROPN
iajs-3148	1	19	r.	r.	PROPN
iajs-3148	1	20	ibraheem	ibraheem	PROPN
iajs-3148	1	21	*	*	PUNCT
iajs-3148	1	22	corresponding	correspond	VERB
iajs-3148	1	23	author	author	NOUN
iajs-3148	1	24	:	:	PUNCT
iajs-3148	1	25	samaraammar82@gmail.com	samaraammar82@gmail.com	X
iajs-3148	1	26	abstract	abstract	ADJ
iajs-3148	1	27	psoriasis	psoriasis	NOUN
iajs-3148	1	28	is	be	AUX
iajs-3148	1	29	defined	define	VERB
iajs-3148	1	30	as	as	ADP
iajs-3148	1	31	a	a	DET
iajs-3148	1	32	series	series	NOUN
iajs-3148	1	33	of	of	ADP
iajs-3148	1	34	events	event	NOUN
iajs-3148	1	35	that	that	PRON
iajs-3148	1	36	begins	begin	VERB
iajs-3148	1	37	in	in	ADP
iajs-3148	1	38	its	its	PRON
iajs-3148	1	39	initial	initial	ADJ
iajs-3148	1	40	stage	stage	NOUN
iajs-3148	1	41	with	with	ADP
iajs-3148	1	42	dermatitis	dermatitis	NOUN
iajs-3148	1	43	and	and	CCONJ
iajs-3148	1	44	then	then	ADV
iajs-3148	1	45	progresses	progress	VERB
iajs-3148	1	46	to	to	ADP
iajs-3148	1	47	more	more	ADV
iajs-3148	1	48	widespread	widespread	ADJ
iajs-3148	1	49	inflammation	inflammation	NOUN
iajs-3148	1	50	and	and	CCONJ
iajs-3148	1	51	increased	increase	VERB
iajs-3148	1	52	oxidative	oxidative	ADJ
iajs-3148	1	53	stress	stress	NOUN
iajs-3148	1	54	.	.	PUNCT
iajs-3148	2	1	the	the	DET
iajs-3148	2	2	aim	aim	NOUN
iajs-3148	2	3	of	of	ADP
iajs-3148	2	4	this	this	DET
iajs-3148	2	5	study	study	NOUN
iajs-3148	2	6	was	be	AUX
iajs-3148	2	7	to	to	PART
iajs-3148	2	8	determine	determine	VERB
iajs-3148	2	9	whether	whether	SCONJ
iajs-3148	2	10	psoriasis	psoriasis	NOUN
iajs-3148	2	11	and	and	CCONJ
iajs-3148	2	12	the	the	DET
iajs-3148	2	13	levels	level	NOUN
iajs-3148	2	14	of	of	ADP
iajs-3148	2	15	il-15	il-15	NOUN
iajs-3148	2	16	,	,	PUNCT
iajs-3148	2	17	il-23	il-23	NOUN
iajs-3148	2	18	,	,	PUNCT
iajs-3148	2	19	and	and	CCONJ
iajs-3148	2	20	tnf	tnf	PROPN
iajs-3148	2	21	-	-	PUNCT
iajs-3148	2	22	α	α	PROPN
iajs-3148	2	23	are	be	AUX
iajs-3148	2	24	related	relate	VERB
iajs-3148	2	25	,	,	PUNCT
iajs-3148	2	26	the	the	DET
iajs-3148	2	27	elisa	elisa	NOUN
iajs-3148	2	28	technique	technique	NOUN
iajs-3148	2	29	was	be	AUX
iajs-3148	2	30	used	use	VERB
iajs-3148	2	31	to	to	PART
iajs-3148	2	32	detect	detect	VERB
iajs-3148	2	33	the	the	DET
iajs-3148	2	34	levels	level	NOUN
iajs-3148	2	35	of	of	ADP
iajs-3148	2	36	inflammation	inflammation	NOUN
iajs-3148	2	37	in	in	ADP
iajs-3148	2	38	psoriasis	psoriasis	NOUN
iajs-3148	2	39	patients	patient	NOUN
iajs-3148	2	40	and	and	CCONJ
iajs-3148	2	41	to	to	PART
iajs-3148	2	42	compare	compare	VERB
iajs-3148	2	43	them	they	PRON
iajs-3148	2	44	with	with	ADP
iajs-3148	2	45	healthy	healthy	ADJ
iajs-3148	2	46	individuals	individual	NOUN
iajs-3148	2	47	.	.	PUNCT
iajs-3148	3	1	this	this	DET
iajs-3148	3	2	study	study	NOUN
iajs-3148	3	3	included	include	VERB
iajs-3148	3	4	150	150	NUM
iajs-3148	3	5	samples	sample	NOUN
iajs-3148	3	6	,	,	PUNCT
iajs-3148	3	7	including	include	VERB
iajs-3148	3	8	90	90	NUM
iajs-3148	3	9	patients	patient	NOUN
iajs-3148	3	10	with	with	ADP
iajs-3148	3	11	psoriasis	psoriasis	NOUN
iajs-3148	3	12	and	and	CCONJ
iajs-3148	3	13	60	60	NUM
iajs-3148	3	14	healthy	healthy	ADJ
iajs-3148	3	15	individuals	individual	NOUN
iajs-3148	3	16	,	,	PUNCT
iajs-3148	3	17	and	and	CCONJ
iajs-3148	3	18	the	the	DET
iajs-3148	3	19	study	study	NOUN
iajs-3148	3	20	was	be	AUX
iajs-3148	3	21	conducted	conduct	VERB
iajs-3148	3	22	from	from	ADP
iajs-3148	3	23	november	november	PROPN
iajs-3148	3	24	2021	2021	NUM
iajs-3148	3	25	to	to	ADP
iajs-3148	3	26	april	april	PROPN
iajs-3148	3	27	2022	2022	NUM
iajs-3148	3	28	.	.	PUNCT
iajs-3148	4	1	the	the	DET
iajs-3148	4	2	current	current	ADJ
iajs-3148	4	3	study	study	NOUN
iajs-3148	4	4	revealed	reveal	VERB
iajs-3148	4	5	that	that	SCONJ
iajs-3148	4	6	there	there	PRON
iajs-3148	4	7	was	be	VERB
iajs-3148	4	8	a	a	DET
iajs-3148	4	9	significant	significant	ADJ
iajs-3148	4	10	difference	difference	NOUN
iajs-3148	4	11	in	in	ADP
iajs-3148	4	12	the	the	DET
iajs-3148	4	13	level	level	NOUN
iajs-3148	4	14	of	of	ADP
iajs-3148	4	15	tnf	tnf	PROPN
iajs-3148	4	16	-	-	PUNCT
iajs-3148	4	17	α	α	PROPN
iajs-3148	4	18	in	in	ADP
iajs-3148	4	19	the	the	DET
iajs-3148	4	20	group	group	NOUN
iajs-3148	4	21	of	of	ADP
iajs-3148	4	22	psoriasis	psoriasis	NOUN
iajs-3148	4	23	patients	patient	NOUN
iajs-3148	4	24	compared	compare	VERB
iajs-3148	4	25	to	to	ADP
iajs-3148	4	26	its	its	PRON
iajs-3148	4	27	level	level	NOUN
iajs-3148	4	28	in	in	ADP
iajs-3148	4	29	healthy	healthy	ADJ
iajs-3148	4	30	individuals	individual	NOUN
iajs-3148	4	31	.	.	PUNCT
iajs-3148	5	1	also	also	ADV
iajs-3148	5	2	,	,	PUNCT
iajs-3148	5	3	there	there	PRON
iajs-3148	5	4	was	be	VERB
iajs-3148	5	5	a	a	DET
iajs-3148	5	6	significant	significant	ADJ
iajs-3148	5	7	increase	increase	NOUN
iajs-3148	5	8	in	in	ADP
iajs-3148	5	9	the	the	DET
iajs-3148	5	10	level	level	NOUN
iajs-3148	5	11	of	of	ADP
iajs-3148	5	12	il-23	il-23	NOUN
iajs-3148	5	13	in	in	ADP
iajs-3148	5	14	psoriasis	psoriasis	NOUN
iajs-3148	5	15	patients	patient	NOUN
iajs-3148	5	16	compared	compare	VERB
iajs-3148	5	17	to	to	ADP
iajs-3148	5	18	its	its	PRON
iajs-3148	5	19	level	level	NOUN
iajs-3148	5	20	in	in	ADP
iajs-3148	5	21	the	the	DET
iajs-3148	5	22	healthy	healthy	ADJ
iajs-3148	5	23	individuals	individual	NOUN
iajs-3148	5	24	,	,	PUNCT
iajs-3148	5	25	while	while	SCONJ
iajs-3148	5	26	there	there	PRON
iajs-3148	5	27	was	be	VERB
iajs-3148	5	28	no	no	DET
iajs-3148	5	29	significant	significant	ADJ
iajs-3148	5	30	difference	difference	NOUN
iajs-3148	5	31	in	in	ADP
iajs-3148	5	32	the	the	DET
iajs-3148	5	33	level	level	NOUN
iajs-3148	5	34	of	of	ADP
iajs-3148	5	35	il15	il15	PROPN
iajs-3148	5	36	between	between	ADP
iajs-3148	5	37	the	the	DET
iajs-3148	5	38	two	two	NUM
iajs-3148	5	39	groups	group	NOUN
iajs-3148	5	40	.	.	PUNCT
iajs-3148	6	1	however	however	ADV
iajs-3148	6	2	,	,	PUNCT
iajs-3148	6	3	the	the	DET
iajs-3148	6	4	statistical	statistical	ADJ
iajs-3148	6	5	study	study	NOUN
iajs-3148	6	6	showed	show	VERB
iajs-3148	6	7	a	a	DET
iajs-3148	6	8	positive	positive	ADJ
iajs-3148	6	9	and	and	CCONJ
iajs-3148	6	10	highly	highly	ADV
iajs-3148	6	11	significant	significant	ADJ
iajs-3148	6	12	correlation	correlation	NOUN
iajs-3148	6	13	between	between	ADP
iajs-3148	6	14	il-15	il-15	NOUN
iajs-3148	6	15	and	and	CCONJ
iajs-3148	6	16	il-23	il-23	NOUN
iajs-3148	6	17	levels	level	NOUN
iajs-3148	6	18	in	in	ADP
iajs-3148	6	19	psoriasis	psoriasis	NOUN
iajs-3148	6	20	patients	patient	NOUN
iajs-3148	6	21	,	,	PUNCT
iajs-3148	6	22	as	as	ADV
iajs-3148	6	23	well	well	ADV
iajs-3148	6	24	as	as	ADP
iajs-3148	6	25	the	the	DET
iajs-3148	6	26	same	same	ADJ
iajs-3148	6	27	relationship	relationship	NOUN
iajs-3148	6	28	between	between	ADP
iajs-3148	6	29	il-15	il-15	NOUN
iajs-3148	6	30	and	and	CCONJ
iajs-3148	6	31	tnf	tnf	PROPN
iajs-3148	6	32	-	-	PUNCT
iajs-3148	6	33	α	α	PROPN
iajs-3148	6	34	levels	level	NOUN
iajs-3148	6	35	,	,	PUNCT
iajs-3148	6	36	in	in	ADP
iajs-3148	6	37	addition	addition	NOUN
iajs-3148	6	38	to	to	ADP
iajs-3148	6	39	a	a	DET
iajs-3148	6	40	significant	significant	ADJ
iajs-3148	6	41	correlation	correlation	NOUN
iajs-3148	6	42	between	between	ADP
iajs-3148	6	43	il-23	il-23	NOUN
iajs-3148	6	44	and	and	CCONJ
iajs-3148	6	45	tnf	tnf	PROPN
iajs-3148	6	46	-	-	PUNCT
iajs-3148	6	47	α	α	PROPN
iajs-3148	6	48	levels	level	NOUN
iajs-3148	6	49	in	in	ADP
iajs-3148	6	50	the	the	DET
iajs-3148	6	51	group	group	NOUN
iajs-3148	6	52	of	of	ADP
iajs-3148	6	53	patients	patient	NOUN
iajs-3148	6	54	.	.	PUNCT
iajs-3148	7	1	this	this	PRON
iajs-3148	7	2	shows	show	VERB
iajs-3148	7	3	that	that	SCONJ
iajs-3148	7	4	there	there	PRON
iajs-3148	7	5	is	be	VERB
iajs-3148	7	6	a	a	DET
iajs-3148	7	7	clear	clear	ADJ
iajs-3148	7	8	association	association	NOUN
iajs-3148	7	9	between	between	ADP
iajs-3148	7	10	these	these	DET
iajs-3148	7	11	interleukins	interleukin	NOUN
iajs-3148	7	12	and	and	CCONJ
iajs-3148	7	13	psoriasis	psoriasis	NOUN
iajs-3148	7	14	and	and	CCONJ
iajs-3148	7	15	its	its	PRON
iajs-3148	7	16	association	association	NOUN
iajs-3148	7	17	with	with	ADP
iajs-3148	7	18	the	the	DET
iajs-3148	7	19	inflammatory	inflammatory	ADJ
iajs-3148	7	20	status	status	NOUN
iajs-3148	7	21	of	of	ADP
iajs-3148	7	22	psoriasis	psoriasis	NOUN
iajs-3148	7	23	patients	patient	NOUN
iajs-3148	7	24	,	,	PUNCT
iajs-3148	7	25	although	although	SCONJ
iajs-3148	7	26	there	there	PRON
iajs-3148	7	27	was	be	VERB
iajs-3148	7	28	no	no	DET
iajs-3148	7	29	increase	increase	NOUN
iajs-3148	7	30	in	in	ADP
iajs-3148	7	31	the	the	DET
iajs-3148	7	32	level	level	NOUN
iajs-3148	7	33	of	of	ADP
iajs-3148	7	34	interleukin-15	interleukin-15	PROPN
iajs-3148	7	35	,	,	PUNCT
iajs-3148	7	36	the	the	DET
iajs-3148	7	37	association	association	NOUN
iajs-3148	7	38	of	of	ADP
iajs-3148	7	39	interleukin-15	interleukin-15	PROPN
iajs-3148	7	40	with	with	ADP
iajs-3148	7	41	other	other	ADJ
iajs-3148	7	42	inflammatory	inflammatory	ADJ
iajs-3148	7	43	indicators	indicator	NOUN
iajs-3148	7	44	proves	prove	VERB
iajs-3148	7	45	its	its	PRON
iajs-3148	7	46	involvement	involvement	NOUN
iajs-3148	7	47	in	in	ADP
iajs-3148	7	48	psoriasis	psoriasis	NOUN
iajs-3148	7	49	and	and	CCONJ
iajs-3148	7	50	an	an	DET
iajs-3148	7	51	indirect	indirect	ADJ
iajs-3148	7	52	effect	effect	NOUN
iajs-3148	7	53	on	on	ADP
iajs-3148	7	54	the	the	DET
iajs-3148	7	55	inflammatory	inflammatory	ADJ
iajs-3148	7	56	state	state	NOUN
iajs-3148	7	57	of	of	ADP
iajs-3148	7	58	psoriasis	psoriasis	NOUN
iajs-3148	7	59	.	.	PUNCT
iajs-3148	8	1	keywords	keyword	NOUN
iajs-3148	8	2	:	:	PUNCT
iajs-3148	8	3	psoriasis	psoriasis	NOUN
iajs-3148	8	4	,	,	PUNCT
iajs-3148	8	5	il-15	il-15	ADV
iajs-3148	8	6	,	,	PUNCT
iajs-3148	8	7	il-23	il-23	NOUN
iajs-3148	8	8	,	,	PUNCT
iajs-3148	8	9	tnf	tnf	PROPN
iajs-3148	8	10	-	-	PUNCT
iajs-3148	8	11	α	α	PROPN
iajs-3148	8	12	.	.	NOUN
iajs-3148	8	13	1	1	NUM
iajs-3148	8	14	.	.	X
iajs-3148	8	15	introduction	introduction	NOUN
iajs-3148	8	16	psoriasis	psoriasis	NOUN
iajs-3148	8	17	is	be	AUX
iajs-3148	8	18	a	a	DET
iajs-3148	8	19	widespread	widespread	ADJ
iajs-3148	8	20	,	,	PUNCT
iajs-3148	8	21	chronic	chronic	ADJ
iajs-3148	8	22	papulosquamous	papulosquamous	ADJ
iajs-3148	8	23	skin	skin	NOUN
iajs-3148	8	24	disease	disease	NOUN
iajs-3148	8	25	that	that	PRON
iajs-3148	8	26	affects	affect	VERB
iajs-3148	8	27	people	people	NOUN
iajs-3148	8	28	of	of	ADP
iajs-3148	8	29	all	all	DET
iajs-3148	8	30	ages	age	NOUN
iajs-3148	8	31	and	and	CCONJ
iajs-3148	8	32	causes	cause	VERB
iajs-3148	8	33	significant	significant	ADJ
iajs-3148	8	34	harm	harm	NOUN
iajs-3148	8	35	to	to	ADP
iajs-3148	8	36	individuals	individual	NOUN
iajs-3148	8	37	and	and	CCONJ
iajs-3148	8	38	society	society	NOUN
iajs-3148	9	1	[	[	X
iajs-3148	9	2	1	1	NUM
iajs-3148	9	3	]	]	PUNCT
iajs-3148	9	4	.	.	PUNCT
iajs-3148	10	1	it	it	PRON
iajs-3148	10	2	is	be	AUX
iajs-3148	10	3	one	one	NUM
iajs-3148	10	4	of	of	ADP
iajs-3148	10	5	the	the	DET
iajs-3148	10	6	chronic	chronic	ADJ
iajs-3148	10	7	autoimmune	autoimmune	NOUN
iajs-3148	10	8	diseases	disease	NOUN
iajs-3148	10	9	affecting	affect	VERB
iajs-3148	10	10	the	the	DET
iajs-3148	10	11	skin	skin	NOUN
iajs-3148	10	12	of	of	ADP
iajs-3148	10	13	0.6	0.6	NUM
iajs-3148	10	14	-	-	SYM
iajs-3148	10	15	4.8	4.8	NUM
iajs-3148	10	16	%	%	NOUN
iajs-3148	10	17	of	of	ADP
iajs-3148	10	18	the	the	DET
iajs-3148	10	19	world	world	NOUN
iajs-3148	10	20	's	's	PART
iajs-3148	10	21	population	population	NOUN
iajs-3148	10	22	[	[	X
iajs-3148	10	23	2,3	2,3	NUM
iajs-3148	10	24	]	]	X
iajs-3148	10	25	nearly	nearly	ADV
iajs-3148	10	26	100	100	NUM
iajs-3148	10	27	million	million	NUM
iajs-3148	10	28	people	people	NOUN
iajs-3148	10	29	worldwide	worldwide	ADV
iajs-3148	10	30	have	have	VERB
iajs-3148	10	31	psoriasis	psoriasis	NOUN
iajs-3148	10	32	[	[	X
iajs-3148	10	33	4	4	NUM
iajs-3148	10	34	]	]	PUNCT
iajs-3148	10	35	.	.	PUNCT
iajs-3148	11	1	the	the	DET
iajs-3148	11	2	disease	disease	NOUN
iajs-3148	11	3	often	often	ADV
iajs-3148	11	4	appears	appear	VERB
iajs-3148	11	5	during	during	ADP
iajs-3148	11	6	the	the	DET
iajs-3148	11	7	period	period	NOUN
iajs-3148	11	8	of	of	ADP
iajs-3148	11	9	the	the	DET
iajs-3148	11	10	second	second	ADJ
iajs-3148	11	11	and	and	CCONJ
iajs-3148	11	12	fourth	fourth	ADJ
iajs-3148	11	13	decades	decade	NOUN
iajs-3148	11	14	of	of	ADP
iajs-3148	11	15	life	life	NOUN
iajs-3148	11	16	in	in	ADP
iajs-3148	11	17	patients	patient	NOUN
iajs-3148	11	18	with	with	ADP
iajs-3148	11	19	psoriasis	psoriasis	NOUN
iajs-3148	11	20	[	[	X
iajs-3148	11	21	5	5	NUM
iajs-3148	11	22	]	]	X
iajs-3148	11	23	psoriasis	psoriasis	NOUN
iajs-3148	11	24	has	have	AUX
iajs-3148	11	25	been	be	AUX
iajs-3148	11	26	linked	link	VERB
iajs-3148	11	27	to	to	ADP
iajs-3148	11	28	a	a	DET
iajs-3148	11	29	variety	variety	NOUN
iajs-3148	11	30	of	of	ADP
iajs-3148	11	31	behavioral	behavioral	ADJ
iajs-3148	11	32	doi.org/10.30526/37.1.3148	doi.org/10.30526/37.1.3148	NOUN
iajs-3148	11	33	received	receive	VERB
iajs-3148	11	34	17	17	NUM
iajs-3148	11	35	december	december	PROPN
iajs-3148	11	36	2022	2022	NUM
iajs-3148	11	37	,	,	PUNCT
iajs-3148	11	38	received	receive	VERB
iajs-3148	11	39	14	14	NUM
iajs-3148	11	40	march	march	NOUN
iajs-3148	11	41	2023	2023	NUM
iajs-3148	11	42	,	,	PUNCT
iajs-3148	11	43	accepted	accept	VERB
iajs-3148	11	44	5	5	NUM
iajs-3148	11	45	april	april	PROPN
iajs-3148	11	46	2023	2023	NUM
iajs-3148	11	47	,	,	PUNCT
iajs-3148	11	48	published	publish	VERB
iajs-3148	11	49	in	in	ADP
iajs-3148	11	50	20	20	NUM
iajs-3148	11	51	january	january	NOUN
iajs-3148	11	52	2024	2024	NUM
iajs-3148	11	53	a	a	DET
iajs-3148	11	54	study	study	NOUN
iajs-3148	11	55	correlation	correlation	NOUN
iajs-3148	11	56	between	between	ADP
iajs-3148	11	57	levels	level	NOUN
iajs-3148	11	58	il-15	il-15	ADV
iajs-3148	11	59	,	,	PUNCT
iajs-3148	11	60	il-23	il-23	NOUN
iajs-3148	11	61	and	and	CCONJ
iajs-3148	11	62	tnf	tnf	PROPN
iajs-3148	11	63	-	-	PUNCT
iajs-3148	11	64	α	α	PROPN
iajs-3148	11	65	in	in	ADP
iajs-3148	11	66	a	a	DET
iajs-3148	11	67	sample	sample	NOUN
iajs-3148	11	68	of	of	ADP
iajs-3148	11	69	iraqi	iraqi	ADJ
iajs-3148	11	70	psoriasis	psoriasis	NOUN
iajs-3148	11	71	patients	patient	NOUN
iajs-3148	11	72	1,2biotechnology	1,2biotechnology	PROPN
iajs-3148	11	73	department	department	NOUN
iajs-3148	11	74	,	,	PUNCT
iajs-3148	11	75	college	college	NOUN
iajs-3148	11	76	of	of	ADP
iajs-3148	11	77	science	science	NOUN
iajs-3148	11	78	,	,	PUNCT
iajs-3148	11	79	university	university	NOUN
iajs-3148	11	80	of	of	ADP
iajs-3148	11	81	baghdad	baghdad	PROPN
iajs-3148	11	82	,	,	PUNCT
iajs-3148	11	83	baghdad	baghdad	PROPN
iajs-3148	11	84	,	,	PUNCT
iajs-3148	11	85	iraq	iraq	PROPN
iajs-3148	11	86	.	.	PUNCT
iajs-3148	12	1	ihjpas	ihjpas	PROPN
iajs-3148	12	2	.	.	PUNCT
iajs-3148	13	1	37	37	NUM
iajs-3148	13	2	(	(	PUNCT
iajs-3148	13	3	1	1	NUM
iajs-3148	13	4	)	)	PUNCT
iajs-3148	13	5	2024	2024	NUM
iajs-3148	13	6	ibn	ibn	PROPN
iajs-3148	13	7	al	al	PROPN
iajs-3148	13	8	-	-	PUNCT
iajs-3148	13	9	haitham	haitham	PROPN
iajs-3148	13	10	journal	journal	PROPN
iajs-3148	13	11	for	for	ADP
iajs-3148	13	12	pure	pure	ADJ
iajs-3148	13	13	and	and	CCONJ
iajs-3148	13	14	applied	applied	ADJ
iajs-3148	13	15	sciences	sciences	PROPN
iajs-3148	13	16	journal	journal	PROPN
iajs-3148	13	17	homepage	homepage	NOUN
iajs-3148	13	18	:	:	PUNCT
iajs-3148	13	19	jih.uobaghdad.edu.iq	jih.uobaghdad.edu.iq	NOUN
iajs-3148	13	20	pissn	pissn	ADJ
iajs-3148	13	21	:	:	PUNCT
iajs-3148	13	22	1609	1609	NUM
iajs-3148	13	23	-	-	SYM
iajs-3148	13	24	4042	4042	NUM
iajs-3148	13	25	,	,	PUNCT
iajs-3148	13	26	eissn	eissn	NOUN
iajs-3148	13	27	:	:	PUNCT
iajs-3148	13	28	2521	2521	NUM
iajs-3148	13	29	-	-	SYM
iajs-3148	13	30	3407	3407	NUM
iajs-3148	13	31	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	NOUN
iajs-3148	13	32	mailto:samaraammar82@gmail.com	mailto:samaraammar82@gmail.com	X
iajs-3148	13	33	https://orcid.org/0000-0000-0000-0000	https://orcid.org/0000-0000-0000-0000	PROPN
iajs-3148	13	34	mailto:samaraammar82@gmail.com	mailto:samaraammar82@gmail.com	PROPN
iajs-3148	13	35	https://orcid.org/0000-0002-2605-4133	https://orcid.org/0000-0002-2605-4133	PROPN
iajs-3148	13	36	mailto:shaima.ibraheem@sc.uobaghdad.edu.iq	mailto:shaima.ibraheem@sc.uobaghdad.edu.iq	NOUN
iajs-3148	13	37	https://jih.uobaghdad.edu.iq/index.php/j/index#1609-4042	https://jih.uobaghdad.edu.iq/index.php/j/index#1609-4042	PROPN
iajs-3148	13	38	https://jih.uobaghdad.edu.iq/index.php/j/index#2521-3407	https://jih.uobaghdad.edu.iq/index.php/j/index#2521-3407	NOUN
iajs-3148	13	39	ihjpas	ihjpa	NOUN
iajs-3148	13	40	.	.	PUNCT
iajs-3148	14	1	37	37	NUM
iajs-3148	14	2	(	(	PUNCT
iajs-3148	14	3	1	1	NUM
iajs-3148	14	4	)	)	PUNCT
iajs-3148	14	5	2024	2024	NUM
iajs-3148	14	6	76	76	NUM
iajs-3148	14	7	and	and	CCONJ
iajs-3148	14	8	systemic	systemic	ADJ
iajs-3148	14	9	issues	issue	NOUN
iajs-3148	14	10	,	,	PUNCT
iajs-3148	14	11	including	include	VERB
iajs-3148	14	12	psoriatic	psoriatic	ADJ
iajs-3148	14	13	arthritis	arthritis	NOUN
iajs-3148	14	14	,	,	PUNCT
iajs-3148	14	15	anxiety	anxiety	NOUN
iajs-3148	14	16	,	,	PUNCT
iajs-3148	14	17	depression	depression	NOUN
iajs-3148	14	18	,	,	PUNCT
iajs-3148	14	19	obesity	obesity	NOUN
iajs-3148	14	20	,	,	PUNCT
iajs-3148	14	21	hypertension	hypertension	NOUN
iajs-3148	14	22	,	,	PUNCT
iajs-3148	14	23	diabetes	diabetes	NOUN
iajs-3148	14	24	mellitus	mellitus	NOUN
iajs-3148	14	25	,	,	PUNCT
iajs-3148	14	26	hyperlipidemia	hyperlipidemia	NOUN
iajs-3148	14	27	,	,	PUNCT
iajs-3148	14	28	metabolic	metabolic	NOUN
iajs-3148	14	29	syndrome	syndrome	NOUN
iajs-3148	14	30	,	,	PUNCT
iajs-3148	14	31	smoking	smoking	NOUN
iajs-3148	14	32	,	,	PUNCT
iajs-3148	14	33	cardiovascular	cardiovascular	ADJ
iajs-3148	14	34	disease	disease	NOUN
iajs-3148	14	35	,	,	PUNCT
iajs-3148	14	36	alcoholism	alcoholism	NOUN
iajs-3148	14	37	,	,	PUNCT
iajs-3148	14	38	crohn	crohn	PROPN
iajs-3148	14	39	's	's	PART
iajs-3148	14	40	disease	disease	NOUN
iajs-3148	14	41	,	,	PUNCT
iajs-3148	14	42	lymphoma	lymphoma	NOUN
iajs-3148	14	43	,	,	PUNCT
iajs-3148	14	44	and	and	CCONJ
iajs-3148	14	45	multiple	multiple	ADJ
iajs-3148	14	46	sclerosis	sclerosis	NOUN
iajs-3148	14	47	[	[	X
iajs-3148	14	48	6	6	NUM
iajs-3148	14	49	]	]	PUNCT
iajs-3148	14	50	.	.	PUNCT
iajs-3148	15	1	most	most	ADJ
iajs-3148	15	2	recent	recent	ADJ
iajs-3148	15	3	reports	report	NOUN
iajs-3148	15	4	and	and	CCONJ
iajs-3148	15	5	research	research	NOUN
iajs-3148	15	6	indicate	indicate	VERB
iajs-3148	15	7	that	that	SCONJ
iajs-3148	15	8	psoriasis	psoriasis	NOUN
iajs-3148	15	9	is	be	AUX
iajs-3148	15	10	an	an	DET
iajs-3148	15	11	abnormal	abnormal	ADJ
iajs-3148	15	12	proliferation	proliferation	NOUN
iajs-3148	15	13	of	of	ADP
iajs-3148	15	14	keratinocytes	keratinocyte	NOUN
iajs-3148	15	15	mediated	mediate	VERB
iajs-3148	15	16	by	by	ADP
iajs-3148	15	17	t	t	PROPN
iajs-3148	15	18	lymphocytes	lymphocyte	VERB
iajs-3148	15	19	[	[	X
iajs-3148	15	20	7	7	NUM
iajs-3148	15	21	]	]	PUNCT
iajs-3148	15	22	.	.	PUNCT
iajs-3148	16	1	il-23	il-23	NOUN
iajs-3148	16	2	is	be	AUX
iajs-3148	16	3	primarily	primarily	ADV
iajs-3148	16	4	produced	produce	VERB
iajs-3148	16	5	by	by	ADP
iajs-3148	16	6	antigen	antigen	NOUN
iajs-3148	16	7	-	-	PUNCT
iajs-3148	16	8	presenting	present	VERB
iajs-3148	16	9	cells	cell	NOUN
iajs-3148	16	10	(	(	PUNCT
iajs-3148	16	11	apc	apc	PROPN
iajs-3148	16	12	)	)	PUNCT
iajs-3148	16	13	,	,	PUNCT
iajs-3148	16	14	and	and	CCONJ
iajs-3148	16	15	its	its	PRON
iajs-3148	16	16	receptor	receptor	NOUN
iajs-3148	16	17	is	be	AUX
iajs-3148	16	18	expressed	express	VERB
iajs-3148	16	19	by	by	ADP
iajs-3148	16	20	a	a	DET
iajs-3148	16	21	wide	wide	ADJ
iajs-3148	16	22	range	range	NOUN
iajs-3148	16	23	of	of	ADP
iajs-3148	16	24	innate	innate	ADJ
iajs-3148	16	25	and	and	CCONJ
iajs-3148	16	26	adaptive	adaptive	ADJ
iajs-3148	16	27	immune	immune	ADJ
iajs-3148	16	28	cells	cell	NOUN
iajs-3148	16	29	to	to	PART
iajs-3148	16	30	enhance	enhance	VERB
iajs-3148	16	31	their	their	PRON
iajs-3148	16	32	functions	function	NOUN
iajs-3148	16	33	[	[	X
iajs-3148	16	34	8	8	NUM
iajs-3148	16	35	]	]	PUNCT
iajs-3148	16	36	.	.	PUNCT
iajs-3148	17	1	external	external	ADJ
iajs-3148	17	2	events	event	NOUN
iajs-3148	17	3	like	like	ADP
iajs-3148	17	4	trauma	trauma	NOUN
iajs-3148	17	5	or	or	CCONJ
iajs-3148	17	6	infection	infection	NOUN
iajs-3148	17	7	cause	cause	VERB
iajs-3148	17	8	host	host	NOUN
iajs-3148	17	9	cell	cell	NOUN
iajs-3148	17	10	-	-	PUNCT
iajs-3148	17	11	derived	derive	VERB
iajs-3148	17	12	nucleotides	nucleotide	NOUN
iajs-3148	17	13	to	to	PART
iajs-3148	17	14	form	form	VERB
iajs-3148	17	15	a	a	DET
iajs-3148	17	16	compound	compound	NOUN
iajs-3148	17	17	with	with	ADP
iajs-3148	17	18	antimicrobial	antimicrobial	ADJ
iajs-3148	17	19	peptides	peptide	NOUN
iajs-3148	17	20	synthesized	synthesize	VERB
iajs-3148	17	21	by	by	ADP
iajs-3148	17	22	keratinocytes	keratinocyte	NOUN
iajs-3148	17	23	.	.	PUNCT
iajs-3148	18	1	the	the	DET
iajs-3148	18	2	plasmacyte	plasmacyte	NOUN
iajs-3148	18	3	dendritic	dendritic	ADJ
iajs-3148	18	4	cell	cell	NOUN
iajs-3148	18	5	produces	produce	VERB
iajs-3148	18	6	type	type	NOUN
iajs-3148	18	7	i	i	PRON
iajs-3148	18	8	interferons	interferon	NOUN
iajs-3148	18	9	,	,	PUNCT
iajs-3148	18	10	which	which	PRON
iajs-3148	18	11	stimulate	stimulate	VERB
iajs-3148	18	12	myeloid	myeloid	ADJ
iajs-3148	18	13	dendritic	dendritic	ADJ
iajs-3148	18	14	cells	cell	NOUN
iajs-3148	18	15	to	to	PART
iajs-3148	18	16	secrete	secrete	VERB
iajs-3148	18	17	il-23	il-23	NOUN
iajs-3148	18	18	and	and	CCONJ
iajs-3148	18	19	tnf	tnf	PROPN
iajs-3148	18	20	-	-	PUNCT
iajs-3148	18	21	α	α	PROPN
iajs-3148	19	1	[	[	X
iajs-3148	19	2	9	9	NUM
iajs-3148	19	3	]	]	PUNCT
iajs-3148	19	4	.	.	PUNCT
iajs-3148	20	1	according	accord	VERB
iajs-3148	20	2	to	to	ADP
iajs-3148	20	3	recent	recent	ADJ
iajs-3148	20	4	research	research	NOUN
iajs-3148	20	5	,	,	PUNCT
iajs-3148	20	6	activated	activate	VERB
iajs-3148	20	7	t	t	NOUN
iajs-3148	20	8	cells	cell	NOUN
iajs-3148	20	9	and	and	CCONJ
iajs-3148	20	10	dcs	dcs	PROPN
iajs-3148	20	11	are	be	AUX
iajs-3148	20	12	essential	essential	ADJ
iajs-3148	20	13	to	to	ADP
iajs-3148	20	14	the	the	DET
iajs-3148	20	15	pathogenesis	pathogenesis	NOUN
iajs-3148	20	16	of	of	ADP
iajs-3148	20	17	psoriasis	psoriasis	NOUN
iajs-3148	20	18	,	,	PUNCT
iajs-3148	20	19	psoriasis	psoriasis	NOUN
iajs-3148	20	20	is	be	AUX
iajs-3148	20	21	significantly	significantly	ADV
iajs-3148	20	22	brought	bring	VERB
iajs-3148	20	23	on	on	ADP
iajs-3148	20	24	by	by	ADP
iajs-3148	20	25	the	the	DET
iajs-3148	20	26	il-23	il-23	NOUN
iajs-3148	20	27	production	production	NOUN
iajs-3148	20	28	pathway	pathway	NOUN
iajs-3148	20	29	,	,	PUNCT
iajs-3148	20	30	which	which	PRON
iajs-3148	20	31	shows	show	VERB
iajs-3148	20	32	that	that	SCONJ
iajs-3148	20	33	keratinocytes	keratinocyte	NOUN
iajs-3148	20	34	can	can	AUX
iajs-3148	20	35	create	create	VERB
iajs-3148	20	36	il-23[10	il-23[10	ADV
iajs-3148	20	37	]	]	PUNCT
iajs-3148	20	38	.	.	PUNCT
iajs-3148	21	1	il-23	il-23	NOUN
iajs-3148	21	2	may	may	AUX
iajs-3148	21	3	therefore	therefore	ADV
iajs-3148	21	4	play	play	VERB
iajs-3148	21	5	a	a	DET
iajs-3148	21	6	major	major	ADJ
iajs-3148	21	7	role	role	NOUN
iajs-3148	21	8	in	in	ADP
iajs-3148	21	9	type	type	NOUN
iajs-3148	21	10	1	1	NUM
iajs-3148	21	11	human	human	ADJ
iajs-3148	21	12	autoimmune	autoimmune	NOUN
iajs-3148	21	13	and	and	CCONJ
iajs-3148	21	14	inflammatory	inflammatory	ADJ
iajs-3148	21	15	disorders	disorder	NOUN
iajs-3148	21	16	[	[	X
iajs-3148	21	17	11	11	NUM
iajs-3148	21	18	]	]	PUNCT
iajs-3148	21	19	.	.	PUNCT
iajs-3148	22	1	interleukin-15	interleukin-15	PROPN
iajs-3148	22	2	is	be	AUX
iajs-3148	22	3	a	a	DET
iajs-3148	22	4	pleiotropic	pleiotropic	ADJ
iajs-3148	22	5	cytokine	cytokine	NOUN
iajs-3148	22	6	of	of	ADP
iajs-3148	22	7	the	the	DET
iajs-3148	22	8	4	4	NUM
iajs-3148	22	9	-	-	PUNCT
iajs-3148	22	10	α	α	PRON
iajs-3148	22	11	-	-	PUNCT
iajs-3148	22	12	helix	helix	ADJ
iajs-3148	22	13	bundle	bundle	NOUN
iajs-3148	22	14	cytokine	cytokine	NOUN
iajs-3148	22	15	family	family	NOUN
iajs-3148	22	16	that	that	PRON
iajs-3148	22	17	includes	include	VERB
iajs-3148	22	18	not	not	PART
iajs-3148	22	19	only	only	ADV
iajs-3148	22	20	cytokines	cytokine	NOUN
iajs-3148	22	21	such	such	ADJ
iajs-3148	22	22	as	as	ADP
iajs-3148	22	23	il-2	il-2	NUM
iajs-3148	22	24	,	,	PUNCT
iajs-3148	22	25	il-3	il-3	PRON
iajs-3148	22	26	,	,	PUNCT
iajs-3148	22	27	il-4	il-4	NOUN
iajs-3148	22	28	,	,	PUNCT
iajs-3148	22	29	il-6	il-6	NUM
iajs-3148	22	30	and	and	CCONJ
iajs-3148	22	31	il-21	il-21	NOUN
iajs-3148	22	32	,	,	PUNCT
iajs-3148	22	33	but	but	CCONJ
iajs-3148	22	34	also	also	ADV
iajs-3148	22	35	growth	growth	NOUN
iajs-3148	22	36	factors	factor	NOUN
iajs-3148	22	37	like	like	ADP
iajs-3148	22	38	granulocyte	granulocyte	ADJ
iajs-3148	22	39	-	-	PUNCT
iajs-3148	22	40	macrophage	macrophage	ADJ
iajs-3148	22	41	colony	colony	NOUN
iajs-3148	22	42	-	-	PUNCT
iajs-3148	22	43	stimulating	stimulate	VERB
iajs-3148	22	44	factor	factor	NOUN
iajs-3148	22	45	(	(	PUNCT
iajs-3148	22	46	gm	gm	PROPN
iajs-3148	22	47	-	-	PUNCT
iajs-3148	22	48	csf	csf	NOUN
iajs-3148	22	49	)	)	PUNCT
iajs-3148	22	50	,	,	PUNCT
iajs-3148	22	51	granulocyte	granulocyte	ADJ
iajs-3148	22	52	colony	colony	NOUN
iajs-3148	22	53	-	-	PUNCT
iajs-3148	22	54	stimulating	stimulate	VERB
iajs-3148	22	55	factor	factor	NOUN
iajs-3148	22	56	(	(	PUNCT
iajs-3148	22	57	g	g	NOUN
iajs-3148	22	58	-	-	PUNCT
iajs-3148	22	59	csf	csf	NOUN
iajs-3148	22	60	)	)	PUNCT
iajs-3148	22	61	,	,	PUNCT
iajs-3148	22	62	erythropoietin	erythropoietin	ADJ
iajs-3148	22	63	and	and	CCONJ
iajs-3148	22	64	classical	classical	ADJ
iajs-3148	22	65	hormones	hormone	NOUN
iajs-3148	22	66	,	,	PUNCT
iajs-3148	22	67	including	include	VERB
iajs-3148	22	68	human	human	ADJ
iajs-3148	22	69	growth	growth	NOUN
iajs-3148	22	70	hormone	hormone	NOUN
iajs-3148	22	71	and	and	CCONJ
iajs-3148	22	72	prolactin	prolactin	NOUN
iajs-3148	22	73	,	,	PUNCT
iajs-3148	22	74	[	[	X
iajs-3148	22	75	12].interleukin-15	12].interleukin-15	NUM
iajs-3148	22	76	blood	blood	NOUN
iajs-3148	22	77	levels	level	NOUN
iajs-3148	22	78	which	which	PRON
iajs-3148	22	79	are	be	AUX
iajs-3148	22	80	essential	essential	ADJ
iajs-3148	22	81	for	for	ADP
iajs-3148	22	82	regulating	regulate	VERB
iajs-3148	22	83	nk	nk	PROPN
iajs-3148	22	84	cell	cell	NOUN
iajs-3148	22	85	activity	activity	NOUN
iajs-3148	22	86	were	be	AUX
iajs-3148	22	87	also	also	ADV
iajs-3148	22	88	discovered	discover	VERB
iajs-3148	22	89	to	to	PART
iajs-3148	22	90	be	be	AUX
iajs-3148	22	91	similar	similar	ADJ
iajs-3148	22	92	in	in	ADP
iajs-3148	22	93	both	both	DET
iajs-3148	22	94	psoriasis	psoriasis	NOUN
iajs-3148	22	95	patients	patient	NOUN
iajs-3148	22	96	and	and	CCONJ
iajs-3148	22	97	healthy	healthy	ADJ
iajs-3148	22	98	controls[13	controls[13	PROPN
iajs-3148	22	99	]	]	PUNCT
iajs-3148	22	100	.	.	PUNCT
iajs-3148	23	1	tnf	tnf	PROPN
iajs-3148	23	2	-	-	PUNCT
iajs-3148	23	3	α	α	PROPN
iajs-3148	23	4	is	be	AUX
iajs-3148	23	5	one	one	NUM
iajs-3148	23	6	of	of	ADP
iajs-3148	23	7	the	the	DET
iajs-3148	23	8	most	most	ADV
iajs-3148	23	9	important	important	ADJ
iajs-3148	23	10	cytokines	cytokine	NOUN
iajs-3148	23	11	involved	involve	VERB
iajs-3148	23	12	in	in	ADP
iajs-3148	23	13	the	the	DET
iajs-3148	23	14	inflammation	inflammation	NOUN
iajs-3148	23	15	that	that	PRON
iajs-3148	23	16	causes	cause	VERB
iajs-3148	23	17	psoriasis	psoriasis	NOUN
iajs-3148	23	18	,	,	PUNCT
iajs-3148	23	19	and	and	CCONJ
iajs-3148	23	20	high	high	ADJ
iajs-3148	23	21	levels	level	NOUN
iajs-3148	23	22	of	of	ADP
iajs-3148	23	23	tnf	tnf	PROPN
iajs-3148	23	24	have	have	AUX
iajs-3148	23	25	been	be	AUX
iajs-3148	23	26	found	find	VERB
iajs-3148	23	27	in	in	ADP
iajs-3148	23	28	the	the	DET
iajs-3148	23	29	blood	blood	NOUN
iajs-3148	23	30	of	of	ADP
iajs-3148	23	31	psoriasis	psoriasis	NOUN
iajs-3148	23	32	patients	patient	NOUN
iajs-3148	23	33	in	in	ADP
iajs-3148	23	34	recent	recent	ADJ
iajs-3148	23	35	years	year	NOUN
iajs-3148	23	36	.	.	PUNCT
iajs-3148	24	1	tnf	tnf	PROPN
iajs-3148	24	2	is	be	AUX
iajs-3148	24	3	produced	produce	VERB
iajs-3148	24	4	during	during	ADP
iajs-3148	24	5	the	the	DET
iajs-3148	24	6	inflammatory	inflammatory	ADJ
iajs-3148	24	7	response	response	NOUN
iajs-3148	24	8	that	that	PRON
iajs-3148	24	9	causes	cause	VERB
iajs-3148	24	10	psoriasis	psoriasis	NOUN
iajs-3148	24	11	by	by	ADP
iajs-3148	24	12	the	the	DET
iajs-3148	24	13	dysfunction	dysfunction	NOUN
iajs-3148	24	14	of	of	ADP
iajs-3148	24	15	immune	immune	ADJ
iajs-3148	24	16	cells	cell	NOUN
iajs-3148	24	17	such	such	ADJ
iajs-3148	24	18	as	as	ADP
iajs-3148	24	19	t	t	PROPN
iajs-3148	24	20	cells	cell	NOUN
iajs-3148	24	21	,	,	PUNCT
iajs-3148	24	22	macrophages	macrophage	NOUN
iajs-3148	24	23	,	,	PUNCT
iajs-3148	24	24	activated	activated	ADJ
iajs-3148	24	25	keratinocytes	keratinocyte	NOUN
iajs-3148	24	26	,	,	PUNCT
iajs-3148	24	27	and	and	CCONJ
iajs-3148	24	28	dendritic	dendritic	ADJ
iajs-3148	24	29	cells	cell	NOUN
iajs-3148	24	30	.	.	PUNCT
iajs-3148	25	1	it	it	PRON
iajs-3148	25	2	is	be	AUX
iajs-3148	25	3	also	also	ADV
iajs-3148	25	4	produced	produce	VERB
iajs-3148	25	5	directly	directly	ADV
iajs-3148	25	6	from	from	ADP
iajs-3148	25	7	activated	activate	VERB
iajs-3148	25	8	macrophages	macrophage	NOUN
iajs-3148	25	9	as	as	ADV
iajs-3148	25	10	well	well	ADV
iajs-3148	25	11	as	as	ADP
iajs-3148	25	12	from	from	ADP
iajs-3148	25	13	other	other	ADJ
iajs-3148	25	14	cells	cell	NOUN
iajs-3148	25	15	.	.	PUNCT
iajs-3148	26	1	as	as	ADP
iajs-3148	26	2	for	for	ADP
iajs-3148	26	3	irregular	irregular	ADJ
iajs-3148	26	4	production	production	NOUN
iajs-3148	26	5	,	,	PUNCT
iajs-3148	26	6	it	it	PRON
iajs-3148	26	7	is	be	AUX
iajs-3148	26	8	the	the	DET
iajs-3148	26	9	cause	cause	NOUN
iajs-3148	26	10	of	of	ADP
iajs-3148	26	11	different	different	ADJ
iajs-3148	26	12	types	type	NOUN
iajs-3148	26	13	of	of	ADP
iajs-3148	26	14	diseases	disease	NOUN
iajs-3148	26	15	[	[	X
iajs-3148	26	16	14	14	NUM
iajs-3148	26	17	,	,	PUNCT
iajs-3148	26	18	15	15	NUM
iajs-3148	26	19	]	]	PUNCT
iajs-3148	26	20	.	.	PUNCT
iajs-3148	27	1	in	in	ADP
iajs-3148	27	2	addition	addition	NOUN
iajs-3148	27	3	,	,	PUNCT
iajs-3148	27	4	all	all	PRON
iajs-3148	27	5	of	of	ADP
iajs-3148	27	6	these	these	DET
iajs-3148	27	7	cytokines	cytokine	NOUN
iajs-3148	27	8	stimulate	stimulate	VERB
iajs-3148	27	9	psoriasis	psoriasis	NOUN
iajs-3148	27	10	,	,	PUNCT
iajs-3148	27	11	so	so	SCONJ
iajs-3148	27	12	they	they	PRON
iajs-3148	27	13	were	be	AUX
iajs-3148	27	14	selected	select	VERB
iajs-3148	27	15	in	in	ADP
iajs-3148	27	16	this	this	DET
iajs-3148	27	17	study	study	NOUN
iajs-3148	27	18	[	[	X
iajs-3148	27	19	16	16	NUM
iajs-3148	27	20	,	,	PUNCT
iajs-3148	27	21	17	17	NUM
iajs-3148	27	22	]	]	PUNCT
iajs-3148	27	23	.	.	PUNCT
iajs-3148	28	1	several	several	ADJ
iajs-3148	28	2	reports	report	NOUN
iajs-3148	28	3	and	and	CCONJ
iajs-3148	28	4	research	research	NOUN
iajs-3148	28	5	have	have	AUX
iajs-3148	28	6	also	also	ADV
iajs-3148	28	7	shown	show	VERB
iajs-3148	28	8	that	that	SCONJ
iajs-3148	28	9	the	the	DET
iajs-3148	28	10	inflammatory	inflammatory	ADJ
iajs-3148	28	11	response	response	NOUN
iajs-3148	28	12	by	by	ADP
iajs-3148	28	13	tumor	tumor	NOUN
iajs-3148	28	14	necrosis	necrosis	NOUN
iajs-3148	28	15	factor	factor	NOUN
iajs-3148	28	16	and	and	CCONJ
iajs-3148	28	17	other	other	ADJ
iajs-3148	28	18	cytokines	cytokine	NOUN
iajs-3148	28	19	il-23	il-23	NOUN
iajs-3148	28	20	that	that	PRON
iajs-3148	28	21	leads	lead	VERB
iajs-3148	28	22	to	to	ADP
iajs-3148	28	23	the	the	DET
iajs-3148	28	24	stimulation	stimulation	NOUN
iajs-3148	28	25	of	of	ADP
iajs-3148	28	26	angiogenesis	angiogenesis	NOUN
iajs-3148	28	27	and	and	CCONJ
iajs-3148	28	28	proliferation	proliferation	NOUN
iajs-3148	28	29	of	of	ADP
iajs-3148	28	30	keratinocytes	keratinocyte	NOUN
iajs-3148	28	31	,	,	PUNCT
iajs-3148	28	32	clearly	clearly	ADV
iajs-3148	28	33	contributes	contribute	VERB
iajs-3148	28	34	to	to	ADP
iajs-3148	28	35	the	the	DET
iajs-3148	28	36	development	development	NOUN
iajs-3148	28	37	of	of	ADP
iajs-3148	28	38	plaque	plaque	NOUN
iajs-3148	28	39	psoriasis	psoriasis	NOUN
iajs-3148	28	40	[	[	X
iajs-3148	28	41	18	18	NUM
iajs-3148	28	42	]	]	PUNCT
iajs-3148	28	43	.	.	PUNCT
iajs-3148	29	1	in	in	ADP
iajs-3148	29	2	addition	addition	NOUN
iajs-3148	29	3	,	,	PUNCT
iajs-3148	29	4	the	the	DET
iajs-3148	29	5	results	result	NOUN
iajs-3148	29	6	showed	show	VERB
iajs-3148	29	7	a	a	DET
iajs-3148	29	8	positive	positive	ADJ
iajs-3148	29	9	relationship	relationship	NOUN
iajs-3148	29	10	between	between	ADP
iajs-3148	29	11	tnf	tnf	PROPN
iajs-3148	29	12	and	and	CCONJ
iajs-3148	29	13	disease	disease	NOUN
iajs-3148	29	14	severity	severity	NOUN
iajs-3148	29	15	[	[	X
iajs-3148	29	16	19	19	NUM
iajs-3148	29	17	]	]	PUNCT
iajs-3148	29	18	.	.	PUNCT
iajs-3148	30	1	this	this	DET
iajs-3148	30	2	study	study	NOUN
iajs-3148	30	3	aimed	aim	VERB
iajs-3148	30	4	to	to	PART
iajs-3148	30	5	analyses	analyse	VERB
iajs-3148	30	6	the	the	DET
iajs-3148	30	7	association	association	NOUN
iajs-3148	30	8	between	between	ADP
iajs-3148	30	9	the	the	DET
iajs-3148	30	10	general	general	ADJ
iajs-3148	30	11	inflammatory	inflammatory	ADJ
iajs-3148	30	12	state	state	NOUN
iajs-3148	30	13	of	of	ADP
iajs-3148	30	14	the	the	DET
iajs-3148	30	15	body	body	NOUN
iajs-3148	30	16	and	and	CCONJ
iajs-3148	30	17	its	its	PRON
iajs-3148	30	18	association	association	NOUN
iajs-3148	30	19	with	with	ADP
iajs-3148	30	20	psoriasis	psoriasis	NOUN
iajs-3148	30	21	in	in	ADP
iajs-3148	30	22	terms	term	NOUN
iajs-3148	30	23	of	of	ADP
iajs-3148	30	24	these	these	DET
iajs-3148	30	25	cytokines	cytokine	NOUN
iajs-3148	30	26	.	.	PUNCT
iajs-3148	31	1	2	2	X
iajs-3148	31	2	.	.	X
iajs-3148	31	3	materials	material	NOUN
iajs-3148	31	4	and	and	CCONJ
iajs-3148	31	5	methods	method	NOUN
iajs-3148	31	6	2.1	2.1	NUM
iajs-3148	31	7	.	.	PUNCT
iajs-3148	32	1	controls	control	NOUN
iajs-3148	32	2	and	and	CCONJ
iajs-3148	32	3	patients	patient	NOUN
iajs-3148	32	4	this	this	DET
iajs-3148	32	5	study	study	NOUN
iajs-3148	32	6	included	include	VERB
iajs-3148	32	7	90	90	NUM
iajs-3148	32	8	patients	patient	NOUN
iajs-3148	32	9	with	with	ADP
iajs-3148	32	10	psoriasis	psoriasis	NOUN
iajs-3148	32	11	between	between	ADP
iajs-3148	32	12	the	the	DET
iajs-3148	32	13	ages	age	NOUN
iajs-3148	32	14	of	of	ADP
iajs-3148	32	15	11	11	NUM
iajs-3148	32	16	and	and	CCONJ
iajs-3148	32	17	73	73	NUM
iajs-3148	32	18	years	year	NOUN
iajs-3148	32	19	.	.	PUNCT
iajs-3148	33	1	all	all	PRON
iajs-3148	33	2	of	of	ADP
iajs-3148	33	3	these	these	DET
iajs-3148	33	4	patients	patient	NOUN
iajs-3148	33	5	were	be	AUX
iajs-3148	33	6	from	from	ADP
iajs-3148	33	7	al	al	PROPN
iajs-3148	33	8	-	-	PUNCT
iajs-3148	33	9	yarmouk	yarmouk	ADV
iajs-3148	33	10	hospital	hospital	NOUN
iajs-3148	33	11	located	locate	VERB
iajs-3148	33	12	in	in	ADP
iajs-3148	33	13	the	the	DET
iajs-3148	33	14	city	city	NOUN
iajs-3148	33	15	of	of	ADP
iajs-3148	33	16	baghdad	baghdad	PROPN
iajs-3148	33	17	,	,	PUNCT
iajs-3148	33	18	and	and	CCONJ
iajs-3148	33	19	60	60	NUM
iajs-3148	33	20	healthy	healthy	ADJ
iajs-3148	33	21	individuals	individual	NOUN
iajs-3148	33	22	of	of	ADP
iajs-3148	33	23	the	the	DET
iajs-3148	33	24	same	same	ADJ
iajs-3148	33	25	age	age	NOUN
iajs-3148	33	26	represented	represent	VERB
iajs-3148	33	27	the	the	DET
iajs-3148	33	28	control	control	NOUN
iajs-3148	33	29	group	group	NOUN
iajs-3148	33	30	,	,	PUNCT
iajs-3148	33	31	the	the	DET
iajs-3148	33	32	samples	sample	NOUN
iajs-3148	33	33	were	be	AUX
iajs-3148	33	34	collected	collect	VERB
iajs-3148	33	35	in	in	ADP
iajs-3148	33	36	a	a	DET
iajs-3148	33	37	random	random	ADJ
iajs-3148	33	38	way	way	NOUN
iajs-3148	33	39	,	,	PUNCT
iajs-3148	33	40	where	where	SCONJ
iajs-3148	33	41	the	the	DET
iajs-3148	33	42	number	number	NOUN
iajs-3148	33	43	of	of	ADP
iajs-3148	33	44	males	male	NOUN
iajs-3148	33	45	participating	participate	VERB
iajs-3148	33	46	in	in	ADP
iajs-3148	33	47	this	this	DET
iajs-3148	33	48	study	study	NOUN
iajs-3148	33	49	was	be	AUX
iajs-3148	33	50	73	73	NUM
iajs-3148	33	51	and	and	CCONJ
iajs-3148	33	52	the	the	DET
iajs-3148	33	53	number	number	NOUN
iajs-3148	33	54	of	of	ADP
iajs-3148	33	55	females	female	NOUN
iajs-3148	33	56	was	be	AUX
iajs-3148	33	57	77	77	NUM
iajs-3148	33	58	,	,	PUNCT
iajs-3148	33	59	and	and	CCONJ
iajs-3148	33	60	samples	sample	NOUN
iajs-3148	33	61	were	be	AUX
iajs-3148	33	62	collected	collect	VERB
iajs-3148	33	63	during	during	ADP
iajs-3148	33	64	a	a	DET
iajs-3148	33	65	period	period	NOUN
iajs-3148	33	66	between	between	ADP
iajs-3148	33	67	(	(	PUNCT
iajs-3148	33	68	november	november	PROPN
iajs-3148	33	69	2021	2021	NUM
iajs-3148	33	70	to	to	ADP
iajs-3148	33	71	april	april	PROPN
iajs-3148	33	72	2022	2022	NUM
iajs-3148	33	73	)	)	PUNCT
iajs-3148	33	74	.	.	PUNCT
iajs-3148	34	1	ihjpas	ihjpas	PROPN
iajs-3148	34	2	.	.	PUNCT
iajs-3148	35	1	37	37	NUM
iajs-3148	35	2	(	(	PUNCT
iajs-3148	35	3	1	1	NUM
iajs-3148	35	4	)	)	PUNCT
iajs-3148	35	5	2024	2024	NUM
iajs-3148	35	6	77	77	NUM
iajs-3148	35	7	2.2	2.2	NUM
iajs-3148	35	8	.	.	PUNCT
iajs-3148	35	9	immune	immune	ADJ
iajs-3148	35	10	assays	assay	NOUN
iajs-3148	35	11	psoriasis	psoriasis	NOUN
iajs-3148	35	12	patients	patient	NOUN
iajs-3148	35	13	and	and	CCONJ
iajs-3148	35	14	healthy	healthy	ADJ
iajs-3148	35	15	individuals	individual	NOUN
iajs-3148	35	16	were	be	AUX
iajs-3148	35	17	studied	study	VERB
iajs-3148	35	18	in	in	ADP
iajs-3148	35	19	a	a	DET
iajs-3148	35	20	case	case	NOUN
iajs-3148	35	21	-	-	PUNCT
iajs-3148	35	22	control	control	NOUN
iajs-3148	35	23	study	study	NOUN
iajs-3148	35	24	to	to	PART
iajs-3148	35	25	determine	determine	VERB
iajs-3148	35	26	the	the	DET
iajs-3148	35	27	levels	level	NOUN
iajs-3148	35	28	of	of	ADP
iajs-3148	35	29	pro	pro	ADJ
iajs-3148	35	30	-	-	ADJ
iajs-3148	35	31	inflammatory	inflammatory	ADJ
iajs-3148	35	32	cytokines	cytokine	NOUN
iajs-3148	35	33	(	(	PUNCT
iajs-3148	35	34	il-15	il-15	NOUN
iajs-3148	35	35	,	,	PUNCT
iajs-3148	35	36	il-23	il-23	NOUN
iajs-3148	35	37	,	,	PUNCT
iajs-3148	35	38	and	and	CCONJ
iajs-3148	35	39	tnf	tnf	PROPN
iajs-3148	35	40	-	-	PUNCT
iajs-3148	35	41	α	α	NOUN
iajs-3148	35	42	)	)	PUNCT
iajs-3148	35	43	in	in	ADP
iajs-3148	35	44	psoriasis	psoriasis	NOUN
iajs-3148	35	45	patients	patient	NOUN
iajs-3148	35	46	according	accord	VERB
iajs-3148	35	47	to	to	ADP
iajs-3148	35	48	the	the	DET
iajs-3148	35	49	manufacturer	manufacturer	NOUN
iajs-3148	35	50	’s	’s	PART
iajs-3148	35	51	protocol	protocol	NOUN
iajs-3148	35	52	.	.	PUNCT
iajs-3148	36	1	the	the	DET
iajs-3148	36	2	levels	level	NOUN
iajs-3148	36	3	of	of	ADP
iajs-3148	36	4	each	each	PRON
iajs-3148	36	5	of	of	ADP
iajs-3148	36	6	these	these	DET
iajs-3148	36	7	cytokines	cytokine	NOUN
iajs-3148	36	8	were	be	AUX
iajs-3148	36	9	estimated	estimate	VERB
iajs-3148	36	10	using	use	VERB
iajs-3148	36	11	an	an	DET
iajs-3148	36	12	elisa	elisa	NOUN
iajs-3148	36	13	for	for	ADP
iajs-3148	36	14	each	each	DET
iajs-3148	36	15	group	group	NOUN
iajs-3148	36	16	of	of	ADP
iajs-3148	36	17	these	these	DET
iajs-3148	36	18	cytokines	cytokine	NOUN
iajs-3148	36	19	.	.	PUNCT
iajs-3148	37	1	all	all	ADV
iajs-3148	37	2	from	from	ADP
iajs-3148	37	3	the	the	DET
iajs-3148	37	4	same	same	ADJ
iajs-3148	37	5	manufacturer	manufacturer	NOUN
iajs-3148	37	6	,	,	PUNCT
iajs-3148	37	7	bioassay	bioassay	NOUN
iajs-3148	37	8	technology	technology	NOUN
iajs-3148	37	9	laboratory	laboratory	NOUN
iajs-3148	37	10	venous	venous	ADJ
iajs-3148	37	11	blood	blood	NOUN
iajs-3148	37	12	was	be	AUX
iajs-3148	37	13	obtained	obtain	VERB
iajs-3148	37	14	using	use	VERB
iajs-3148	37	15	a	a	DET
iajs-3148	37	16	sterile	sterile	ADJ
iajs-3148	37	17	syringe	syringe	NOUN
iajs-3148	37	18	.	.	PUNCT
iajs-3148	38	1	6	6	NUM
iajs-3148	38	2	ml	ml	NOUN
iajs-3148	38	3	of	of	ADP
iajs-3148	38	4	blood	blood	NOUN
iajs-3148	38	5	was	be	AUX
iajs-3148	38	6	drawn	draw	VERB
iajs-3148	38	7	and	and	CCONJ
iajs-3148	38	8	then	then	ADV
iajs-3148	38	9	placed	place	VERB
iajs-3148	38	10	in	in	ADP
iajs-3148	38	11	a	a	DET
iajs-3148	38	12	gel	gel	NOUN
iajs-3148	38	13	tube	tube	NOUN
iajs-3148	38	14	,	,	PUNCT
iajs-3148	38	15	and	and	CCONJ
iajs-3148	38	16	the	the	DET
iajs-3148	38	17	tube	tube	NOUN
iajs-3148	38	18	was	be	AUX
iajs-3148	38	19	placed	place	VERB
iajs-3148	38	20	in	in	ADP
iajs-3148	38	21	a	a	DET
iajs-3148	38	22	centrifuge	centrifuge	NOUN
iajs-3148	38	23	at	at	ADP
iajs-3148	38	24	2000–3000	2000–3000	NUM
iajs-3148	38	25	rpm	rpm	NOUN
iajs-3148	38	26	for	for	ADP
iajs-3148	38	27	20	20	NUM
iajs-3148	38	28	min	min	NOUN
iajs-3148	38	29	.	.	PUNCT
iajs-3148	39	1	the	the	DET
iajs-3148	39	2	serum	serum	NOUN
iajs-3148	39	3	was	be	AUX
iajs-3148	39	4	stored	store	VERB
iajs-3148	39	5	in	in	ADP
iajs-3148	39	6	1.5	1.5	NUM
iajs-3148	39	7	ml	ml	ADP
iajs-3148	39	8	eppendorf	eppendorf	PROPN
iajs-3148	39	9	tubes	tube	NOUN
iajs-3148	39	10	and	and	CCONJ
iajs-3148	39	11	kept	keep	VERB
iajs-3148	39	12	at	at	ADP
iajs-3148	39	13	−20	−20	PROPN
iajs-3148	39	14	°	°	ADP
iajs-3148	39	15	c	c	NOUN
iajs-3148	39	16	until	until	SCONJ
iajs-3148	39	17	all	all	DET
iajs-3148	39	18	serological	serological	ADJ
iajs-3148	39	19	markers	marker	NOUN
iajs-3148	39	20	had	have	AUX
iajs-3148	39	21	been	be	AUX
iajs-3148	39	22	measured	measure	VERB
iajs-3148	39	23	.	.	PUNCT
iajs-3148	40	1	the	the	DET
iajs-3148	40	2	elisa	elisa	NOUN
iajs-3148	40	3	plate	plate	NOUN
iajs-3148	40	4	was	be	AUX
iajs-3148	40	5	measured	measure	VERB
iajs-3148	40	6	using	use	VERB
iajs-3148	40	7	a	a	DET
iajs-3148	40	8	special	special	ADJ
iajs-3148	40	9	device	device	NOUN
iajs-3148	40	10	called	call	VERB
iajs-3148	40	11	elisa	elisa	NOUN
iajs-3148	40	12	reader	reader	NOUN
iajs-3148	40	13	with	with	ADP
iajs-3148	40	14	an	an	DET
iajs-3148	40	15	absorbance	absorbance	NOUN
iajs-3148	40	16	of	of	ADP
iajs-3148	40	17	450	450	NUM
iajs-3148	40	18	nm	nm	NOUN
iajs-3148	40	19	to	to	PART
iajs-3148	40	20	determine	determine	VERB
iajs-3148	40	21	all	all	DET
iajs-3148	40	22	concentrations	concentration	NOUN
iajs-3148	40	23	of	of	ADP
iajs-3148	40	24	il15	il15	PROPN
iajs-3148	40	25	,	,	PUNCT
iajs-3148	40	26	tnf	tnf	PROPN
iajs-3148	40	27	-	-	PUNCT
iajs-3148	40	28	α	α	PROPN
iajs-3148	40	29	and	and	CCONJ
iajs-3148	40	30	il23	il23	PROPN
iajs-3148	40	31	for	for	ADP
iajs-3148	40	32	each	each	DET
iajs-3148	40	33	sample	sample	NOUN
iajs-3148	40	34	,	,	PUNCT
iajs-3148	40	35	each	each	DET
iajs-3148	40	36	cytokine	cytokine	NOUN
iajs-3148	40	37	used	use	VERB
iajs-3148	40	38	had	have	VERB
iajs-3148	40	39	its	its	PRON
iajs-3148	40	40	absorbance	absorbance	NOUN
iajs-3148	40	41	according	accord	VERB
iajs-3148	40	42	to	to	ADP
iajs-3148	40	43	the	the	DET
iajs-3148	40	44	manufacturer	manufacturer	NOUN
iajs-3148	40	45	's	's	PART
iajs-3148	40	46	protocol	protocol	NOUN
iajs-3148	40	47	of	of	ADP
iajs-3148	40	48	the	the	DET
iajs-3148	40	49	kits	kit	NOUN
iajs-3148	40	50	.	.	PUNCT
iajs-3148	41	1	2.3	2.3	NUM
iajs-3148	41	2	.	.	PUNCT
iajs-3148	42	1	statistical	statistical	ADJ
iajs-3148	42	2	analysis	analysis	NOUN
iajs-3148	42	3	the	the	DET
iajs-3148	42	4	data	datum	NOUN
iajs-3148	42	5	were	be	AUX
iajs-3148	42	6	analysed	analyse	VERB
iajs-3148	42	7	using	use	VERB
iajs-3148	42	8	ibm	ibm	PROPN
iajs-3148	42	9	spss	spss	PROPN
iajs-3148	42	10	v26	v26	PROPN
iajs-3148	42	11	software	software	NOUN
iajs-3148	42	12	.	.	PUNCT
iajs-3148	43	1	the	the	DET
iajs-3148	43	2	results	result	NOUN
iajs-3148	43	3	reported	report	VERB
iajs-3148	43	4	in	in	ADP
iajs-3148	43	5	this	this	DET
iajs-3148	43	6	study	study	NOUN
iajs-3148	43	7	were	be	AUX
iajs-3148	43	8	expressed	express	VERB
iajs-3148	43	9	as	as	ADP
iajs-3148	43	10	mean±sd	mean±sd	PROPN
iajs-3148	43	11	.	.	PUNCT
iajs-3148	44	1	levene	levene	PROPN
iajs-3148	44	2	's	's	PART
iajs-3148	44	3	test	test	NOUN
iajs-3148	44	4	for	for	ADP
iajs-3148	44	5	equality	equality	NOUN
iajs-3148	44	6	of	of	ADP
iajs-3148	44	7	variances	variance	NOUN
iajs-3148	44	8	was	be	AUX
iajs-3148	44	9	used	use	VERB
iajs-3148	44	10	for	for	ADP
iajs-3148	44	11	il15	il15	PROPN
iajs-3148	44	12	,	,	PUNCT
iajs-3148	44	13	il	il	PROPN
iajs-3148	44	14	23	23	NUM
iajs-3148	44	15	,	,	PUNCT
iajs-3148	44	16	and	and	CCONJ
iajs-3148	44	17	tnf	tnf	PROPN
iajs-3148	44	18	-	-	PUNCT
iajs-3148	44	19	α	α	PROPN
iajs-3148	44	20	and	and	CCONJ
iajs-3148	44	21	the	the	DET
iajs-3148	44	22	p	p	NOUN
iajs-3148	44	23	-	-	PUNCT
iajs-3148	44	24	value	value	NOUN
iajs-3148	44	25	were	be	AUX
iajs-3148	44	26	0.126	0.126	NUM
iajs-3148	44	27	,	,	PUNCT
iajs-3148	44	28	0.375	0.375	NUM
iajs-3148	44	29	,	,	PUNCT
iajs-3148	44	30	and	and	CCONJ
iajs-3148	44	31	0.845	0.845	NUM
iajs-3148	44	32	respectively	respectively	ADV
iajs-3148	44	33	,	,	PUNCT
iajs-3148	44	34	based	base	VERB
iajs-3148	44	35	on	on	ADP
iajs-3148	44	36	this	this	DET
iajs-3148	44	37	result	result	NOUN
iajs-3148	44	38	,	,	PUNCT
iajs-3148	44	39	parametric	parametric	ADJ
iajs-3148	44	40	tests	test	NOUN
iajs-3148	44	41	were	be	AUX
iajs-3148	44	42	used	use	VERB
iajs-3148	44	43	.	.	PUNCT
iajs-3148	45	1	z	z	X
iajs-3148	45	2	-	-	PUNCT
iajs-3148	45	3	test	test	NOUN
iajs-3148	45	4	was	be	AUX
iajs-3148	45	5	used	use	VERB
iajs-3148	45	6	to	to	PART
iajs-3148	45	7	compare	compare	VERB
iajs-3148	45	8	two	two	NUM
iajs-3148	45	9	proportions	proportion	NOUN
iajs-3148	45	10	.	.	PUNCT
iajs-3148	46	1	independent	independent	ADJ
iajs-3148	46	2	t	t	PROPN
iajs-3148	46	3	-	-	PUNCT
iajs-3148	46	4	tests	test	NOUN
iajs-3148	46	5	were	be	AUX
iajs-3148	46	6	used	use	VERB
iajs-3148	46	7	to	to	PART
iajs-3148	46	8	test	test	VERB
iajs-3148	46	9	between	between	ADP
iajs-3148	46	10	study	study	NOUN
iajs-3148	46	11	groups	group	NOUN
iajs-3148	46	12	.	.	PUNCT
iajs-3148	47	1	pearson	pearson	PROPN
iajs-3148	47	2	correlation	correlation	PROPN
iajs-3148	47	3	coefficient	coefficient	PROPN
iajs-3148	47	4	test	test	NOUN
iajs-3148	47	5	was	be	AUX
iajs-3148	47	6	used	use	VERB
iajs-3148	47	7	to	to	PART
iajs-3148	47	8	evaluate	evaluate	VERB
iajs-3148	47	9	the	the	DET
iajs-3148	47	10	linear	linear	ADJ
iajs-3148	47	11	relationship	relationship	NOUN
iajs-3148	47	12	between	between	ADP
iajs-3148	47	13	two	two	NUM
iajs-3148	47	14	continuous	continuous	ADJ
iajs-3148	47	15	variables	variable	NOUN
iajs-3148	47	16	using	use	VERB
iajs-3148	47	17	spss	spss	PROPN
iajs-3148	47	18	v.26	v.26	PRON
iajs-3148	47	19	,	,	PUNCT
iajs-3148	47	20	and	and	CCONJ
iajs-3148	47	21	if	if	SCONJ
iajs-3148	47	22	the	the	DET
iajs-3148	47	23	categorical	categorical	ADJ
iajs-3148	47	24	variable	variable	NOUN
iajs-3148	47	25	has	have	VERB
iajs-3148	47	26	two	two	NUM
iajs-3148	47	27	levels	level	NOUN
iajs-3148	47	28	,	,	PUNCT
iajs-3148	47	29	a	a	DET
iajs-3148	47	30	point	point	NOUN
iajs-3148	47	31	-	-	PUNCT
iajs-3148	47	32	biserial	biserial	ADJ
iajs-3148	47	33	correlation	correlation	NOUN
iajs-3148	47	34	was	be	AUX
iajs-3148	47	35	used	use	VERB
iajs-3148	47	36	.	.	PUNCT
iajs-3148	48	1	probability	probability	NOUN
iajs-3148	48	2	values	value	NOUN
iajs-3148	48	3	less	less	ADJ
iajs-3148	48	4	than	than	ADP
iajs-3148	48	5	0.05	0.05	NUM
iajs-3148	48	6	and	and	CCONJ
iajs-3148	48	7	0.01	0.01	NUM
iajs-3148	48	8	were	be	AUX
iajs-3148	48	9	considered	consider	VERB
iajs-3148	48	10	significantly	significantly	ADV
iajs-3148	48	11	different	different	ADJ
iajs-3148	48	12	[	[	X
iajs-3148	48	13	20	20	NUM
iajs-3148	48	14	]	]	PUNCT
iajs-3148	48	15	.	.	PUNCT
iajs-3148	49	1	3	3	X
iajs-3148	49	2	.	.	NOUN
iajs-3148	49	3	results	result	NOUN
iajs-3148	49	4	and	and	CCONJ
iajs-3148	49	5	discussion	discussion	NOUN
iajs-3148	49	6	this	this	DET
iajs-3148	49	7	study	study	NOUN
iajs-3148	49	8	was	be	AUX
iajs-3148	49	9	conducted	conduct	VERB
iajs-3148	49	10	on	on	ADP
iajs-3148	49	11	150	150	NUM
iajs-3148	49	12	iraqi	iraqi	ADJ
iajs-3148	49	13	subjects	subject	NOUN
iajs-3148	49	14	(	(	PUNCT
iajs-3148	49	15	90	90	NUM
iajs-3148	49	16	patients	patient	NOUN
iajs-3148	49	17	with	with	ADP
iajs-3148	49	18	psoriasis	psoriasis	NOUN
iajs-3148	49	19	and	and	CCONJ
iajs-3148	49	20	60	60	NUM
iajs-3148	49	21	patients	patient	NOUN
iajs-3148	49	22	in	in	ADP
iajs-3148	49	23	healthy	healthy	ADJ
iajs-3148	49	24	individuals	individual	NOUN
iajs-3148	49	25	(	(	PUNCT
iajs-3148	49	26	control	control	NOUN
iajs-3148	49	27	groups	group	NOUN
iajs-3148	49	28	)	)	PUNCT
iajs-3148	49	29	.	.	PUNCT
iajs-3148	50	1	this	this	DET
iajs-3148	50	2	study	study	NOUN
iajs-3148	50	3	focused	focus	VERB
iajs-3148	50	4	on	on	ADP
iajs-3148	50	5	a	a	DET
iajs-3148	50	6	cytokine	cytokine	NOUN
iajs-3148	50	7	(	(	PUNCT
iajs-3148	50	8	tnf	tnf	PROPN
iajs-3148	50	9	-	-	PUNCT
iajs-3148	50	10	α	α	NOUN
iajs-3148	50	11	)	)	PUNCT
iajs-3148	50	12	and	and	CCONJ
iajs-3148	50	13	two	two	NUM
iajs-3148	50	14	interleukins	interleukin	NOUN
iajs-3148	50	15	(	(	PUNCT
iajs-3148	50	16	il-23	il-23	NOUN
iajs-3148	50	17	and	and	CCONJ
iajs-3148	50	18	il-15	il-15	X
iajs-3148	50	19	)	)	PUNCT
iajs-3148	50	20	.	.	PUNCT
iajs-3148	51	1	a	a	DET
iajs-3148	51	2	significant	significant	ADJ
iajs-3148	51	3	increase	increase	NOUN
iajs-3148	51	4	in	in	ADP
iajs-3148	51	5	the	the	DET
iajs-3148	51	6	level	level	NOUN
iajs-3148	51	7	of	of	ADP
iajs-3148	51	8	tnf	tnf	PROPN
iajs-3148	51	9	-	-	PUNCT
iajs-3148	51	10	α	α	PROPN
iajs-3148	51	11	was	be	AUX
iajs-3148	51	12	observed	observe	VERB
iajs-3148	51	13	in	in	ADP
iajs-3148	51	14	the	the	DET
iajs-3148	51	15	psoriasis	psoriasis	NOUN
iajs-3148	51	16	patients	patient	NOUN
iajs-3148	51	17	group	group	NOUN
iajs-3148	51	18	compared	compare	VERB
iajs-3148	51	19	to	to	ADP
iajs-3148	51	20	its	its	PRON
iajs-3148	51	21	level	level	NOUN
iajs-3148	51	22	in	in	ADP
iajs-3148	51	23	the	the	DET
iajs-3148	51	24	healthy	healthy	ADJ
iajs-3148	51	25	group	group	NOUN
iajs-3148	51	26	and	and	CCONJ
iajs-3148	51	27	the	the	DET
iajs-3148	51	28	p	p	NOUN
iajs-3148	51	29	-	-	PUNCT
iajs-3148	51	30	value	value	NOUN
iajs-3148	51	31	was	be	AUX
iajs-3148	51	32	(	(	PUNCT
iajs-3148	51	33	0.033	0.033	NUM
iajs-3148	51	34	*	*	NUM
iajs-3148	51	35	)	)	PUNCT
iajs-3148	51	36	(	(	PUNCT
iajs-3148	51	37	figure	figure	NOUN
iajs-3148	51	38	1	1	NUM
iajs-3148	51	39	)	)	PUNCT
iajs-3148	51	40	.	.	PUNCT
iajs-3148	52	1	also	also	ADV
iajs-3148	52	2	,	,	PUNCT
iajs-3148	52	3	there	there	PRON
iajs-3148	52	4	was	be	VERB
iajs-3148	52	5	a	a	DET
iajs-3148	52	6	significant	significant	ADJ
iajs-3148	52	7	increase	increase	NOUN
iajs-3148	52	8	in	in	ADP
iajs-3148	52	9	the	the	DET
iajs-3148	52	10	level	level	NOUN
iajs-3148	52	11	of	of	ADP
iajs-3148	52	12	il-23	il-23	NOUN
iajs-3148	52	13	in	in	ADP
iajs-3148	52	14	psoriasis	psoriasis	NOUN
iajs-3148	52	15	patients	patient	NOUN
iajs-3148	52	16	compared	compare	VERB
iajs-3148	52	17	to	to	ADP
iajs-3148	52	18	its	its	PRON
iajs-3148	52	19	level	level	NOUN
iajs-3148	52	20	in	in	ADP
iajs-3148	52	21	the	the	DET
iajs-3148	52	22	healthy	healthy	ADJ
iajs-3148	52	23	individuals	individual	NOUN
iajs-3148	52	24	,	,	PUNCT
iajs-3148	52	25	and	and	CCONJ
iajs-3148	52	26	the	the	DET
iajs-3148	52	27	p	p	NOUN
iajs-3148	52	28	value	value	NOUN
iajs-3148	52	29	was	be	AUX
iajs-3148	52	30	(	(	PUNCT
iajs-3148	52	31	0.001	0.001	NUM
iajs-3148	52	32	*	*	NOUN
iajs-3148	52	33	*	*	NOUN
iajs-3148	52	34	)	)	PUNCT
iajs-3148	52	35	(	(	PUNCT
iajs-3148	52	36	figure	figure	NOUN
iajs-3148	52	37	2	2	NUM
iajs-3148	52	38	)	)	PUNCT
iajs-3148	52	39	.	.	PUNCT
iajs-3148	53	1	while	while	SCONJ
iajs-3148	53	2	there	there	PRON
iajs-3148	53	3	was	be	VERB
iajs-3148	53	4	no	no	DET
iajs-3148	53	5	significant	significant	ADJ
iajs-3148	53	6	difference	difference	NOUN
iajs-3148	53	7	in	in	ADP
iajs-3148	53	8	il15	il15	PROPN
iajs-3148	53	9	level	level	NOUN
iajs-3148	53	10	between	between	ADP
iajs-3148	53	11	the	the	DET
iajs-3148	53	12	two	two	NUM
iajs-3148	53	13	groups	group	NOUN
iajs-3148	53	14	and	and	CCONJ
iajs-3148	53	15	the	the	DET
iajs-3148	53	16	p	p	NOUN
iajs-3148	53	17	-	-	PUNCT
iajs-3148	53	18	value	value	NOUN
iajs-3148	53	19	was	be	AUX
iajs-3148	53	20	(	(	PUNCT
iajs-3148	53	21	0.201	0.201	NUM
iajs-3148	53	22	n.s	n.s	PROPN
iajs-3148	53	23	)	)	PUNCT
iajs-3148	53	24	(	(	PUNCT
iajs-3148	53	25	figure	figure	NOUN
iajs-3148	53	26	3	3	NUM
iajs-3148	53	27	)	)	PUNCT
iajs-3148	53	28	.	.	PUNCT
iajs-3148	54	1	ihjpas	ihjpas	PROPN
iajs-3148	54	2	.	.	PUNCT
iajs-3148	55	1	37	37	NUM
iajs-3148	55	2	(	(	PUNCT
iajs-3148	55	3	1	1	NUM
iajs-3148	55	4	)	)	PUNCT
iajs-3148	55	5	2024	2024	NUM
iajs-3148	55	6	78	78	NUM
iajs-3148	55	7	figure	figure	NOUN
iajs-3148	55	8	1	1	NUM
iajs-3148	55	9	.	.	PUNCT
iajs-3148	55	10	serum	serum	NOUN
iajs-3148	55	11	level	level	NOUN
iajs-3148	55	12	of	of	ADP
iajs-3148	55	13	tnf	tnf	PROPN
iajs-3148	55	14	-	-	PUNCT
iajs-3148	55	15	α	α	PROPN
iajs-3148	55	16	in	in	ADP
iajs-3148	55	17	psoriasis	psoriasis	NOUN
iajs-3148	55	18	patients	patient	NOUN
iajs-3148	55	19	compared	compare	VERB
iajs-3148	55	20	to	to	ADP
iajs-3148	55	21	the	the	DET
iajs-3148	55	22	control	control	NOUN
iajs-3148	55	23	.	.	PUNCT
iajs-3148	56	1	figure	figure	NOUN
iajs-3148	56	2	2	2	NUM
iajs-3148	56	3	.	.	NOUN
iajs-3148	56	4	il-23	il-23	NOUN
iajs-3148	56	5	serum	serum	NOUN
iajs-3148	56	6	levels	level	NOUN
iajs-3148	56	7	in	in	ADP
iajs-3148	56	8	psoriasis	psoriasis	NOUN
iajs-3148	56	9	patients	patient	NOUN
iajs-3148	56	10	and	and	CCONJ
iajs-3148	56	11	controls	control	NOUN
iajs-3148	56	12	.	.	PUNCT
iajs-3148	57	1	figure	figure	NOUN
iajs-3148	57	2	3	3	NUM
iajs-3148	57	3	.	.	PUNCT
iajs-3148	57	4	serum	serum	NOUN
iajs-3148	57	5	level	level	NOUN
iajs-3148	57	6	of	of	ADP
iajs-3148	57	7	il-15(mg	il-15(mg	PROPN
iajs-3148	57	8	/	/	SYM
iajs-3148	57	9	l	l	NOUN
iajs-3148	57	10	)	)	PUNCT
iajs-3148	57	11	in	in	ADP
iajs-3148	57	12	psoriasis	psoriasis	NOUN
iajs-3148	57	13	patients	patient	NOUN
iajs-3148	57	14	compared	compare	VERB
iajs-3148	57	15	to	to	ADP
iajs-3148	57	16	the	the	DET
iajs-3148	57	17	control	control	NOUN
iajs-3148	57	18	.	.	PUNCT
iajs-3148	58	1	0	0	NUM
iajs-3148	58	2	20	20	NUM
iajs-3148	58	3	40	40	NUM
iajs-3148	58	4	60	60	NUM
iajs-3148	58	5	80	80	NUM
iajs-3148	58	6	100	100	NUM
iajs-3148	58	7	120	120	NUM
iajs-3148	58	8	140	140	NUM
iajs-3148	58	9	160	160	NUM
iajs-3148	58	10	180	180	NUM
iajs-3148	58	11	200	200	NUM
iajs-3148	58	12	patient	patient	NOUN
iajs-3148	58	13	control	control	NOUN
iajs-3148	58	14	182.38	182.38	NUM
iajs-3148	58	15	151.98	151.98	NUM
iajs-3148	58	16	tn	tn	NOUN
iajs-3148	58	17	fα	fα	ADP
iajs-3148	58	18	(	(	PUNCT
iajs-3148	58	19	m	m	PROPN
iajs-3148	58	20	g/	g/	NOUN
iajs-3148	58	21	l	l	NOUN
iajs-3148	58	22	)	)	PUNCT
iajs-3148	58	23	study	study	NOUN
iajs-3148	58	24	group	group	NOUN
iajs-3148	58	25	0	0	NUM
iajs-3148	58	26	20	20	NUM
iajs-3148	58	27	40	40	NUM
iajs-3148	58	28	60	60	NUM
iajs-3148	58	29	80	80	NUM
iajs-3148	58	30	100	100	NUM
iajs-3148	58	31	120	120	NUM
iajs-3148	58	32	patient	patient	NOUN
iajs-3148	58	33	control	control	NOUN
iajs-3148	58	34	118.56	118.56	NUM
iajs-3148	58	35	49.89	49.89	NUM
iajs-3148	58	36	li	li	NOUN
iajs-3148	58	37	-2	-2	NOUN
iajs-3148	58	38	3	3	NUM
iajs-3148	58	39	(	(	PUNCT
iajs-3148	58	40	m	m	PROPN
iajs-3148	58	41	g/	g/	NOUN
iajs-3148	58	42	l	l	NOUN
iajs-3148	58	43	)	)	PUNCT
iajs-3148	58	44	study	study	NOUN
iajs-3148	58	45	group	group	NOUN
iajs-3148	58	46	540	540	NUM
iajs-3148	58	47	550	550	NUM
iajs-3148	58	48	560	560	NUM
iajs-3148	58	49	570	570	NUM
iajs-3148	58	50	580	580	NUM
iajs-3148	58	51	590	590	NUM
iajs-3148	58	52	600	600	NUM
iajs-3148	58	53	610	610	NUM
iajs-3148	58	54	620	620	NUM
iajs-3148	58	55	patient	patient	NOUN
iajs-3148	58	56	control	control	NOUN
iajs-3148	58	57	568.96	568.96	NUM
iajs-3148	58	58	613.76	613.76	NUM
iajs-3148	58	59	li	li	NOUN
iajs-3148	58	60	-1	-1	ADP
iajs-3148	58	61	5	5	NUM
iajs-3148	58	62	(	(	PUNCT
iajs-3148	58	63	m	m	PROPN
iajs-3148	58	64	g/	g/	NOUN
iajs-3148	58	65	l	l	NOUN
iajs-3148	58	66	)	)	PUNCT
iajs-3148	58	67	study	study	NOUN
iajs-3148	58	68	group	group	NOUN
iajs-3148	58	69	ihjpas	ihjpa	VERB
iajs-3148	58	70	.	.	PUNCT
iajs-3148	59	1	37	37	NUM
iajs-3148	59	2	(	(	PUNCT
iajs-3148	59	3	1	1	NUM
iajs-3148	59	4	)	)	PUNCT
iajs-3148	59	5	2024	2024	NUM
iajs-3148	59	6	79	79	NUM
iajs-3148	59	7	tnf	tnf	PROPN
iajs-3148	59	8	-	-	PUNCT
iajs-3148	59	9	α	α	PROPN
iajs-3148	59	10	may	may	AUX
iajs-3148	59	11	lead	lead	VERB
iajs-3148	59	12	to	to	ADP
iajs-3148	59	13	the	the	DET
iajs-3148	59	14	enhancement	enhancement	NOUN
iajs-3148	59	15	of	of	ADP
iajs-3148	59	16	psoriasis	psoriasis	NOUN
iajs-3148	59	17	by	by	ADP
iajs-3148	59	18	collaborating	collaborate	VERB
iajs-3148	59	19	with	with	ADP
iajs-3148	59	20	other	other	ADJ
iajs-3148	59	21	cytokines	cytokine	NOUN
iajs-3148	59	22	,	,	PUNCT
iajs-3148	59	23	according	accord	VERB
iajs-3148	59	24	to	to	ADP
iajs-3148	59	25	theory	theory	NOUN
iajs-3148	59	26	,	,	PUNCT
iajs-3148	59	27	tnf	tnf	PROPN
iajs-3148	59	28	-	-	PUNCT
iajs-3148	59	29	α	α	PROPN
iajs-3148	59	30	is	be	AUX
iajs-3148	59	31	believed	believe	VERB
iajs-3148	59	32	to	to	PART
iajs-3148	59	33	be	be	AUX
iajs-3148	59	34	involved	involve	VERB
iajs-3148	59	35	in	in	ADP
iajs-3148	59	36	the	the	DET
iajs-3148	59	37	psoriasis	psoriasis	NOUN
iajs-3148	59	38	development	development	NOUN
iajs-3148	59	39	process	process	NOUN
iajs-3148	59	40	[	[	X
iajs-3148	59	41	21	21	NUM
iajs-3148	59	42	]	]	PUNCT
iajs-3148	59	43	.	.	PUNCT
iajs-3148	60	1	in	in	ADP
iajs-3148	60	2	various	various	ADJ
iajs-3148	60	3	studies	study	NOUN
iajs-3148	60	4	,	,	PUNCT
iajs-3148	60	5	it	it	PRON
iajs-3148	60	6	was	be	AUX
iajs-3148	60	7	discovered	discover	VERB
iajs-3148	60	8	that	that	SCONJ
iajs-3148	60	9	psoriatic	psoriatic	ADJ
iajs-3148	60	10	patients	patient	NOUN
iajs-3148	60	11	'	'	PART
iajs-3148	60	12	blood	blood	NOUN
iajs-3148	60	13	and	and	CCONJ
iajs-3148	60	14	lesional	lesional	ADJ
iajs-3148	60	15	skin	skin	NOUN
iajs-3148	60	16	tnf	tnf	PROPN
iajs-3148	60	17	-	-	PUNCT
iajs-3148	60	18	α	α	PROPN
iajs-3148	60	19	levels	level	NOUN
iajs-3148	60	20	were	be	AUX
iajs-3148	60	21	significantly	significantly	ADV
iajs-3148	60	22	greater	great	ADJ
iajs-3148	60	23	than	than	ADP
iajs-3148	60	24	those	those	PRON
iajs-3148	60	25	of	of	ADP
iajs-3148	60	26	healthy	healthy	ADJ
iajs-3148	60	27	controls	control	NOUN
iajs-3148	60	28	.	.	PUNCT
iajs-3148	61	1	in	in	ADP
iajs-3148	61	2	addition	addition	NOUN
iajs-3148	61	3	,	,	PUNCT
iajs-3148	61	4	reducing	reduce	VERB
iajs-3148	61	5	the	the	DET
iajs-3148	61	6	number	number	NOUN
iajs-3148	61	7	of	of	ADP
iajs-3148	61	8	t	t	NOUN
iajs-3148	61	9	cells	cell	NOUN
iajs-3148	61	10	and	and	CCONJ
iajs-3148	61	11	reducing	reduce	VERB
iajs-3148	61	12	epidermal	epidermal	ADJ
iajs-3148	61	13	hyperplasia	hyperplasia	NOUN
iajs-3148	61	14	in	in	ADP
iajs-3148	61	15	people	people	NOUN
iajs-3148	61	16	with	with	ADP
iajs-3148	61	17	skin	skin	NOUN
iajs-3148	61	18	psoriasis	psoriasis	NOUN
iajs-3148	61	19	using	use	VERB
iajs-3148	61	20	a	a	DET
iajs-3148	61	21	specific	specific	ADJ
iajs-3148	61	22	drug	drug	NOUN
iajs-3148	61	23	as	as	SCONJ
iajs-3148	61	24	the	the	DET
iajs-3148	61	25	improvement	improvement	NOUN
iajs-3148	61	26	in	in	ADP
iajs-3148	61	27	the	the	DET
iajs-3148	61	28	health	health	NOUN
iajs-3148	61	29	status	status	NOUN
iajs-3148	61	30	of	of	ADP
iajs-3148	61	31	patients	patient	NOUN
iajs-3148	61	32	with	with	ADP
iajs-3148	61	33	psoriasis	psoriasis	NOUN
iajs-3148	61	34	was	be	AUX
iajs-3148	61	35	associated	associate	VERB
iajs-3148	61	36	with	with	ADP
iajs-3148	61	37	a	a	DET
iajs-3148	61	38	decrease	decrease	NOUN
iajs-3148	61	39	in	in	ADP
iajs-3148	61	40	the	the	DET
iajs-3148	61	41	level	level	NOUN
iajs-3148	61	42	of	of	ADP
iajs-3148	61	43	tnf	tnf	PROPN
iajs-3148	61	44	-	-	PUNCT
iajs-3148	61	45	α	α	PROPN
iajs-3148	61	46	in	in	ADP
iajs-3148	61	47	the	the	DET
iajs-3148	61	48	patients	patient	NOUN
iajs-3148	61	49	'	'	PART
iajs-3148	61	50	blood	blood	NOUN
iajs-3148	61	51	[	[	X
iajs-3148	61	52	22	22	NUM
iajs-3148	61	53	,	,	PUNCT
iajs-3148	61	54	23	23	NUM
iajs-3148	61	55	,	,	PUNCT
iajs-3148	61	56	24	24	NUM
iajs-3148	61	57	]	]	PUNCT
iajs-3148	61	58	.	.	PUNCT
iajs-3148	62	1	in	in	ADP
iajs-3148	62	2	2022	2022	NUM
iajs-3148	62	3	,	,	PUNCT
iajs-3148	62	4	tnf	tnf	PROPN
iajs-3148	62	5	inhibitors	inhibitor	NOUN
iajs-3148	62	6	,	,	PUNCT
iajs-3148	62	7	especially	especially	ADV
iajs-3148	62	8	etanercept	etanercept	NOUN
iajs-3148	62	9	,	,	PUNCT
iajs-3148	62	10	were	be	AUX
iajs-3148	62	11	used	use	VERB
iajs-3148	62	12	as	as	ADP
iajs-3148	62	13	a	a	DET
iajs-3148	62	14	safe	safe	ADJ
iajs-3148	62	15	treatment	treatment	NOUN
iajs-3148	62	16	for	for	ADP
iajs-3148	62	17	psoriasis	psoriasis	NOUN
iajs-3148	62	18	in	in	ADP
iajs-3148	62	19	cases	case	NOUN
iajs-3148	62	20	that	that	PRON
iajs-3148	62	21	were	be	AUX
iajs-3148	62	22	infected	infect	VERB
iajs-3148	62	23	with	with	ADP
iajs-3148	62	24	hiv	hiv	PROPN
iajs-3148	62	25	at	at	ADP
iajs-3148	62	26	the	the	DET
iajs-3148	62	27	same	same	ADJ
iajs-3148	62	28	time	time	NOUN
iajs-3148	62	29	[	[	X
iajs-3148	62	30	25	25	NUM
iajs-3148	62	31	,	,	PUNCT
iajs-3148	62	32	26	26	NUM
iajs-3148	62	33	]	]	PUNCT
iajs-3148	62	34	.	.	PUNCT
iajs-3148	63	1	several	several	ADJ
iajs-3148	63	2	reports	report	NOUN
iajs-3148	63	3	and	and	CCONJ
iajs-3148	63	4	research	research	NOUN
iajs-3148	63	5	have	have	AUX
iajs-3148	63	6	also	also	ADV
iajs-3148	63	7	demonstrated	demonstrate	VERB
iajs-3148	63	8	that	that	SCONJ
iajs-3148	63	9	the	the	DET
iajs-3148	63	10	inflammatory	inflammatory	ADJ
iajs-3148	63	11	response	response	NOUN
iajs-3148	63	12	by	by	ADP
iajs-3148	63	13	tnf	tnf	PROPN
iajs-3148	63	14	-	-	PUNCT
iajs-3148	63	15	α	α	PROPN
iajs-3148	63	16	and	and	CCONJ
iajs-3148	63	17	other	other	ADJ
iajs-3148	63	18	cytokines	cytokine	NOUN
iajs-3148	63	19	leads	lead	VERB
iajs-3148	63	20	to	to	ADP
iajs-3148	63	21	the	the	DET
iajs-3148	63	22	stimulation	stimulation	NOUN
iajs-3148	63	23	of	of	ADP
iajs-3148	63	24	angiogenesis	angiogenesis	NOUN
iajs-3148	63	25	and	and	CCONJ
iajs-3148	63	26	proliferation	proliferation	NOUN
iajs-3148	63	27	of	of	ADP
iajs-3148	63	28	keratinocytes	keratinocyte	NOUN
iajs-3148	63	29	,	,	PUNCT
iajs-3148	63	30	which	which	PRON
iajs-3148	63	31	contributes	contribute	VERB
iajs-3148	63	32	to	to	ADP
iajs-3148	63	33	the	the	DET
iajs-3148	63	34	development	development	NOUN
iajs-3148	63	35	of	of	ADP
iajs-3148	63	36	plaque	plaque	NOUN
iajs-3148	63	37	psoriasis	psoriasis	NOUN
iajs-3148	63	38	[	[	X
iajs-3148	63	39	27	27	NUM
iajs-3148	63	40	]	]	PUNCT
iajs-3148	63	41	.	.	PUNCT
iajs-3148	64	1	in	in	ADP
iajs-3148	64	2	addition	addition	NOUN
iajs-3148	64	3	,	,	PUNCT
iajs-3148	64	4	many	many	ADJ
iajs-3148	64	5	types	type	NOUN
iajs-3148	64	6	of	of	ADP
iajs-3148	64	7	research	research	NOUN
iajs-3148	64	8	showed	show	VERB
iajs-3148	64	9	a	a	DET
iajs-3148	64	10	positive	positive	ADJ
iajs-3148	64	11	correlation	correlation	NOUN
iajs-3148	64	12	between	between	ADP
iajs-3148	64	13	tnf	tnf	PROPN
iajs-3148	64	14	-	-	PUNCT
iajs-3148	64	15	α	α	PROPN
iajs-3148	64	16	and	and	CCONJ
iajs-3148	64	17	disease	disease	NOUN
iajs-3148	64	18	severity	severity	NOUN
iajs-3148	64	19	(	(	PUNCT
iajs-3148	64	20	pasi	pasi	NOUN
iajs-3148	64	21	)	)	PUNCT
iajs-3148	65	1	[	[	X
iajs-3148	65	2	28	28	NUM
iajs-3148	65	3	,	,	PUNCT
iajs-3148	65	4	29	29	NUM
iajs-3148	65	5	,	,	PUNCT
iajs-3148	65	6	30	30	NUM
iajs-3148	65	7	]	]	PUNCT
iajs-3148	65	8	.	.	PUNCT
iajs-3148	66	1	in	in	ADP
iajs-3148	66	2	recent	recent	ADJ
iajs-3148	66	3	research	research	NOUN
iajs-3148	66	4	,	,	PUNCT
iajs-3148	66	5	it	it	PRON
iajs-3148	66	6	was	be	AUX
iajs-3148	66	7	proved	prove	VERB
iajs-3148	66	8	that	that	SCONJ
iajs-3148	66	9	il-23	il-23	NOUN
iajs-3148	66	10	is	be	AUX
iajs-3148	66	11	one	one	NUM
iajs-3148	66	12	of	of	ADP
iajs-3148	66	13	the	the	DET
iajs-3148	66	14	most	most	ADV
iajs-3148	66	15	important	important	ADJ
iajs-3148	66	16	cytokines	cytokine	NOUN
iajs-3148	66	17	in	in	ADP
iajs-3148	66	18	the	the	DET
iajs-3148	66	19	world	world	NOUN
iajs-3148	66	20	of	of	ADP
iajs-3148	66	21	the	the	DET
iajs-3148	66	22	inflammatory	inflammatory	ADJ
iajs-3148	66	23	process	process	NOUN
iajs-3148	66	24	that	that	PRON
iajs-3148	66	25	leads	lead	VERB
iajs-3148	66	26	to	to	ADP
iajs-3148	66	27	psoriasis	psoriasis	NOUN
iajs-3148	66	28	,	,	PUNCT
iajs-3148	66	29	in	in	ADP
iajs-3148	66	30	addition	addition	NOUN
iajs-3148	66	31	to	to	ADP
iajs-3148	66	32	its	its	PRON
iajs-3148	66	33	importance	importance	NOUN
iajs-3148	66	34	in	in	ADP
iajs-3148	66	35	stimulating	stimulate	VERB
iajs-3148	66	36	and	and	CCONJ
iajs-3148	66	37	activating	activate	VERB
iajs-3148	66	38	th-17	th-17	NOUN
iajs-3148	66	39	,	,	PUNCT
iajs-3148	66	40	which	which	PRON
iajs-3148	66	41	in	in	ADP
iajs-3148	66	42	turn	turn	NOUN
iajs-3148	66	43	forms	form	VERB
iajs-3148	66	44	the	the	DET
iajs-3148	66	45	psoriasis	psoriasis	NOUN
iajs-3148	66	46	plaque	plaque	NOUN
iajs-3148	66	47	[	[	X
iajs-3148	66	48	31,32	31,32	NUM
iajs-3148	66	49	]	]	PUNCT
iajs-3148	66	50	.	.	PUNCT
iajs-3148	67	1	the	the	DET
iajs-3148	67	2	plasma	plasma	NOUN
iajs-3148	67	3	level	level	NOUN
iajs-3148	67	4	of	of	ADP
iajs-3148	67	5	il-23	il-23	NOUN
iajs-3148	67	6	for	for	ADP
iajs-3148	67	7	patients	patient	NOUN
iajs-3148	67	8	with	with	ADP
iajs-3148	67	9	psoriasis	psoriasis	NOUN
iajs-3148	67	10	vulgaris	vulgaris	NOUN
iajs-3148	67	11	was	be	AUX
iajs-3148	67	12	found	find	VERB
iajs-3148	67	13	to	to	PART
iajs-3148	67	14	be	be	AUX
iajs-3148	67	15	higher	high	ADJ
iajs-3148	67	16	when	when	SCONJ
iajs-3148	67	17	compared	compare	VERB
iajs-3148	67	18	to	to	ADP
iajs-3148	67	19	the	the	DET
iajs-3148	67	20	control	control	NOUN
iajs-3148	67	21	group	group	NOUN
iajs-3148	67	22	,	,	PUNCT
iajs-3148	67	23	and	and	CCONJ
iajs-3148	67	24	these	these	DET
iajs-3148	67	25	results	result	NOUN
iajs-3148	67	26	were	be	AUX
iajs-3148	67	27	consistent	consistent	ADJ
iajs-3148	67	28	with	with	ADP
iajs-3148	67	29	many	many	ADJ
iajs-3148	67	30	types	type	NOUN
iajs-3148	67	31	of	of	ADP
iajs-3148	67	32	research	research	NOUN
iajs-3148	67	33	and	and	CCONJ
iajs-3148	67	34	studies	study	NOUN
iajs-3148	67	35	[	[	X
iajs-3148	67	36	33	33	NUM
iajs-3148	67	37	,	,	PUNCT
iajs-3148	67	38	34	34	NUM
iajs-3148	67	39	,	,	PUNCT
iajs-3148	67	40	35	35	NUM
iajs-3148	67	41	,	,	PUNCT
iajs-3148	67	42	36	36	NUM
iajs-3148	67	43	,	,	PUNCT
iajs-3148	67	44	37	37	NUM
iajs-3148	67	45	]	]	PUNCT
iajs-3148	67	46	.	.	PUNCT
iajs-3148	68	1	likewise	likewise	ADV
iajs-3148	68	2	,	,	PUNCT
iajs-3148	68	3	il-23	il-23	NOUN
iajs-3148	68	4	is	be	AUX
iajs-3148	68	5	one	one	NUM
iajs-3148	68	6	of	of	ADP
iajs-3148	68	7	the	the	DET
iajs-3148	68	8	cytokines	cytokine	NOUN
iajs-3148	68	9	involved	involve	VERB
iajs-3148	68	10	in	in	ADP
iajs-3148	68	11	the	the	DET
iajs-3148	68	12	immune	immune	ADJ
iajs-3148	68	13	response	response	NOUN
iajs-3148	68	14	to	to	ADP
iajs-3148	68	15	fungal	fungal	ADJ
iajs-3148	68	16	and	and	CCONJ
iajs-3148	68	17	bacterial	bacterial	ADJ
iajs-3148	68	18	infections	infection	NOUN
iajs-3148	68	19	[	[	X
iajs-3148	68	20	38	38	NUM
iajs-3148	68	21	]	]	PUNCT
iajs-3148	68	22	,	,	PUNCT
iajs-3148	68	23	the	the	DET
iajs-3148	68	24	dysregulated	dysregulated	ADJ
iajs-3148	68	25	production	production	NOUN
iajs-3148	68	26	of	of	ADP
iajs-3148	68	27	il-23	il-23	NOUN
iajs-3148	68	28	also	also	ADV
iajs-3148	68	29	stimulates	stimulate	VERB
iajs-3148	68	30	autoimmune	autoimmune	ADJ
iajs-3148	68	31	inflammation	inflammation	NOUN
iajs-3148	68	32	[	[	X
iajs-3148	68	33	39	39	NUM
iajs-3148	68	34	]	]	PUNCT
iajs-3148	68	35	.	.	PUNCT
iajs-3148	69	1	in	in	ADP
iajs-3148	69	2	some	some	DET
iajs-3148	69	3	studies	study	NOUN
iajs-3148	69	4	,	,	PUNCT
iajs-3148	69	5	they	they	PRON
iajs-3148	69	6	have	have	AUX
iajs-3148	69	7	targeted	target	VERB
iajs-3148	69	8	anti	anti	ADJ
iajs-3148	69	9	-	-	ADJ
iajs-3148	69	10	tnf	tnf	ADJ
iajs-3148	69	11	-	-	PUNCT
iajs-3148	69	12	α	α	NOUN
iajs-3148	69	13	and	and	CCONJ
iajs-3148	69	14	il-23	il-23	NOUN
iajs-3148	69	15	antibodies	antibody	NOUN
iajs-3148	69	16	as	as	ADP
iajs-3148	69	17	an	an	DET
iajs-3148	69	18	effective	effective	ADJ
iajs-3148	69	19	treatment	treatment	NOUN
iajs-3148	69	20	for	for	ADP
iajs-3148	69	21	moderate	moderate	ADJ
iajs-3148	69	22	to	to	ADP
iajs-3148	69	23	severe	severe	ADJ
iajs-3148	69	24	psoriasis	psoriasis	NOUN
iajs-3148	69	25	patients	patient	NOUN
iajs-3148	69	26	[	[	X
iajs-3148	69	27	40	40	NUM
iajs-3148	69	28	]	]	PUNCT
iajs-3148	69	29	.	.	PUNCT
iajs-3148	70	1	this	this	PRON
iajs-3148	70	2	is	be	AUX
iajs-3148	70	3	evidence	evidence	NOUN
iajs-3148	70	4	of	of	ADP
iajs-3148	70	5	its	its	PRON
iajs-3148	70	6	moral	moral	ADJ
iajs-3148	70	7	association	association	NOUN
iajs-3148	70	8	with	with	ADP
iajs-3148	70	9	psoriasis	psoriasis	NOUN
iajs-3148	70	10	.	.	PUNCT
iajs-3148	71	1	il-15	il-15	PUNCT
iajs-3148	71	2	is	be	AUX
iajs-3148	71	3	an	an	DET
iajs-3148	71	4	important	important	ADJ
iajs-3148	71	5	cytokine	cytokine	NOUN
iajs-3148	71	6	in	in	ADP
iajs-3148	71	7	the	the	DET
iajs-3148	71	8	activity	activity	NOUN
iajs-3148	71	9	of	of	ADP
iajs-3148	71	10	natural	natural	ADJ
iajs-3148	71	11	killer	killer	NOUN
iajs-3148	71	12	cells	cell	NOUN
iajs-3148	71	13	,	,	PUNCT
iajs-3148	71	14	but	but	CCONJ
iajs-3148	71	15	in	in	ADP
iajs-3148	71	16	our	our	PRON
iajs-3148	71	17	study	study	NOUN
iajs-3148	71	18	,	,	PUNCT
iajs-3148	71	19	the	the	DET
iajs-3148	71	20	level	level	NOUN
iajs-3148	71	21	of	of	ADP
iajs-3148	71	22	il15	il15	PROPN
iajs-3148	71	23	did	do	AUX
iajs-3148	71	24	not	not	PART
iajs-3148	71	25	show	show	VERB
iajs-3148	71	26	any	any	DET
iajs-3148	71	27	change	change	NOUN
iajs-3148	71	28	in	in	ADP
iajs-3148	71	29	psoriasis	psoriasis	NOUN
iajs-3148	71	30	patients	patient	NOUN
iajs-3148	71	31	compared	compare	VERB
iajs-3148	71	32	to	to	ADP
iajs-3148	71	33	control	control	NOUN
iajs-3148	71	34	,	,	PUNCT
iajs-3148	71	35	also	also	ADV
iajs-3148	71	36	,	,	PUNCT
iajs-3148	71	37	this	this	DET
iajs-3148	71	38	statistical	statistical	ADJ
iajs-3148	71	39	result	result	NOUN
iajs-3148	71	40	was	be	AUX
iajs-3148	71	41	in	in	ADP
iajs-3148	71	42	agreement	agreement	NOUN
iajs-3148	71	43	with	with	ADP
iajs-3148	71	44	other	other	ADJ
iajs-3148	71	45	studies	study	NOUN
iajs-3148	71	46	[	[	X
iajs-3148	71	47	41	41	NUM
iajs-3148	71	48	]	]	X
iajs-3148	72	1	[	[	X
iajs-3148	72	2	42	42	NUM
iajs-3148	72	3	]	]	PUNCT
iajs-3148	73	1	[	[	X
iajs-3148	73	2	43	43	NUM
iajs-3148	73	3	]	]	PUNCT
iajs-3148	73	4	.	.	PUNCT
iajs-3148	74	1	interleukin-15	interleukin-15	NOUN
iajs-3148	74	2	blood	blood	NOUN
iajs-3148	74	3	levels	level	NOUN
iajs-3148	74	4	which	which	PRON
iajs-3148	74	5	are	be	AUX
iajs-3148	74	6	essential	essential	ADJ
iajs-3148	74	7	for	for	ADP
iajs-3148	74	8	regulating	regulate	VERB
iajs-3148	74	9	nk	nk	PROPN
iajs-3148	74	10	cell	cell	NOUN
iajs-3148	74	11	activity	activity	NOUN
iajs-3148	74	12	were	be	AUX
iajs-3148	74	13	also	also	ADV
iajs-3148	74	14	discovered	discover	VERB
iajs-3148	74	15	to	to	PART
iajs-3148	74	16	be	be	AUX
iajs-3148	74	17	similar	similar	ADJ
iajs-3148	74	18	in	in	ADP
iajs-3148	74	19	both	both	PRON
iajs-3148	74	20	psoriasis	psoriasis	NOUN
iajs-3148	74	21	patients	patient	NOUN
iajs-3148	74	22	and	and	CCONJ
iajs-3148	74	23	healthy	healthy	ADJ
iajs-3148	74	24	controls	control	NOUN
iajs-3148	74	25	[	[	X
iajs-3148	74	26	45	45	NUM
iajs-3148	74	27	]	]	PUNCT
iajs-3148	74	28	.	.	PUNCT
iajs-3148	75	1	also	also	ADV
iajs-3148	75	2	,	,	PUNCT
iajs-3148	75	3	a	a	DET
iajs-3148	75	4	number	number	NOUN
iajs-3148	75	5	of	of	ADP
iajs-3148	75	6	studies	study	NOUN
iajs-3148	75	7	were	be	AUX
iajs-3148	75	8	conducted	conduct	VERB
iajs-3148	75	9	on	on	ADP
iajs-3148	75	10	patients	patient	NOUN
iajs-3148	75	11	suffering	suffer	VERB
iajs-3148	75	12	from	from	ADP
iajs-3148	75	13	covid-19	covid-19	PROPN
iajs-3148	75	14	,	,	PUNCT
iajs-3148	75	15	and	and	CCONJ
iajs-3148	75	16	according	accord	VERB
iajs-3148	75	17	to	to	ADP
iajs-3148	75	18	statistical	statistical	ADJ
iajs-3148	75	19	studies	study	NOUN
iajs-3148	75	20	,	,	PUNCT
iajs-3148	75	21	an	an	DET
iajs-3148	75	22	increase	increase	NOUN
iajs-3148	75	23	in	in	ADP
iajs-3148	75	24	the	the	DET
iajs-3148	75	25	level	level	NOUN
iajs-3148	75	26	of	of	ADP
iajs-3148	75	27	il-15	il-15	PUNCT
iajs-3148	75	28	was	be	AUX
iajs-3148	75	29	found	find	VERB
iajs-3148	75	30	in	in	ADP
iajs-3148	75	31	the	the	DET
iajs-3148	75	32	blood	blood	NOUN
iajs-3148	75	33	of	of	ADP
iajs-3148	75	34	patients	patient	NOUN
iajs-3148	75	35	,	,	PUNCT
iajs-3148	75	36	and	and	CCONJ
iajs-3148	75	37	this	this	PRON
iajs-3148	75	38	indicates	indicate	VERB
iajs-3148	75	39	an	an	DET
iajs-3148	75	40	inflammatory	inflammatory	ADJ
iajs-3148	75	41	cycle	cycle	NOUN
iajs-3148	75	42	.	.	PUNCT
iajs-3148	76	1	despite	despite	SCONJ
iajs-3148	76	2	this	this	PRON
iajs-3148	76	3	,	,	PUNCT
iajs-3148	76	4	an	an	DET
iajs-3148	76	5	increase	increase	NOUN
iajs-3148	76	6	in	in	ADP
iajs-3148	76	7	the	the	DET
iajs-3148	76	8	level	level	NOUN
iajs-3148	76	9	of	of	ADP
iajs-3148	76	10	il-15	il-15	NOUN
iajs-3148	76	11	was	be	AUX
iajs-3148	76	12	not	not	PART
iajs-3148	76	13	observed	observe	VERB
iajs-3148	76	14	in	in	ADP
iajs-3148	76	15	patients	patient	NOUN
iajs-3148	76	16	with	with	ADP
iajs-3148	76	17	psoriasis.[46	psoriasis.[46	NOUN
iajs-3148	76	18	]	]	PUNCT
iajs-3148	76	19	it	it	PRON
iajs-3148	76	20	has	have	AUX
iajs-3148	76	21	also	also	ADV
iajs-3148	76	22	been	be	AUX
iajs-3148	76	23	demonstrated	demonstrate	VERB
iajs-3148	76	24	that	that	SCONJ
iajs-3148	76	25	il-15	il-15	NOUN
iajs-3148	76	26	is	be	AUX
iajs-3148	76	27	a	a	DET
iajs-3148	76	28	potentially	potentially	ADV
iajs-3148	76	29	relevant	relevant	ADJ
iajs-3148	76	30	target	target	NOUN
iajs-3148	76	31	in	in	ADP
iajs-3148	76	32	the	the	DET
iajs-3148	76	33	il-17	il-17	NUM
iajs-3148	76	34	response	response	NOUN
iajs-3148	76	35	in	in	ADP
iajs-3148	76	36	psoriasis	psoriasis	NOUN
iajs-3148	76	37	.	.	PUNCT
iajs-3148	77	1	however	however	ADV
iajs-3148	77	2	,	,	PUNCT
iajs-3148	77	3	its	its	PRON
iajs-3148	77	4	mechanism	mechanism	NOUN
iajs-3148	77	5	is	be	AUX
iajs-3148	77	6	weak	weak	ADJ
iajs-3148	77	7	in	in	ADP
iajs-3148	77	8	humans	human	NOUN
iajs-3148	77	9	and	and	CCONJ
iajs-3148	77	10	this	this	PRON
iajs-3148	77	11	may	may	AUX
iajs-3148	77	12	explain	explain	VERB
iajs-3148	77	13	the	the	DET
iajs-3148	77	14	lack	lack	NOUN
iajs-3148	77	15	of	of	ADP
iajs-3148	77	16	levels	level	NOUN
iajs-3148	77	17	in	in	ADP
iajs-3148	77	18	the	the	DET
iajs-3148	77	19	blood	blood	NOUN
iajs-3148	77	20	of	of	ADP
iajs-3148	77	21	patients	patient	NOUN
iajs-3148	77	22	with	with	ADP
iajs-3148	77	23	psoriasis	psoriasis	NOUN
iajs-3148	77	24	[	[	X
iajs-3148	77	25	47	47	NUM
iajs-3148	77	26	]	]	PUNCT
iajs-3148	77	27	ihjpas	ihjpa	NOUN
iajs-3148	77	28	.	.	PUNCT
iajs-3148	78	1	37	37	NUM
iajs-3148	78	2	(	(	PUNCT
iajs-3148	78	3	1	1	NUM
iajs-3148	78	4	)	)	PUNCT
iajs-3148	78	5	2024	2024	NUM
iajs-3148	78	6	80	80	NUM
iajs-3148	78	7	figure	figure	NOUN
iajs-3148	78	8	4	4	NUM
iajs-3148	78	9	:	:	PUNCT
iajs-3148	78	10	correlation	correlation	NOUN
iajs-3148	78	11	between	between	ADP
iajs-3148	78	12	serum	serum	NOUN
iajs-3148	78	13	levels	level	NOUN
iajs-3148	78	14	of	of	ADP
iajs-3148	78	15	il-23	il-23	NOUN
iajs-3148	78	16	and	and	CCONJ
iajs-3148	78	17	il-15	il-15	NOUN
iajs-3148	78	18	in	in	ADP
iajs-3148	78	19	psoriasis	psoriasis	NOUN
iajs-3148	78	20	patients	patient	NOUN
iajs-3148	78	21	.	.	PUNCT
iajs-3148	79	1	(	(	PUNCT
iajs-3148	79	2	p	p	X
iajs-3148	79	3	<	<	X
iajs-3148	79	4	0.01	0.01	NUM
iajs-3148	79	5	,	,	PUNCT
iajs-3148	79	6	r=0.52	r=0.52	NOUN
iajs-3148	79	7	)	)	PUNCT
iajs-3148	79	8	the	the	DET
iajs-3148	79	9	statistical	statistical	ADJ
iajs-3148	79	10	study	study	NOUN
iajs-3148	79	11	showed	show	VERB
iajs-3148	79	12	a	a	DET
iajs-3148	79	13	positive	positive	ADJ
iajs-3148	79	14	and	and	CCONJ
iajs-3148	79	15	strong	strong	ADJ
iajs-3148	79	16	significant	significant	ADJ
iajs-3148	79	17	correlation	correlation	NOUN
iajs-3148	79	18	between	between	ADP
iajs-3148	79	19	the	the	DET
iajs-3148	79	20	levels	level	NOUN
iajs-3148	79	21	of	of	ADP
iajs-3148	79	22	il-15	il-15	NOUN
iajs-3148	79	23	and	and	CCONJ
iajs-3148	79	24	il-23	il-23	NOUN
iajs-3148	79	25	in	in	ADP
iajs-3148	79	26	patients	patient	NOUN
iajs-3148	79	27	with	with	ADP
iajs-3148	79	28	psoriasis	psoriasis	NOUN
iajs-3148	79	29	,	,	PUNCT
iajs-3148	79	30	which	which	PRON
iajs-3148	79	31	means	mean	VERB
iajs-3148	79	32	that	that	SCONJ
iajs-3148	79	33	the	the	DET
iajs-3148	79	34	increase	increase	NOUN
iajs-3148	79	35	of	of	ADP
iajs-3148	79	36	one	one	NUM
iajs-3148	79	37	of	of	ADP
iajs-3148	79	38	them	they	PRON
iajs-3148	79	39	may	may	AUX
iajs-3148	79	40	lead	lead	VERB
iajs-3148	79	41	to	to	ADP
iajs-3148	79	42	a	a	DET
iajs-3148	79	43	rise	rise	NOUN
iajs-3148	79	44	in	in	ADP
iajs-3148	79	45	the	the	DET
iajs-3148	79	46	other	other	ADJ
iajs-3148	79	47	in	in	ADP
iajs-3148	79	48	this	this	DET
iajs-3148	79	49	pathological	pathological	ADJ
iajs-3148	79	50	condition	condition	NOUN
iajs-3148	79	51	(	(	PUNCT
iajs-3148	79	52	figure	figure	NOUN
iajs-3148	79	53	4	4	NUM
iajs-3148	79	54	)	)	PUNCT
iajs-3148	79	55	.	.	PUNCT
iajs-3148	80	1	de	de	PROPN
iajs-3148	80	2	jesús‐gil	jesús‐gil	PROPN
iajs-3148	80	3	et	et	PROPN
iajs-3148	80	4	al	al	PROPN
iajs-3148	80	5	is	be	AUX
iajs-3148	80	6	found	find	VERB
iajs-3148	80	7	that	that	SCONJ
iajs-3148	80	8	both	both	PRON
iajs-3148	80	9	il-15	il-15	NOUN
iajs-3148	80	10	and	and	CCONJ
iajs-3148	80	11	l-23	l-23	NOUN
iajs-3148	80	12	are	be	AUX
iajs-3148	80	13	present	present	ADJ
iajs-3148	80	14	in	in	ADP
iajs-3148	80	15	patients	patient	NOUN
iajs-3148	80	16	with	with	ADP
iajs-3148	80	17	psoriasis	psoriasis	NOUN
iajs-3148	80	18	[	[	X
iajs-3148	80	19	48	48	NUM
iajs-3148	80	20	]	]	PUNCT
iajs-3148	80	21	.	.	PUNCT
iajs-3148	81	1	also	also	ADV
iajs-3148	81	2	,	,	PUNCT
iajs-3148	81	3	the	the	DET
iajs-3148	81	4	present	present	ADJ
iajs-3148	81	5	results	result	NOUN
iajs-3148	81	6	came	come	VERB
iajs-3148	81	7	in	in	ADP
iajs-3148	81	8	line	line	NOUN
iajs-3148	81	9	with	with	ADP
iajs-3148	81	10	these	these	DET
iajs-3148	81	11	previous	previous	ADJ
iajs-3148	81	12	studies	study	NOUN
iajs-3148	81	13	.	.	PUNCT
iajs-3148	82	1	where	where	SCONJ
iajs-3148	82	2	the	the	DET
iajs-3148	82	3	results	result	NOUN
iajs-3148	82	4	indicate	indicate	VERB
iajs-3148	82	5	the	the	DET
iajs-3148	82	6	synergistic	synergistic	ADJ
iajs-3148	82	7	action	action	NOUN
iajs-3148	82	8	of	of	ADP
iajs-3148	82	9	il-15	il-15	NOUN
iajs-3148	82	10	and	and	CCONJ
iajs-3148	82	11	il-23	il-23	NOUN
iajs-3148	82	12	selectively	selectively	ADV
iajs-3148	82	13	in	in	ADP
iajs-3148	82	14	cutaneous	cutaneous	ADJ
iajs-3148	82	15	lymphocyte	lymphocyte	NOUN
iajs-3148	82	16	-	-	PUNCT
iajs-3148	82	17	associated	associate	VERB
iajs-3148	82	18	antigen	antigen	NOUN
iajs-3148	82	19	(	(	PUNCT
iajs-3148	82	20	cla	cla	NOUN
iajs-3148	82	21	)	)	PUNCT
iajs-3148	82	22	positive	positive	ADJ
iajs-3148	82	23	(	(	PUNCT
iajs-3148	82	24	+	+	ADJ
iajs-3148	82	25	)	)	PUNCT
iajs-3148	82	26	memory	memory	NOUN
iajs-3148	82	27	t	t	NOUN
iajs-3148	82	28	cells	cell	NOUN
iajs-3148	82	29	in	in	ADP
iajs-3148	82	30	psoriasis	psoriasis	NOUN
iajs-3148	82	31	[	[	X
iajs-3148	82	32	49	49	NUM
iajs-3148	82	33	]	]	PUNCT
iajs-3148	82	34	,	,	PUNCT
iajs-3148	82	35	some	some	DET
iajs-3148	82	36	research	research	NOUN
iajs-3148	82	37	has	have	AUX
iajs-3148	82	38	also	also	ADV
iajs-3148	82	39	indicated	indicate	VERB
iajs-3148	82	40	that	that	SCONJ
iajs-3148	82	41	il-15	il-15	AUX
iajs-3148	82	42	not	not	PART
iajs-3148	82	43	only	only	ADV
iajs-3148	82	44	increased	increase	VERB
iajs-3148	82	45	il-23	il-23	NOUN
iajs-3148	82	46	-	-	PUNCT
iajs-3148	82	47	expressing	express	VERB
iajs-3148	82	48	cd4	cd4	PROPN
iajs-3148	82	49	+	+	PROPN
iajs-3148	82	50	t	t	NOUN
iajs-3148	82	51	cells	cell	NOUN
iajs-3148	82	52	,	,	PUNCT
iajs-3148	82	53	but	but	CCONJ
iajs-3148	82	54	also	also	ADV
iajs-3148	82	55	enhanced	enhance	VERB
iajs-3148	82	56	antigen	antigen	ADP
iajs-3148	82	57	-specific	-specific	PROPN
iajs-3148	82	58	il-17	il-17	PART
iajs-3148	82	59	production	production	NOUN
iajs-3148	82	60	,	,	PUNCT
iajs-3148	82	61	synergistic	synergistic	ADJ
iajs-3148	82	62	with	with	ADP
iajs-3148	82	63	il-23	il-23	NOUN
iajs-3148	82	64	this	this	PRON
iajs-3148	82	65	explains	explain	VERB
iajs-3148	82	66	the	the	DET
iajs-3148	82	67	positive	positive	ADJ
iajs-3148	82	68	correlation	correlation	NOUN
iajs-3148	82	69	between	between	ADP
iajs-3148	82	70	these	these	DET
iajs-3148	82	71	cytokines	cytokine	NOUN
iajs-3148	82	72	[	[	X
iajs-3148	82	73	50	50	NUM
iajs-3148	82	74	]	]	PUNCT
iajs-3148	82	75	.	.	PUNCT
iajs-3148	83	1	the	the	DET
iajs-3148	83	2	same	same	ADJ
iajs-3148	83	3	correlation	correlation	NOUN
iajs-3148	83	4	was	be	AUX
iajs-3148	83	5	noted	note	VERB
iajs-3148	83	6	between	between	ADP
iajs-3148	83	7	the	the	DET
iajs-3148	83	8	level	level	NOUN
iajs-3148	83	9	of	of	ADP
iajs-3148	83	10	il-15	il-15	NOUN
iajs-3148	83	11	and	and	CCONJ
iajs-3148	83	12	the	the	DET
iajs-3148	83	13	tnf	tnf	PROPN
iajs-3148	83	14	-	-	PUNCT
iajs-3148	83	15	α	α	NOUN
iajs-3148	83	16	level	level	NOUN
iajs-3148	83	17	,	,	PUNCT
iajs-3148	83	18	and	and	CCONJ
iajs-3148	83	19	a	a	DET
iajs-3148	83	20	moderate	moderate	ADJ
iajs-3148	83	21	positive	positive	ADJ
iajs-3148	83	22	significant	significant	ADJ
iajs-3148	83	23	correlation	correlation	NOUN
iajs-3148	83	24	coefficient	coefficient	NOUN
iajs-3148	83	25	was	be	AUX
iajs-3148	83	26	found	find	VERB
iajs-3148	83	27	between	between	ADP
iajs-3148	83	28	them	they	PRON
iajs-3148	83	29	in	in	ADP
iajs-3148	83	30	the	the	DET
iajs-3148	83	31	group	group	NOUN
iajs-3148	83	32	of	of	ADP
iajs-3148	83	33	patients	patient	NOUN
iajs-3148	83	34	(	(	PUNCT
iajs-3148	83	35	figure	figure	NOUN
iajs-3148	83	36	5	5	NUM
iajs-3148	83	37	)	)	PUNCT
iajs-3148	83	38	.	.	PUNCT
iajs-3148	84	1	also	also	ADV
iajs-3148	84	2	,	,	PUNCT
iajs-3148	84	3	a	a	DET
iajs-3148	84	4	significant	significant	ADJ
iajs-3148	84	5	correlation	correlation	NOUN
iajs-3148	84	6	was	be	AUX
iajs-3148	84	7	strong	strong	ADJ
iajs-3148	84	8	between	between	ADP
iajs-3148	84	9	the	the	DET
iajs-3148	84	10	level	level	NOUN
iajs-3148	84	11	of	of	ADP
iajs-3148	84	12	il-23	il-23	NOUN
iajs-3148	84	13	and	and	CCONJ
iajs-3148	84	14	tnfα	tnfα	NOUN
iajs-3148	84	15	in	in	ADP
iajs-3148	84	16	the	the	DET
iajs-3148	84	17	group	group	NOUN
iajs-3148	84	18	of	of	ADP
iajs-3148	84	19	patients	patient	NOUN
iajs-3148	84	20	(	(	PUNCT
iajs-3148	84	21	figure	figure	VERB
iajs-3148	84	22	6	6	NUM
iajs-3148	84	23	)	)	PUNCT
iajs-3148	84	24	.	.	PUNCT
iajs-3148	85	1	figure	figure	NOUN
iajs-3148	85	2	5	5	NUM
iajs-3148	85	3	.	.	PUNCT
iajs-3148	85	4	correlation	correlation	NOUN
iajs-3148	85	5	between	between	ADP
iajs-3148	85	6	serum	serum	NOUN
iajs-3148	85	7	levels	level	NOUN
iajs-3148	85	8	of	of	ADP
iajs-3148	85	9	tnf	tnf	PROPN
iajs-3148	85	10	-	-	PUNCT
iajs-3148	85	11	α	α	PROPN
iajs-3148	85	12	and	and	CCONJ
iajs-3148	85	13	il-15	il-15	NOUN
iajs-3148	85	14	in	in	ADP
iajs-3148	85	15	psoriasis	psoriasis	NOUN
iajs-3148	85	16	patients	patient	NOUN
iajs-3148	85	17	.	.	PUNCT
iajs-3148	86	1	(	(	PUNCT
iajs-3148	86	2	p	p	X
iajs-3148	86	3	<	<	X
iajs-3148	86	4	0.01	0.01	NUM
iajs-3148	86	5	,	,	PUNCT
iajs-3148	86	6	r=0.49	r=0.49	NOUN
iajs-3148	86	7	)	)	PUNCT
iajs-3148	86	8	9008007006005004003002001000	9008007006005004003002001000	NUM
iajs-3148	86	9	1000	1000	NUM
iajs-3148	86	10	800	800	NUM
iajs-3148	86	11	600	600	NUM
iajs-3148	86	12	400	400	NUM
iajs-3148	86	13	200	200	NUM
iajs-3148	86	14	0	0	NUM
iajs-3148	86	15	r	r	NOUN
iajs-3148	86	16	=	=	NOUN
iajs-3148	86	17	0.49	0.49	NUM
iajs-3148	86	18	p	p	NOUN
iajs-3148	86	19	-	-	PUNCT
iajs-3148	86	20	value	value	NOUN
iajs-3148	86	21	=	=	NOUN
iajs-3148	86	22	0.001	0.001	NUM
iajs-3148	86	23	r	r	NOUN
iajs-3148	86	24	-	-	PUNCT
iajs-3148	86	25	sq	sq	ADJ
iajs-3148	86	26	=	=	NOUN
iajs-3148	86	27	22.9	22.9	NUM
iajs-3148	86	28	%	%	NOUN
iajs-3148	86	29	il-15	il-15	NOUN
iajs-3148	86	30	tn	tn	NOUN
iajs-3148	86	31	fα	fα	NOUN
iajs-3148	86	32	ihjpas	ihjpas	PROPN
iajs-3148	86	33	.	.	PUNCT
iajs-3148	87	1	37	37	NUM
iajs-3148	87	2	(	(	PUNCT
iajs-3148	87	3	1	1	NUM
iajs-3148	87	4	)	)	PUNCT
iajs-3148	87	5	2024	2024	NUM
iajs-3148	87	6	81	81	NUM
iajs-3148	87	7	figure	figure	NOUN
iajs-3148	87	8	6	6	NUM
iajs-3148	87	9	:	:	PUNCT
iajs-3148	87	10	correlation	correlation	NOUN
iajs-3148	87	11	between	between	ADP
iajs-3148	87	12	serum	serum	NOUN
iajs-3148	87	13	levels	level	NOUN
iajs-3148	87	14	of	of	ADP
iajs-3148	87	15	tnf	tnf	PROPN
iajs-3148	87	16	-	-	PUNCT
iajs-3148	87	17	α	α	PROPN
iajs-3148	87	18	and	and	CCONJ
iajs-3148	87	19	il-23	il-23	NOUN
iajs-3148	87	20	in	in	ADP
iajs-3148	87	21	psoriasis	psoriasis	NOUN
iajs-3148	87	22	patients	patient	NOUN
iajs-3148	87	23	.	.	PUNCT
iajs-3148	88	1	(	(	PUNCT
iajs-3148	88	2	p	p	X
iajs-3148	88	3	<	<	X
iajs-3148	88	4	0.01	0.01	NUM
iajs-3148	88	5	,	,	PUNCT
iajs-3148	88	6	r=0.77	r=0.77	NOUN
iajs-3148	89	1	)	)	PUNCT
iajs-3148	89	2	the	the	DET
iajs-3148	89	3	reason	reason	NOUN
iajs-3148	89	4	for	for	ADP
iajs-3148	89	5	this	this	DET
iajs-3148	89	6	correlation	correlation	NOUN
iajs-3148	89	7	is	be	AUX
iajs-3148	89	8	that	that	PRON
iajs-3148	89	9	il-15	il-15	ADV
iajs-3148	89	10	facilitates	facilitate	VERB
iajs-3148	89	11	the	the	DET
iajs-3148	89	12	persistence	persistence	NOUN
iajs-3148	89	13	of	of	ADP
iajs-3148	89	14	lymphocytes	lymphocyte	NOUN
iajs-3148	89	15	and	and	CCONJ
iajs-3148	89	16	also	also	ADV
iajs-3148	89	17	stimulates	stimulate	VERB
iajs-3148	89	18	the	the	DET
iajs-3148	89	19	production	production	NOUN
iajs-3148	89	20	of	of	ADP
iajs-3148	89	21	certain	certain	ADJ
iajs-3148	89	22	inflammatory	inflammatory	ADJ
iajs-3148	89	23	cytokines	cytokine	NOUN
iajs-3148	89	24	,	,	PUNCT
iajs-3148	89	25	one	one	NUM
iajs-3148	89	26	of	of	ADP
iajs-3148	89	27	which	which	PRON
iajs-3148	89	28	is	be	AUX
iajs-3148	89	29	tnf	tnf	PROPN
iajs-3148	89	30	-	-	PUNCT
iajs-3148	89	31	α	α	PROPN
iajs-3148	89	32	.	.	PUNCT
iajs-3148	90	1	in	in	ADP
iajs-3148	90	2	addition	addition	NOUN
iajs-3148	90	3	,	,	PUNCT
iajs-3148	90	4	dysregulated	dysregulated	ADJ
iajs-3148	90	5	expression	expression	NOUN
iajs-3148	90	6	of	of	ADP
iajs-3148	90	7	il-15	il-15	NOUN
iajs-3148	90	8	can	can	AUX
iajs-3148	90	9	lead	lead	VERB
iajs-3148	90	10	to	to	ADP
iajs-3148	90	11	the	the	DET
iajs-3148	90	12	development	development	NOUN
iajs-3148	90	13	of	of	ADP
iajs-3148	90	14	autoimmune	autoimmune	ADJ
iajs-3148	90	15	diseases	disease	NOUN
iajs-3148	90	16	[	[	X
iajs-3148	90	17	51	51	NUM
iajs-3148	90	18	]	]	PUNCT
iajs-3148	90	19	.	.	PUNCT
iajs-3148	91	1	the	the	DET
iajs-3148	91	2	present	present	ADJ
iajs-3148	91	3	results	result	NOUN
iajs-3148	91	4	are	be	AUX
iajs-3148	91	5	in	in	ADP
iajs-3148	91	6	agreement	agreement	NOUN
iajs-3148	91	7	with	with	ADP
iajs-3148	91	8	some	some	DET
iajs-3148	91	9	previous	previous	ADJ
iajs-3148	91	10	studies	study	NOUN
iajs-3148	91	11	previous	previous	ADJ
iajs-3148	91	12	studies	study	NOUN
iajs-3148	91	13	.	.	PUNCT
iajs-3148	92	1	also	also	ADV
iajs-3148	92	2	,	,	PUNCT
iajs-3148	92	3	fraga	fraga	PROPN
iajs-3148	92	4	et	et	PROPN
iajs-3148	92	5	al	al	PROPN
iajs-3148	92	6	.	.	PROPN
iajs-3148	92	7	said	say	VERB
iajs-3148	92	8	that	that	SCONJ
iajs-3148	92	9	there	there	PRON
iajs-3148	92	10	is	be	VERB
iajs-3148	92	11	a	a	DET
iajs-3148	92	12	linear	linear	ADJ
iajs-3148	92	13	relationship	relationship	NOUN
iajs-3148	92	14	between	between	ADP
iajs-3148	92	15	il-23	il-23	NOUN
iajs-3148	92	16	and	and	CCONJ
iajs-3148	92	17	tnf	tnf	PROPN
iajs-3148	92	18	-	-	PUNCT
iajs-3148	92	19	α	α	PROPN
iajs-3148	92	20	production	production	NOUN
iajs-3148	92	21	by	by	ADP
iajs-3148	92	22	type	type	NOUN
iajs-3148	92	23	1	1	NUM
iajs-3148	92	24	t	t	NOUN
iajs-3148	92	25	cells	cell	NOUN
iajs-3148	92	26	[	[	X
iajs-3148	92	27	52	52	NUM
iajs-3148	92	28	]	]	PUNCT
iajs-3148	92	29	,	,	PUNCT
iajs-3148	92	30	and	and	CCONJ
iajs-3148	92	31	this	this	PRON
iajs-3148	92	32	explains	explain	VERB
iajs-3148	92	33	the	the	DET
iajs-3148	92	34	significant	significant	ADJ
iajs-3148	92	35	correlation	correlation	NOUN
iajs-3148	92	36	between	between	ADP
iajs-3148	92	37	il-23	il-23	NOUN
iajs-3148	92	38	and	and	CCONJ
iajs-3148	92	39	tnf	tnf	PROPN
iajs-3148	92	40	-	-	PUNCT
iajs-3148	92	41	α	α	PROPN
iajs-3148	92	42	levels	level	NOUN
iajs-3148	92	43	.	.	PUNCT
iajs-3148	93	1	4	4	X
iajs-3148	93	2	.	.	X
iajs-3148	93	3	conclusions	conclusion	NOUN
iajs-3148	93	4	this	this	PRON
iajs-3148	93	5	indicates	indicate	VERB
iajs-3148	93	6	that	that	SCONJ
iajs-3148	93	7	there	there	PRON
iajs-3148	93	8	is	be	VERB
iajs-3148	93	9	a	a	DET
iajs-3148	93	10	clear	clear	ADJ
iajs-3148	93	11	association	association	NOUN
iajs-3148	93	12	between	between	ADP
iajs-3148	93	13	these	these	DET
iajs-3148	93	14	interleukins	interleukin	NOUN
iajs-3148	93	15	(	(	PUNCT
iajs-3148	93	16	il-15	il-15	NOUN
iajs-3148	93	17	-	-	PUNCT
iajs-3148	93	18	il-23	il-23	NOUN
iajs-3148	93	19	-	-	PUNCT
iajs-3148	93	20	tnf	tnf	NOUN
iajs-3148	93	21	-	-	PUNCT
iajs-3148	93	22	α	α	NOUN
iajs-3148	93	23	)	)	PUNCT
iajs-3148	93	24	as	as	ADV
iajs-3148	93	25	well	well	ADV
iajs-3148	93	26	as	as	SCONJ
iajs-3148	93	27	there	there	PRON
iajs-3148	93	28	may	may	AUX
iajs-3148	93	29	be	be	AUX
iajs-3148	93	30	an	an	DET
iajs-3148	93	31	association	association	NOUN
iajs-3148	93	32	between	between	ADP
iajs-3148	93	33	the	the	DET
iajs-3148	93	34	studied	study	VERB
iajs-3148	93	35	cytokines	cytokine	NOUN
iajs-3148	93	36	and	and	CCONJ
iajs-3148	93	37	indicates	indicate	VERB
iajs-3148	93	38	the	the	DET
iajs-3148	93	39	rise	rise	NOUN
iajs-3148	93	40	in	in	ADP
iajs-3148	93	41	the	the	DET
iajs-3148	93	42	level	level	NOUN
iajs-3148	93	43	of	of	ADP
iajs-3148	93	44	cytokines	cytokine	NOUN
iajs-3148	93	45	in	in	ADP
iajs-3148	93	46	psoriasis	psoriasis	NOUN
iajs-3148	93	47	and	and	CCONJ
iajs-3148	93	48	its	its	PRON
iajs-3148	93	49	control	control	NOUN
iajs-3148	93	50	and	and	CCONJ
iajs-3148	93	51	its	its	PRON
iajs-3148	93	52	association	association	NOUN
iajs-3148	93	53	with	with	ADP
iajs-3148	93	54	the	the	DET
iajs-3148	93	55	inflammatory	inflammatory	ADJ
iajs-3148	93	56	state	state	NOUN
iajs-3148	93	57	of	of	ADP
iajs-3148	93	58	psoriasis	psoriasis	NOUN
iajs-3148	93	59	patients	patient	NOUN
iajs-3148	93	60	although	although	SCONJ
iajs-3148	93	61	there	there	PRON
iajs-3148	93	62	is	be	VERB
iajs-3148	93	63	no	no	PRON
iajs-3148	93	64	there	there	PRON
iajs-3148	93	65	is	be	VERB
iajs-3148	93	66	an	an	DET
iajs-3148	93	67	increase	increase	NOUN
iajs-3148	93	68	in	in	ADP
iajs-3148	93	69	the	the	DET
iajs-3148	93	70	level	level	NOUN
iajs-3148	93	71	of	of	ADP
iajs-3148	93	72	interleukin	interleukin	NOUN
iajs-3148	93	73	15	15	NUM
iajs-3148	93	74	,	,	PUNCT
iajs-3148	93	75	but	but	CCONJ
iajs-3148	93	76	its	its	PRON
iajs-3148	93	77	association	association	NOUN
iajs-3148	93	78	with	with	ADP
iajs-3148	93	79	other	other	ADJ
iajs-3148	93	80	inflammatory	inflammatory	ADJ
iajs-3148	93	81	indicators	indicator	NOUN
iajs-3148	93	82	proves	prove	VERB
iajs-3148	93	83	its	its	PRON
iajs-3148	93	84	involvement	involvement	NOUN
iajs-3148	93	85	in	in	ADP
iajs-3148	93	86	psoriasis	psoriasis	NOUN
iajs-3148	93	87	.	.	PUNCT
iajs-3148	94	1	acknowledgment	acknowledgment	NOUN
iajs-3148	94	2	we	we	PRON
iajs-3148	94	3	extend	extend	VERB
iajs-3148	94	4	our	our	PRON
iajs-3148	94	5	sincere	sincere	ADJ
iajs-3148	94	6	thanks	thank	NOUN
iajs-3148	94	7	to	to	ADP
iajs-3148	94	8	editor	editor	NOUN
iajs-3148	94	9	-	-	PUNCT
iajs-3148	94	10	in	in	ADP
iajs-3148	94	11	-	-	PUNCT
iajs-3148	94	12	chief	chief	NOUN
iajs-3148	94	13	and	and	CCONJ
iajs-3148	94	14	members	member	NOUN
iajs-3148	94	15	of	of	ADP
iajs-3148	94	16	the	the	DET
iajs-3148	94	17	editorial	editorial	ADJ
iajs-3148	94	18	committee	committee	NOUN
iajs-3148	94	19	in	in	ADP
iajs-3148	94	20	ibn	ibn	PROPN
iajs-3148	94	21	al	al	PROPN
iajs-3148	94	22	-	-	PUNCT
iajs-3148	94	23	haitham	haitham	PROPN
iajs-3148	94	24	journal	journal	PROPN
iajs-3148	94	25	for	for	ADP
iajs-3148	94	26	pure	pure	ADJ
iajs-3148	94	27	and	and	CCONJ
iajs-3148	94	28	applied	applied	ADJ
iajs-3148	94	29	sciences	science	NOUN
iajs-3148	94	30	.	.	PUNCT
iajs-3148	95	1	conflict	conflict	NOUN
iajs-3148	95	2	of	of	ADP
iajs-3148	95	3	interest	interest	NOUN
iajs-3148	95	4	there	there	PRON
iajs-3148	95	5	are	be	VERB
iajs-3148	95	6	no	no	DET
iajs-3148	95	7	conflicts	conflict	NOUN
iajs-3148	95	8	of	of	ADP
iajs-3148	95	9	interest	interest	NOUN
iajs-3148	95	10	.	.	PUNCT
iajs-3148	96	1	funding	funding	NOUN
iajs-3148	96	2	there	there	PRON
iajs-3148	96	3	is	be	VERB
iajs-3148	96	4	no	no	DET
iajs-3148	96	5	funding	funding	NOUN
iajs-3148	96	6	for	for	ADP
iajs-3148	96	7	the	the	DET
iajs-3148	96	8	article	article	NOUN
iajs-3148	96	9	.	.	PUNCT
iajs-3148	97	1	ethical	ethical	ADJ
iajs-3148	97	2	clearance	clearance	NOUN
iajs-3148	97	3	the	the	DET
iajs-3148	97	4	samples	sample	NOUN
iajs-3148	97	5	were	be	AUX
iajs-3148	97	6	gained	gain	VERB
iajs-3148	97	7	according	accord	VERB
iajs-3148	97	8	to	to	ADP
iajs-3148	97	9	the	the	DET
iajs-3148	97	10	university	university	NOUN
iajs-3148	97	11	of	of	ADP
iajs-3148	97	12	baghdad	baghdad	PROPN
iajs-3148	97	13	,	,	PUNCT
iajs-3148	97	14	college	college	NOUN
iajs-3148	97	15	of	of	ADP
iajs-3148	97	16	sciences	science	NOUN
iajs-3148	97	17	,	,	PUNCT
iajs-3148	97	18	ethics	ethic	NOUN
iajs-3148	97	19	approval	approval	NOUN
iajs-3148	97	20	committee	committee	NOUN
iajs-3148	97	21	.	.	PUNCT
iajs-3148	98	1	7006005004003002001000	7006005004003002001000	NUM
iajs-3148	98	2	900	900	NUM
iajs-3148	98	3	800	800	NUM
iajs-3148	98	4	700	700	NUM
iajs-3148	98	5	600	600	NUM
iajs-3148	98	6	500	500	NUM
iajs-3148	98	7	400	400	NUM
iajs-3148	98	8	300	300	NUM
iajs-3148	98	9	200	200	NUM
iajs-3148	98	10	100	100	NUM
iajs-3148	98	11	0	0	NUM
iajs-3148	98	12	r	r	NOUN
iajs-3148	98	13	=	=	SYM
iajs-3148	98	14	0.77	0.77	NUM
iajs-3148	98	15	p	p	NOUN
iajs-3148	98	16	-	-	PUNCT
iajs-3148	98	17	value	value	NOUN
iajs-3148	98	18	=	=	NOUN
iajs-3148	98	19	0.001	0.001	NUM
iajs-3148	98	20	r	r	NOUN
iajs-3148	98	21	-	-	PUNCT
iajs-3148	98	22	sq	sq	ADJ
iajs-3148	98	23	=	=	PROPN
iajs-3148	98	24	58.1	58.1	NUM
iajs-3148	98	25	%	%	NOUN
iajs-3148	98	26	li-23	li-23	NOUN
iajs-3148	98	27	tn	tn	NOUN
iajs-3148	98	28	fα	fα	NOUN
iajs-3148	98	29	ihjpas	ihjpa	VERB
iajs-3148	98	30	.	.	PUNCT
iajs-3148	99	1	37	37	NUM
iajs-3148	99	2	(	(	PUNCT
iajs-3148	99	3	1	1	NUM
iajs-3148	99	4	)	)	PUNCT
iajs-3148	99	5	2024	2024	NUM
iajs-3148	99	6	82	82	NUM
iajs-3148	99	7	references	reference	NOUN
iajs-3148	99	8	1	1	NUM
iajs-3148	99	9	.	.	PUNCT
iajs-3148	99	10	naldi	naldi	PROPN
iajs-3148	99	11	,	,	PUNCT
iajs-3148	99	12	l.	l.	PROPN
iajs-3148	99	13	epidemiology	epidemiology	NOUN
iajs-3148	99	14	of	of	ADP
iajs-3148	99	15	psoriasis	psoriasis	NOUN
iajs-3148	99	16	:	:	PUNCT
iajs-3148	99	17	current	current	ADJ
iajs-3148	99	18	drug	drug	NOUN
iajs-3148	99	19	targets	target	NOUN
iajs-3148	99	20	.	.	PUNCT
iajs-3148	100	1	inflamm	inflamm	PROPN
iajs-3148	100	2	.	.	PUNCT
iajs-3148	101	1	allergy	allergy	PROPN
iajs-3148	101	2	,	,	PUNCT
iajs-3148	101	3	2004	2004	NUM
iajs-3148	101	4	;	;	PUNCT
iajs-3148	101	5	3	3	NUM
iajs-3148	101	6	,	,	PUNCT
iajs-3148	101	7	2	2	NUM
iajs-3148	101	8	,	,	PUNCT
iajs-3148	101	9	121	121	NUM
iajs-3148	101	10	–	–	PUNCT
iajs-3148	101	11	128	128	NUM
iajs-3148	101	12	.	.	NOUN
iajs-3148	101	13	2	2	NUM
iajs-3148	101	14	.	.	X
iajs-3148	101	15	numerof	numerof	PROPN
iajs-3148	101	16	,	,	PUNCT
iajs-3148	101	17	r.p	r.p	PROPN
iajs-3148	101	18	.	.	PROPN
iajs-3148	101	19	;	;	PUNCT
iajs-3148	101	20	asadullah	asadullah	PROPN
iajs-3148	101	21	,	,	PUNCT
iajs-3148	101	22	k.	k.	PROPN
iajs-3148	101	23	cytokine	cytokine	PROPN
iajs-3148	101	24	and	and	CCONJ
iajs-3148	101	25	anti	anti	ADJ
iajs-3148	101	26	-	-	ADJ
iajs-3148	101	27	cytokine	cytokine	ADJ
iajs-3148	101	28	therapies	therapy	NOUN
iajs-3148	101	29	for	for	ADP
iajs-3148	101	30	psoriasis	psoriasis	NOUN
iajs-3148	101	31	and	and	CCONJ
iajs-3148	101	32	atopic	atopic	NOUN
iajs-3148	101	33	dermatitis	dermatitis	NOUN
iajs-3148	101	34	.	.	PUNCT
iajs-3148	102	1	j.	j.	PROPN
iajs-3148	102	2	bio	bio	PROPN
iajs-3148	102	3	.	.	PUNCT
iajs-3148	103	1	drugs	drug	NOUN
iajs-3148	103	2	,	,	PUNCT
iajs-3148	103	3	2006	2006	NUM
iajs-3148	103	4	;	;	PUNCT
iajs-3148	103	5	20	20	NUM
iajs-3148	103	6	,	,	PUNCT
iajs-3148	103	7	2,93	2,93	NUM
iajs-3148	103	8	-	-	SYM
iajs-3148	103	9	103	103	NUM
iajs-3148	103	10	.	.	PUNCT
iajs-3148	104	1	3	3	X
iajs-3148	104	2	.	.	X
iajs-3148	104	3	guðjónsson	guðjónsson	PROPN
iajs-3148	104	4	,	,	PUNCT
iajs-3148	104	5	j.	j.	PROPN
iajs-3148	104	6	e.	e.	PROPN
iajs-3148	104	7	;	;	PUNCT
iajs-3148	104	8	valdimarsson	valdimarsson	PROPN
iajs-3148	104	9	,	,	PUNCT
iajs-3148	104	10	h.	h.	PROPN
iajs-3148	104	11	;	;	PUNCT
iajs-3148	104	12	kárason	kárason	PROPN
iajs-3148	104	13	,	,	PUNCT
iajs-3148	104	14	a.	a.	NOUN
iajs-3148	104	15	;	;	PUNCT
iajs-3148	104	16	antonsdóttir	antonsdóttir	PROPN
iajs-3148	104	17	,	,	PUNCT
iajs-3148	104	18	a.	a.	NOUN
iajs-3148	104	19	a.	a.	NOUN
iajs-3148	104	20	;	;	PUNCT
iajs-3148	105	1	rúnarsdóttir	rúnarsdóttir	PROPN
iajs-3148	105	2	,	,	PUNCT
iajs-3148	105	3	e.	e.	PROPN
iajs-3148	105	4	h.;gulcher	h.;gulcher	PROPN
iajs-3148	105	5	,	,	PUNCT
iajs-3148	105	6	j.r	j.r	PROPN
iajs-3148	105	7	.	.	PROPN
iajs-3148	105	8	;	;	PUNCT
iajs-3148	105	9	stefánsson	stefánsson	PROPN
iajs-3148	105	10	,	,	PUNCT
iajs-3148	105	11	k	k	PROPN
iajs-3148	105	12	hla	hla	PROPN
iajs-3148	105	13	-	-	PUNCT
iajs-3148	105	14	cw6	cw6	NOUN
iajs-3148	105	15	-	-	PUNCT
iajs-3148	105	16	positive	positive	ADJ
iajs-3148	105	17	and	and	CCONJ
iajs-3148	105	18	hla	hla	ADJ
iajs-3148	105	19	-	-	PUNCT
iajs-3148	105	20	cw6	cw6	NOUN
iajs-3148	105	21	-	-	PUNCT
iajs-3148	105	22	negative	negative	ADJ
iajs-3148	105	23	patients	patient	NOUN
iajs-3148	105	24	with	with	ADP
iajs-3148	105	25	psoriasis	psoriasis	NOUN
iajs-3148	105	26	vulgaris	vulgaris	NOUN
iajs-3148	105	27	have	have	VERB
iajs-3148	105	28	distinct	distinct	ADJ
iajs-3148	105	29	clinical	clinical	ADJ
iajs-3148	105	30	features	feature	NOUN
iajs-3148	105	31	.	.	PUNCT
iajs-3148	106	1	j.	j.	PROPN
iajs-3148	106	2	investig	investig	PROPN
iajs-3148	106	3	.	.	PROPN
iajs-3148	106	4	dermatol	dermatol	NOUN
iajs-3148	106	5	.	.	PUNCT
iajs-3148	107	1	2002	2002	NUM
iajs-3148	107	2	,	,	PUNCT
iajs-3148	107	3	118	118	NUM
iajs-3148	107	4	,	,	PUNCT
iajs-3148	107	5	2	2	NUM
iajs-3148	107	6	,	,	PUNCT
iajs-3148	107	7	362	362	NUM
iajs-3148	107	8	-	-	SYM
iajs-3148	107	9	365	365	NUM
iajs-3148	107	10	.	.	PUNCT
iajs-3148	108	1	4	4	X
iajs-3148	108	2	.	.	X
iajs-3148	108	3	world	world	PROPN
iajs-3148	108	4	heath	heath	PROPN
iajs-3148	108	5	organization	organization	PROPN
iajs-3148	108	6	,	,	PUNCT
iajs-3148	108	7	global	global	ADJ
iajs-3148	108	8	report	report	NOUN
iajs-3148	108	9	in	in	ADP
iajs-3148	108	10	psoriasis	psoriasis	NOUN
iajs-3148	108	11	,	,	PUNCT
iajs-3148	108	12	2016	2016	NUM
iajs-3148	108	13	.	.	PUNCT
iajs-3148	109	1	5	5	NUM
iajs-3148	109	2	.	.	X
iajs-3148	109	3	kuba	kuba	PROPN
iajs-3148	109	4	,	,	PUNCT
iajs-3148	109	5	r.h	r.h	PROPN
iajs-3148	109	6	.	.	PROPN
iajs-3148	109	7	;	;	PUNCT
iajs-3148	109	8	al	al	PROPN
iajs-3148	109	9	-	-	PUNCT
iajs-3148	109	10	qadhi	qadhi	NOUN
iajs-3148	109	11	,	,	PUNCT
iajs-3148	109	12	b.n	b.n	PROPN
iajs-3148	109	13	.	.	PROPN
iajs-3148	109	14	;	;	PUNCT
iajs-3148	109	15	fadheel	fadheel	PROPN
iajs-3148	109	16	,	,	PUNCT
iajs-3148	109	17	b.m	b.m	PROPN
iajs-3148	109	18	.	.	PROPN
iajs-3148	109	19	;	;	PUNCT
iajs-3148	109	20	effect	effect	NOUN
iajs-3148	109	21	of	of	ADP
iajs-3148	109	22	the	the	DET
iajs-3148	109	23	biological	biological	ADJ
iajs-3148	109	24	drug	drug	NOUN
iajs-3148	109	25	etanercept	etanercept	NOUN
iajs-3148	109	26	on	on	ADP
iajs-3148	109	27	tumor	tumor	NOUN
iajs-3148	109	28	necrosis	necrosis	NOUN
iajs-3148	109	29	factor	factor	NOUN
iajs-3148	109	30	-	-	PUNCT
iajs-3148	109	31	α	α	NOUN
iajs-3148	109	32	levels	level	NOUN
iajs-3148	109	33	in	in	ADP
iajs-3148	109	34	psoriatic	psoriatic	ADJ
iajs-3148	109	35	patients	patient	NOUN
iajs-3148	109	36	.	.	PUNCT
iajs-3148	110	1	iraqi	iraqi	ADJ
iajs-3148	110	2	j.	j.	PROPN
iajs-3148	110	3	sci	sci	PROPN
iajs-3148	110	4	.	.	PROPN
iajs-3148	110	5	,	,	PUNCT
iajs-3148	110	6	2018	2018	NUM
iajs-3148	110	7	,	,	PUNCT
iajs-3148	110	8	59	59	NUM
iajs-3148	110	9	,	,	PUNCT
iajs-3148	110	10	2	2	NUM
iajs-3148	110	11	,	,	PUNCT
iajs-3148	110	12	998–1005	998–1005	NUM
iajs-3148	110	13	.	.	NOUN
iajs-3148	111	1	6	6	NUM
iajs-3148	111	2	.	.	X
iajs-3148	111	3	guenther	guenther	PROPN
iajs-3148	111	4	,	,	PUNCT
iajs-3148	111	5	l.	l.	PROPN
iajs-3148	111	6	;	;	PUNCT
iajs-3148	111	7	gulliver	gulliver	PROPN
iajs-3148	111	8	,	,	PUNCT
iajs-3148	111	9	w.	w.	NOUN
iajs-3148	111	10	psoriasis	psoriasis	NOUN
iajs-3148	111	11	comorbidities	comorbiditie	NOUN
iajs-3148	111	12	.	.	PUNCT
iajs-3148	112	1	j.	j.	PROPN
iajs-3148	112	2	cutan	cutan	PROPN
iajs-3148	112	3	.	.	PUNCT
iajs-3148	113	1	med	med	PROPN
iajs-3148	113	2	.	.	PUNCT
iajs-3148	113	3	surg	surg	PROPN
iajs-3148	113	4	.	.	PUNCT
iajs-3148	114	1	2009	2009	NUM
iajs-3148	114	2	;	;	PUNCT
iajs-3148	114	3	13	13	NUM
iajs-3148	114	4	,	,	PUNCT
iajs-3148	114	5	5,77	5,77	NUM
iajs-3148	114	6	-	-	SYM
iajs-3148	114	7	87	87	NUM
iajs-3148	114	8	.	.	PUNCT
iajs-3148	115	1	7	7	X
iajs-3148	115	2	.	.	X
iajs-3148	115	3	iqbal	iqbal	PROPN
iajs-3148	115	4	,	,	PUNCT
iajs-3148	115	5	m.n	m.n	PROPN
iajs-3148	115	6	.	.	PROPN
iajs-3148	115	7	levels	level	NOUN
iajs-3148	115	8	of	of	ADP
iajs-3148	115	9	interleukins	interleukin	NOUN
iajs-3148	115	10	6	6	NUM
iajs-3148	115	11	and	and	CCONJ
iajs-3148	115	12	8	8	NUM
iajs-3148	115	13	in	in	ADP
iajs-3148	115	14	psoriatic	psoriatic	ADJ
iajs-3148	115	15	patients	patient	NOUN
iajs-3148	115	16	serum	serum	VERB
iajs-3148	115	17	.	.	PUNCT
iajs-3148	116	1	ibn	ibn	PROPN
iajs-3148	116	2	al	al	PROPN
iajs-3148	116	3	-	-	PUNCT
iajs-3148	116	4	haitham	haitham	PROPN
iajs-3148	116	5	j.	j.	PROPN
iajs-3148	116	6	pure	pure	PROPN
iajs-3148	116	7	appl	appl	PROPN
iajs-3148	116	8	.	.	PUNCT
iajs-3148	117	1	sci	sci	PROPN
iajs-3148	117	2	.	.	PROPN
iajs-3148	117	3	,	,	PUNCT
iajs-3148	117	4	2017	2017	NUM
iajs-3148	117	5	,	,	PUNCT
iajs-3148	117	6	23	23	NUM
iajs-3148	117	7	,	,	PUNCT
iajs-3148	117	8	3	3	NUM
iajs-3148	117	9	,	,	PUNCT
iajs-3148	117	10	15	15	NUM
iajs-3148	117	11	-	-	SYM
iajs-3148	117	12	24	24	NUM
iajs-3148	117	13	.	.	NOUN
iajs-3148	117	14	8	8	NUM
iajs-3148	117	15	.	.	PUNCT
iajs-3148	118	1	abdul	abdul	PROPN
iajs-3148	118	2	-	-	PUNCT
iajs-3148	118	3	hussein	hussein	PROPN
iajs-3148	118	4	,	,	PUNCT
iajs-3148	118	5	s.s	s.s	PROPN
iajs-3148	118	6	.	.	PROPN
iajs-3148	118	7	;	;	PUNCT
iajs-3148	118	8	ali	ali	PROPN
iajs-3148	118	9	,	,	PUNCT
iajs-3148	118	10	e.n	e.n	PROPN
iajs-3148	118	11	.	.	PROPN
iajs-3148	118	12	;	;	PUNCT
iajs-3148	118	13	alkhalidi	alkhalidi	PROPN
iajs-3148	118	14	,	,	PUNCT
iajs-3148	118	15	n.m.f	n.m.f	NOUN
iajs-3148	118	16	.	.	PUNCT
iajs-3148	118	17	;	;	PUNCT
iajs-3148	118	18	zaki	zaki	PROPN
iajs-3148	118	19	,	,	PUNCT
iajs-3148	118	20	n.h	n.h	PROPN
iajs-3148	118	21	.	.	PROPN
iajs-3148	118	22	;	;	PUNCT
iajs-3148	118	23	ad’hiah	ad’hiah	PROPN
iajs-3148	118	24	,	,	PUNCT
iajs-3148	118	25	a.h	a.h	PROPN
iajs-3148	118	26	.	.	PROPN
iajs-3148	118	27	roles	role	NOUN
iajs-3148	118	28	of	of	ADP
iajs-3148	118	29	il-17a	il-17a	PROPN
iajs-3148	118	30	and	and	CCONJ
iajs-3148	118	31	il-23	il-23	NOUN
iajs-3148	118	32	in	in	ADP
iajs-3148	118	33	the	the	DET
iajs-3148	118	34	pathogenesis	pathogenesis	NOUN
iajs-3148	118	35	of	of	ADP
iajs-3148	118	36	ulcerative	ulcerative	ADJ
iajs-3148	118	37	colitis	colitis	NOUN
iajs-3148	118	38	and	and	CCONJ
iajs-3148	118	39	crohn	crohn	PROPN
iajs-3148	118	40	’s	’s	PART
iajs-3148	118	41	disease	disease	NOUN
iajs-3148	118	42	.	.	PUNCT
iajs-3148	119	1	iraqi	iraqi	ADJ
iajs-3148	119	2	j.	j.	PROPN
iajs-3148	119	3	sci	sci	PROPN
iajs-3148	119	4	.	.	PROPN
iajs-3148	119	5	,	,	PUNCT
iajs-3148	119	6	2021	2021	NUM
iajs-3148	119	7	;	;	PUNCT
iajs-3148	119	8	62	62	NUM
iajs-3148	119	9	,	,	PUNCT
iajs-3148	119	10	8	8	NUM
iajs-3148	119	11	,	,	PUNCT
iajs-3148	119	12	2526–2535	2526–2535	NUM
iajs-3148	119	13	.	.	NOUN
iajs-3148	119	14	9	9	NUM
iajs-3148	119	15	.	.	X
iajs-3148	119	16	lande	lande	PROPN
iajs-3148	119	17	,	,	PUNCT
iajs-3148	119	18	r.	r.	PROPN
iajs-3148	119	19	;	;	PUNCT
iajs-3148	119	20	gregorio	gregorio	PROPN
iajs-3148	119	21	,	,	PUNCT
iajs-3148	119	22	j.	j.	PROPN
iajs-3148	119	23	;	;	PUNCT
iajs-3148	119	24	facchinetti	facchinetti	PROPN
iajs-3148	119	25	,	,	PUNCT
iajs-3148	119	26	v.	v.	PROPN
iajs-3148	119	27	;	;	PUNCT
iajs-3148	119	28	chatterjee	chatterjee	PROPN
iajs-3148	119	29	,	,	PUNCT
iajs-3148	119	30	b.	b.	PROPN
iajs-3148	119	31	;	;	PUNCT
iajs-3148	119	32	wang	wang	PROPN
iajs-3148	119	33	,	,	PUNCT
iajs-3148	119	34	y.h	y.h	PROPN
iajs-3148	119	35	.	.	PROPN
iajs-3148	119	36	;	;	PUNCT
iajs-3148	119	37	homey	homey	ADJ
iajs-3148	119	38	,	,	PUNCT
iajs-3148	119	39	b.	b.	PROPN
iajs-3148	119	40	;	;	PUNCT
iajs-3148	119	41	gilliet	gilliet	NOUN
iajs-3148	119	42	,	,	PUNCT
iajs-3148	119	43	m.	m.	NOUN
iajs-3148	119	44	plasmacytoid	plasmacytoid	NOUN
iajs-3148	119	45	dendritic	dendritic	ADJ
iajs-3148	119	46	cells	cell	NOUN
iajs-3148	119	47	sense	sense	VERB
iajs-3148	119	48	self	self	NOUN
iajs-3148	119	49	-	-	PUNCT
iajs-3148	119	50	dna	dna	NOUN
iajs-3148	119	51	coupled	couple	VERB
iajs-3148	119	52	with	with	ADP
iajs-3148	119	53	antimicrobial	antimicrobial	ADJ
iajs-3148	119	54	peptide	peptide	NOUN
iajs-3148	119	55	.	.	PUNCT
iajs-3148	120	1	j.	j.	PROPN
iajs-3148	120	2	nat	nat	PROPN
iajs-3148	120	3	.	.	PUNCT
iajs-3148	120	4	,	,	PUNCT
iajs-3148	120	5	2007	2007	NUM
iajs-3148	120	6	;	;	PUNCT
iajs-3148	120	7	449	449	NUM
iajs-3148	120	8	,	,	PUNCT
iajs-3148	120	9	7162	7162	NUM
iajs-3148	120	10	,	,	PUNCT
iajs-3148	120	11	564	564	NUM
iajs-3148	120	12	-	-	SYM
iajs-3148	120	13	569	569	NUM
iajs-3148	120	14	.	.	PUNCT
iajs-3148	121	1	10	10	NUM
iajs-3148	121	2	.	.	PUNCT
iajs-3148	122	1	kauffman	kauffman	PROPN
iajs-3148	122	2	,	,	PUNCT
iajs-3148	122	3	c.l	c.l	PROPN
iajs-3148	122	4	.	.	PROPN
iajs-3148	122	5	;	;	PUNCT
iajs-3148	122	6	aria	aria	PROPN
iajs-3148	122	7	,	,	PUNCT
iajs-3148	122	8	n.	n.	NOUN
iajs-3148	122	9	,	,	PUNCT
iajs-3148	122	10	toichi	toichi	PROPN
iajs-3148	122	11	,	,	PUNCT
iajs-3148	122	12	e.	e.	PROPN
iajs-3148	122	13	;	;	PUNCT
iajs-3148	122	14	mccormick	mccormick	PROPN
iajs-3148	122	15	,	,	PUNCT
iajs-3148	122	16	t.s	t.s	PROPN
iajs-3148	122	17	.	.	PROPN
iajs-3148	122	18	;	;	PUNCT
iajs-3148	122	19	cooper	cooper	PROPN
iajs-3148	122	20	,	,	PUNCT
iajs-3148	122	21	k.d	k.d	PROPN
iajs-3148	122	22	.	.	PROPN
iajs-3148	122	23	;	;	PUNCT
iajs-3148	122	24	gottlieb	gottlieb	PROPN
iajs-3148	122	25	,	,	PUNCT
iajs-3148	122	26	a.b	a.b	PROPN
iajs-3148	122	27	.	.	PROPN
iajs-3148	122	28	;	;	PUNCT
iajs-3148	122	29	mascelli	mascelli	PROPN
iajs-3148	122	30	,	,	PUNCT
iajs-3148	122	31	m.a	m.a	PROPN
iajs-3148	122	32	.	.	PROPN
iajs-3148	122	33	;	;	PUNCT
iajs-3148	122	34	a	a	DET
iajs-3148	122	35	phase	phase	NOUN
iajs-3148	122	36	i	i	PRON
iajs-3148	122	37	study	study	VERB
iajs-3148	122	38	evaluating	evaluate	VERB
iajs-3148	122	39	the	the	DET
iajs-3148	122	40	safety	safety	NOUN
iajs-3148	122	41	,	,	PUNCT
iajs-3148	122	42	pharmacokinetics	pharmacokinetic	NOUN
iajs-3148	122	43	,	,	PUNCT
iajs-3148	122	44	and	and	CCONJ
iajs-3148	122	45	clinical	clinical	ADJ
iajs-3148	122	46	response	response	NOUN
iajs-3148	122	47	of	of	ADP
iajs-3148	122	48	a	a	DET
iajs-3148	122	49	human	human	ADJ
iajs-3148	122	50	il-12	il-12	PRON
iajs-3148	122	51	p40	p40	NOUN
iajs-3148	122	52	antibody	antibody	NOUN
iajs-3148	122	53	in	in	ADP
iajs-3148	122	54	subjects	subject	NOUN
iajs-3148	122	55	with	with	ADP
iajs-3148	122	56	plaque	plaque	NOUN
iajs-3148	122	57	psoriasis	psoriasis	NOUN
iajs-3148	122	58	.	.	PUNCT
iajs-3148	123	1	j.	j.	PROPN
iajs-3148	123	2	investig	investig	PROPN
iajs-3148	123	3	.	.	PROPN
iajs-3148	123	4	dermatol	dermatol	NOUN
iajs-3148	123	5	.	.	PUNCT
iajs-3148	123	6	,	,	PUNCT
iajs-3148	123	7	2004	2004	NUM
iajs-3148	123	8	;	;	PUNCT
iajs-3148	124	1	123	123	NUM
iajs-3148	124	2	,	,	PUNCT
iajs-3148	124	3	6	6	NUM
iajs-3148	124	4	,	,	PUNCT
iajs-3148	124	5	1037	1037	NUM
iajs-3148	124	6	-	-	SYM
iajs-3148	124	7	1044	1044	NUM
iajs-3148	124	8	.	.	PUNCT
iajs-3148	125	1	11	11	NUM
iajs-3148	125	2	.	.	X
iajs-3148	125	3	pietrzak	pietrzak	PROPN
iajs-3148	125	4	,	,	PUNCT
iajs-3148	125	5	a.t	a.t	PROPN
iajs-3148	125	6	.	.	PROPN
iajs-3148	125	7	;	;	PUNCT
iajs-3148	126	1	zalewska	zalewska	PROPN
iajs-3148	126	2	,	,	PUNCT
iajs-3148	126	3	a.	a.	NOUN
iajs-3148	126	4	;	;	PUNCT
iajs-3148	126	5	chodorowska	chodorowska	PROPN
iajs-3148	126	6	,	,	PUNCT
iajs-3148	126	7	g.	g.	PROPN
iajs-3148	126	8	;	;	PUNCT
iajs-3148	126	9	krasowska	krasowska	PROPN
iajs-3148	126	10	,	,	PUNCT
iajs-3148	126	11	d.	d.	PROPN
iajs-3148	126	12	;	;	PUNCT
iajs-3148	126	13	michalak	michalak	NOUN
iajs-3148	126	14	-	-	PUNCT
iajs-3148	126	15	stoma	stoma	NOUN
iajs-3148	126	16	,	,	PUNCT
iajs-3148	126	17	a.	a.	NOUN
iajs-3148	126	18	;	;	PUNCT
iajs-3148	126	19	nockowski	nockowski	ADJ
iajs-3148	126	20	,	,	PUNCT
iajs-3148	126	21	p.	p.	NOUN
iajs-3148	126	22	;	;	PUNCT
iajs-3148	126	23	roliński	roliński	PROPN
iajs-3148	126	24	,	,	PUNCT
iajs-3148	126	25	j.m	j.m	PROPN
iajs-3148	126	26	.	.	PROPN
iajs-3148	126	27	cytokines	cytokine	NOUN
iajs-3148	126	28	and	and	CCONJ
iajs-3148	126	29	anticytokines	anticytokine	NOUN
iajs-3148	126	30	in	in	ADP
iajs-3148	126	31	psoriasis	psoriasis	NOUN
iajs-3148	126	32	.	.	PUNCT
iajs-3148	127	1	j.	j.	PROPN
iajs-3148	127	2	clin	clin	PROPN
iajs-3148	127	3	.	.	PUNCT
iajs-3148	128	1	chimica	chimica	PROPN
iajs-3148	128	2	acta	acta	PROPN
iajs-3148	128	3	,	,	PUNCT
iajs-3148	128	4	2008	2008	NUM
iajs-3148	128	5	;	;	PUNCT
iajs-3148	128	6	394	394	NUM
iajs-3148	128	7	,	,	PUNCT
iajs-3148	128	8	1	1	NUM
iajs-3148	128	9	-	-	SYM
iajs-3148	128	10	2	2	NUM
iajs-3148	128	11	,	,	PUNCT
iajs-3148	128	12	7	7	NUM
iajs-3148	128	13	-	-	SYM
iajs-3148	128	14	21	21	NUM
iajs-3148	128	15	.	.	PUNCT
iajs-3148	129	1	12	12	NUM
iajs-3148	129	2	.	.	PUNCT
iajs-3148	130	1	budagian	budagian	NOUN
iajs-3148	130	2	,	,	PUNCT
iajs-3148	130	3	v.	v.	PROPN
iajs-3148	130	4	;	;	PUNCT
iajs-3148	130	5	bulanova	bulanova	PROPN
iajs-3148	130	6	,	,	PUNCT
iajs-3148	130	7	e.	e.	PROPN
iajs-3148	130	8	;	;	PUNCT
iajs-3148	130	9	paus	paus	PROPN
iajs-3148	130	10	,	,	PUNCT
iajs-3148	130	11	r.	r.	PROPN
iajs-3148	130	12	;	;	PUNCT
iajs-3148	130	13	bulfone	bulfone	NOUN
iajs-3148	130	14	-	-	PUNCT
iajs-3148	130	15	paus	paus	PROPN
iajs-3148	130	16	,	,	PUNCT
iajs-3148	130	17	s.	s.	PROPN
iajs-3148	130	18	il-15	il-15	X
iajs-3148	130	19	/	/	SYM
iajs-3148	130	20	il-15	il-15	NOUN
iajs-3148	130	21	receptor	receptor	NOUN
iajs-3148	130	22	biology	biology	NOUN
iajs-3148	130	23	:	:	PUNCT
iajs-3148	130	24	a	a	DET
iajs-3148	130	25	guided	guide	VERB
iajs-3148	130	26	tour	tour	NOUN
iajs-3148	130	27	through	through	ADP
iajs-3148	130	28	an	an	DET
iajs-3148	130	29	expanding	expand	VERB
iajs-3148	130	30	universe	universe	NOUN
iajs-3148	130	31	.	.	PUNCT
iajs-3148	131	1	j.	j.	PROPN
iajs-3148	131	2	cytokine	cytokine	PROPN
iajs-3148	131	3	growth	growth	NOUN
iajs-3148	131	4	factor	factor	NOUN
iajs-3148	131	5	rev	rev	VERB
iajs-3148	131	6	.	.	PROPN
iajs-3148	131	7	,	,	PUNCT
iajs-3148	131	8	2006	2006	NUM
iajs-3148	131	9	;	;	PUNCT
iajs-3148	131	10	17	17	NUM
iajs-3148	131	11	,	,	PUNCT
iajs-3148	131	12	4	4	NUM
iajs-3148	131	13	,	,	PUNCT
iajs-3148	131	14	259	259	NUM
iajs-3148	131	15	-	-	SYM
iajs-3148	131	16	280	280	NUM
iajs-3148	131	17	.	.	NOUN
iajs-3148	131	18	13	13	NUM
iajs-3148	131	19	.	.	PUNCT
iajs-3148	132	1	dunphy	dunphy	PROPN
iajs-3148	132	2	,	,	PUNCT
iajs-3148	132	3	s.e	s.e	PROPN
iajs-3148	132	4	.	.	PROPN
iajs-3148	132	5	;	;	PUNCT
iajs-3148	132	6	sweeney	sweeney	PROPN
iajs-3148	132	7	,	,	PUNCT
iajs-3148	132	8	c.m	c.m	PROPN
iajs-3148	132	9	.	.	PROPN
iajs-3148	132	10	;	;	PUNCT
iajs-3148	132	11	kelly	kelly	PROPN
iajs-3148	132	12	,	,	PUNCT
iajs-3148	132	13	g.	g.	PROPN
iajs-3148	132	14	;	;	PUNCT
iajs-3148	132	15	tobin	tobin	PROPN
iajs-3148	132	16	,	,	PUNCT
iajs-3148	132	17	a.m.	a.m.	ADV
iajs-3148	132	18	;	;	PUNCT
iajs-3148	132	19	kirby	kirby	PROPN
iajs-3148	132	20	,	,	PUNCT
iajs-3148	132	21	b.	b.	PROPN
iajs-3148	132	22	;	;	PUNCT
iajs-3148	132	23	gardiner	gardiner	PROPN
iajs-3148	132	24	,	,	PUNCT
iajs-3148	132	25	c.m	c.m	PROPN
iajs-3148	132	26	.	.	PROPN
iajs-3148	132	27	natural	natural	ADJ
iajs-3148	132	28	killer	killer	NOUN
iajs-3148	132	29	cells	cell	NOUN
iajs-3148	132	30	from	from	ADP
iajs-3148	132	31	psoriasis	psoriasis	NOUN
iajs-3148	132	32	vulgaris	vulgaris	NOUN
iajs-3148	132	33	patients	patient	NOUN
iajs-3148	132	34	have	have	AUX
iajs-3148	132	35	reduced	reduce	VERB
iajs-3148	132	36	levels	level	NOUN
iajs-3148	132	37	of	of	ADP
iajs-3148	132	38	cytotoxicity	cytotoxicity	NOUN
iajs-3148	132	39	associated	associate	VERB
iajs-3148	132	40	degranulation	degranulation	NOUN
iajs-3148	132	41	and	and	CCONJ
iajs-3148	132	42	cytokine	cytokine	ADJ
iajs-3148	132	43	production	production	NOUN
iajs-3148	132	44	.	.	PUNCT
iajs-3148	133	1	j.	j.	PROPN
iajs-3148	133	2	clin	clin	PROPN
iajs-3148	133	3	.	.	PUNCT
iajs-3148	134	1	immunol	immunol	PROPN
iajs-3148	134	2	.	.	PROPN
iajs-3148	134	3	,	,	PUNCT
iajs-3148	134	4	2015	2015	NUM
iajs-3148	134	5	;	;	PUNCT
iajs-3148	134	6	177	177	NUM
iajs-3148	134	7	,	,	PUNCT
iajs-3148	134	8	43	43	NUM
iajs-3148	134	9	-	-	SYM
iajs-3148	134	10	49	49	NUM
iajs-3148	134	11	.	.	PUNCT
iajs-3148	135	1	14	14	NUM
iajs-3148	135	2	.	.	X
iajs-3148	136	1	majeed	majeed	PROPN
iajs-3148	136	2	,	,	PUNCT
iajs-3148	136	3	i.a	i.a	PROPN
iajs-3148	136	4	.	.	PROPN
iajs-3148	136	5	;	;	PUNCT
iajs-3148	137	1	al	al	PROPN
iajs-3148	137	2	-	-	PUNCT
iajs-3148	137	3	shawi	shawi	PROPN
iajs-3148	137	4	,	,	PUNCT
iajs-3148	137	5	n.n	n.n	PROPN
iajs-3148	137	6	.	.	PROPN
iajs-3148	137	7	effects	effect	NOUN
iajs-3148	137	8	of	of	ADP
iajs-3148	137	9	omega-3	omega-3	NUM
iajs-3148	137	10	co	co	VERB
iajs-3148	137	11	-	-	VERB
iajs-3148	137	12	administered	administer	VERB
iajs-3148	137	13	with	with	ADP
iajs-3148	137	14	therapeutic	therapeutic	ADJ
iajs-3148	137	15	dose	dose	NOUN
iajs-3148	137	16	of	of	ADP
iajs-3148	137	17	lornoxicam	lornoxicam	NOUN
iajs-3148	137	18	on	on	ADP
iajs-3148	137	19	male	male	ADJ
iajs-3148	137	20	rats	rat	NOUN
iajs-3148	137	21	'	'	PART
iajs-3148	137	22	liver	liver	NOUN
iajs-3148	137	23	.	.	PUNCT
iajs-3148	138	1	iraqi	iraqi	ADJ
iajs-3148	138	2	j.	j.	PROPN
iajs-3148	138	3	pharmac	pharmac	PROPN
iajs-3148	138	4	.	.	PUNCT
iajs-3148	139	1	sci	sci	PROPN
iajs-3148	139	2	.	.	PROPN
iajs-3148	139	3	,	,	PUNCT
iajs-3148	139	4	2019	2019	NUM
iajs-3148	139	5	;	;	PUNCT
iajs-3148	139	6	28	28	NUM
iajs-3148	139	7	,	,	PUNCT
iajs-3148	139	8	2	2	NUM
iajs-3148	139	9	,	,	PUNCT
iajs-3148	139	10	159	159	NUM
iajs-3148	139	11	-	-	SYM
iajs-3148	139	12	164	164	NUM
iajs-3148	139	13	.	.	PUNCT
iajs-3148	139	14	15	15	NUM
iajs-3148	139	15	.	.	PUNCT
iajs-3148	139	16	arican	arican	PROPN
iajs-3148	139	17	,	,	PUNCT
iajs-3148	139	18	o.	o.	PROPN
iajs-3148	139	19	;	;	PUNCT
iajs-3148	139	20	aral	aral	PROPN
iajs-3148	139	21	.	.	PUNCT
iajs-3148	139	22	m.	m.	NOUN
iajs-3148	139	23	;	;	PUNCT
iajs-3148	139	24	sasmaz	sasmaz	PROPN
iajs-3148	139	25	,	,	PUNCT
iajs-3148	139	26	s.	s.	PROPN
iajs-3148	139	27	;	;	PUNCT
iajs-3148	139	28	ciragil	ciragil	PROPN
iajs-3148	139	29	p.	p.	PROPN
iajs-3148	139	30	;	;	PUNCT
iajs-3148	139	31	serum	serum	NOUN
iajs-3148	139	32	levels	level	NOUN
iajs-3148	139	33	of	of	ADP
iajs-3148	139	34	tnf	tnf	PROPN
iajs-3148	139	35	-	-	PUNCT
iajs-3148	139	36	α	α	PROPN
iajs-3148	139	37	,	,	PUNCT
iajs-3148	139	38	ifn	ifn	PROPN
iajs-3148	139	39	-	-	PUNCT
iajs-3148	139	40	γ	γ	NOUN
iajs-3148	139	41	,	,	PUNCT
iajs-3148	139	42	il-6	il-6	NOUN
iajs-3148	139	43	,	,	PUNCT
iajs-3148	139	44	il-8	il-8	NOUN
iajs-3148	139	45	,	,	PUNCT
iajs-3148	139	46	il-12	il-12	NOUN
iajs-3148	139	47	,	,	PUNCT
iajs-3148	139	48	il-17	il-17	X
iajs-3148	139	49	,	,	PUNCT
iajs-3148	139	50	and	and	CCONJ
iajs-3148	139	51	il-18	il-18	ADP
iajs-3148	139	52	in	in	ADP
iajs-3148	139	53	patients	patient	NOUN
iajs-3148	139	54	with	with	ADP
iajs-3148	139	55	active	active	ADJ
iajs-3148	139	56	psoriasis	psoriasis	NOUN
iajs-3148	139	57	and	and	CCONJ
iajs-3148	139	58	correlation	correlation	NOUN
iajs-3148	139	59	with	with	ADP
iajs-3148	139	60	disease	disease	NOUN
iajs-3148	139	61	severity	severity	NOUN
iajs-3148	139	62	.	.	PUNCT
iajs-3148	140	1	j.	j.	PROPN
iajs-3148	140	2	med	med	PROPN
iajs-3148	140	3	.	.	PUNCT
iajs-3148	141	1	inflamm	inflamm	PROPN
iajs-3148	141	2	.	.	PROPN
iajs-3148	141	3	,	,	PUNCT
iajs-3148	141	4	2005	2005	NUM
iajs-3148	141	5	;	;	PUNCT
iajs-3148	141	6	5	5	NUM
iajs-3148	141	7	,	,	PUNCT
iajs-3148	141	8	273	273	NUM
iajs-3148	141	9	-	-	SYM
iajs-3148	141	10	279	279	NUM
iajs-3148	141	11	.	.	PUNCT
iajs-3148	142	1	16	16	NUM
iajs-3148	142	2	.	.	PUNCT
iajs-3148	143	1	liu	liu	PROPN
iajs-3148	143	2	.	.	PUNCT
iajs-3148	144	1	t.	t.	PROPN
iajs-3148	144	2	;	;	PUNCT
iajs-3148	144	3	li	li	PROPN
iajs-3148	144	4	,	,	PUNCT
iajs-3148	144	5	s.	s.	PROPN
iajs-3148	144	6	;	;	PUNCT
iajs-3148	144	7	ying	ying	PROPN
iajs-3148	144	8	,	,	PUNCT
iajs-3148	144	9	s.	s.	PROPN
iajs-3148	144	10	the	the	DET
iajs-3148	144	11	il-23	il-23	NOUN
iajs-3148	144	12	/	/	SYM
iajs-3148	144	13	il-17	il-17	NUM
iajs-3148	144	14	pathway	pathway	NOUN
iajs-3148	144	15	in	in	ADP
iajs-3148	144	16	inflammatory	inflammatory	ADJ
iajs-3148	144	17	skin	skin	NOUN
iajs-3148	144	18	diseases	disease	NOUN
iajs-3148	144	19	:	:	PUNCT
iajs-3148	144	20	from	from	ADP
iajs-3148	144	21	bench	bench	NOUN
iajs-3148	144	22	to	to	ADP
iajs-3148	144	23	bedside	bedside	NOUN
iajs-3148	144	24	.	.	PUNCT
iajs-3148	145	1	j.	j.	PROPN
iajs-3148	145	2	front	front	PROPN
iajs-3148	145	3	immunol	immunol	NOUN
iajs-3148	145	4	.	.	PUNCT
iajs-3148	145	5	,	,	PUNCT
iajs-3148	145	6	2020	2020	NUM
iajs-3148	145	7	;	;	PUNCT
iajs-3148	145	8	11	11	NUM
iajs-3148	145	9	,	,	PUNCT
iajs-3148	145	10	59475	59475	NUM
iajs-3148	145	11	.	.	PUNCT
iajs-3148	146	1	17	17	NUM
iajs-3148	146	2	.	.	PUNCT
iajs-3148	147	1	kuchař	kuchař	ADJ
iajs-3148	147	2	,	,	PUNCT
iajs-3148	147	3	m.	m.	NOUN
iajs-3148	147	4	;	;	PUNCT
iajs-3148	147	5	vaňková	vaňková	PROPN
iajs-3148	147	6	,	,	PUNCT
iajs-3148	147	7	l.	l.	PROPN
iajs-3148	147	8	;	;	PUNCT
iajs-3148	147	9	petroková	petroková	PROPN
iajs-3148	147	10	,	,	PUNCT
iajs-3148	147	11	h.	h.	PROPN
iajs-3148	147	12	;	;	PUNCT
iajs-3148	147	13	cerný	cerný	PROPN
iajs-3148	147	14	,	,	PUNCT
iajs-3148	147	15	j.	j.	PROPN
iajs-3148	147	16	;	;	PUNCT
iajs-3148	147	17	osička	osička	PROPN
iajs-3148	147	18	,	,	PUNCT
iajs-3148	147	19	r.	r.	PROPN
iajs-3148	147	20	;	;	PUNCT
iajs-3148	147	21	pelák	pelák	PROPN
iajs-3148	147	22	,	,	PUNCT
iajs-3148	147	23	o.	o.	PROPN
iajs-3148	147	24	;	;	PUNCT
iajs-3148	147	25	sípová	sípová	PROPN
iajs-3148	147	26	,	,	PUNCT
iajs-3148	147	27	h.	h.	PROPN
iajs-3148	147	28	;	;	PUNCT
iajs-3148	147	29	schneider	schneider	PROPN
iajs-3148	147	30	,	,	PUNCT
iajs-3148	147	31	b.	b.	PROPN
iajs-3148	147	32	;	;	PUNCT
iajs-3148	147	33	homola	homola	PROPN
iajs-3148	147	34	,	,	PUNCT
iajs-3148	147	35	j.	j.	PROPN
iajs-3148	147	36	;	;	PUNCT
iajs-3148	147	37	sebo	sebo	NOUN
iajs-3148	147	38	,	,	PUNCT
iajs-3148	147	39	p.	p.	PROPN
iajs-3148	147	40	;	;	PUNCT
iajs-3148	147	41	kalina	kalina	PROPN
iajs-3148	147	42	,	,	PUNCT
iajs-3148	147	43	t.	t.	PROPN
iajs-3148	147	44	;	;	PUNCT
iajs-3148	147	45	malý	malý	NOUN
iajs-3148	147	46	,	,	PUNCT
iajs-3148	147	47	p.	p.	PROPN
iajs-3148	147	48	human	human	ADJ
iajs-3148	147	49	interleukin‐23	interleukin‐23	PROPN
iajs-3148	147	50	receptor	receptor	NOUN
iajs-3148	147	51	antagonists	antagonist	NOUN
iajs-3148	147	52	derived	derive	VERB
iajs-3148	147	53	from	from	ADP
iajs-3148	147	54	an	an	DET
iajs-3148	147	55	albumin‐binding	albumin‐binding	NOUN
iajs-3148	147	56	domain	domain	NOUN
iajs-3148	147	57	scaffold	scaffold	NOUN
iajs-3148	147	58	inhibit	inhibit	NOUN
iajs-3148	147	59	il‐23‐dependent	il‐23‐dependent	PROPN
iajs-3148	147	60	ex	ex	PRON
iajs-3148	147	61	vivo	vivo	ADJ
iajs-3148	147	62	expansion	expansion	NOUN
iajs-3148	147	63	of	of	ADP
iajs-3148	147	64	il‐17‐producing	il‐17‐producing	PROPN
iajs-3148	147	65	t‐cells	t‐cells	PROPN
iajs-3148	147	66	.	.	PUNCT
iajs-3148	148	1	j.	j.	PROPN
iajs-3148	148	2	proteins	protein	NOUN
iajs-3148	148	3	struct	struct	NOUN
iajs-3148	148	4	.	.	PUNCT
iajs-3148	149	1	func	func	PROPN
iajs-3148	149	2	.	.	PUNCT
iajs-3148	150	1	bioinform	bioinform	NOUN
iajs-3148	150	2	.	.	PUNCT
iajs-3148	150	3	,	,	PUNCT
iajs-3148	150	4	2014	2014	NUM
iajs-3148	150	5	;	;	PUNCT
iajs-3148	150	6	82	82	NUM
iajs-3148	150	7	,	,	PUNCT
iajs-3148	150	8	6	6	NUM
iajs-3148	150	9	,	,	PUNCT
iajs-3148	150	10	975989	975989	NUM
iajs-3148	150	11	.	.	PUNCT
iajs-3148	151	1	ihjpas	ihjpas	PROPN
iajs-3148	151	2	.	.	PUNCT
iajs-3148	152	1	37	37	NUM
iajs-3148	152	2	(	(	PUNCT
iajs-3148	152	3	1	1	NUM
iajs-3148	152	4	)	)	PUNCT
iajs-3148	152	5	2024	2024	NUM
iajs-3148	152	6	83	83	NUM
iajs-3148	152	7	18	18	NUM
iajs-3148	152	8	.	.	PUNCT
iajs-3148	152	9	myers	myers	PROPN
iajs-3148	152	10	,	,	PUNCT
iajs-3148	152	11	b.	b.	PROPN
iajs-3148	152	12	;	;	PUNCT
iajs-3148	152	13	thibodeaux	thibodeaux	PROPN
iajs-3148	152	14	,	,	PUNCT
iajs-3148	152	15	q.	q.	PROPN
iajs-3148	152	16	;	;	PUNCT
iajs-3148	152	17	reddy	reddy	PROPN
iajs-3148	152	18	,	,	PUNCT
iajs-3148	152	19	v.	v.	ADP
iajs-3148	152	20	biologic	biologic	ADJ
iajs-3148	152	21	treatment	treatment	NOUN
iajs-3148	152	22	of	of	ADP
iajs-3148	152	23	4	4	NUM
iajs-3148	152	24	hiv	hiv	NOUN
iajs-3148	152	25	-	-	PUNCT
iajs-3148	152	26	positive	positive	ADJ
iajs-3148	152	27	patients	patient	NOUN
iajs-3148	152	28	:	:	PUNCT
iajs-3148	152	29	a	a	DET
iajs-3148	152	30	case	case	NOUN
iajs-3148	152	31	series	series	NOUN
iajs-3148	152	32	and	and	CCONJ
iajs-3148	152	33	literature	literature	PROPN
iajs-3148	152	34	review	review	PROPN
iajs-3148	152	35	.	.	PUNCT
iajs-3148	153	1	j.	j.	PROPN
iajs-3148	153	2	psoriasis	psoriasis	NOUN
iajs-3148	153	3	psoriatic	psoriatic	ADJ
iajs-3148	153	4	arthritis	arthritis	NOUN
iajs-3148	153	5	,	,	PUNCT
iajs-3148	153	6	2021	2021	NUM
iajs-3148	153	7	;	;	PUNCT
iajs-3148	153	8	6	6	NUM
iajs-3148	153	9	,	,	PUNCT
iajs-3148	153	10	1	1	NUM
iajs-3148	153	11	,	,	PUNCT
iajs-3148	153	12	19–26	19–26	NUM
iajs-3148	153	13	.	.	PUNCT
iajs-3148	154	1	19	19	NUM
iajs-3148	154	2	.	.	X
iajs-3148	154	3	abanmi	abanmi	PROPN
iajs-3148	154	4	,	,	PUNCT
iajs-3148	154	5	a.	a.	NOUN
iajs-3148	154	6	;	;	PUNCT
iajs-3148	154	7	al	al	PROPN
iajs-3148	154	8	harthi	harthi	PROPN
iajs-3148	154	9	,	,	PUNCT
iajs-3148	154	10	f.	f.	PROPN
iajs-3148	154	11	;	;	PUNCT
iajs-3148	154	12	al	al	PROPN
iajs-3148	154	13	-	-	PUNCT
iajs-3148	154	14	agla	agla	PROPN
iajs-3148	154	15	.	.	PUNCT
iajs-3148	155	1	r.	r.	PROPN
iajs-3148	155	2	serum	serum	PROPN
iajs-3148	155	3	levels	level	NOUN
iajs-3148	155	4	of	of	ADP
iajs-3148	155	5	proinflammatory	proinflammatory	ADJ
iajs-3148	155	6	cytokines	cytokine	NOUN
iajs-3148	155	7	in	in	ADP
iajs-3148	155	8	psoriasis	psoriasis	NOUN
iajs-3148	155	9	patients	patient	NOUN
iajs-3148	155	10	from	from	ADP
iajs-3148	155	11	saudi	saudi	PROPN
iajs-3148	155	12	arabia	arabia	PROPN
iajs-3148	155	13	.	.	PUNCT
iajs-3148	156	1	int	int	NOUN
iajs-3148	156	2	.	.	PUNCT
iajs-3148	157	1	j.	j.	PROPN
iajs-3148	157	2	dermatol	dermatol	PROPN
iajs-3148	157	3	.	.	PUNCT
iajs-3148	157	4	,	,	PUNCT
iajs-3148	157	5	2005	2005	NUM
iajs-3148	157	6	;	;	PUNCT
iajs-3148	157	7	44	44	NUM
iajs-3148	157	8	,	,	PUNCT
iajs-3148	157	9	1	1	NUM
iajs-3148	157	10	,	,	PUNCT
iajs-3148	157	11	82	82	NUM
iajs-3148	157	12	-	-	SYM
iajs-3148	157	13	83	83	NUM
iajs-3148	157	14	.	.	PUNCT
iajs-3148	158	1	20	20	NUM
iajs-3148	158	2	.	.	PUNCT
iajs-3148	159	1	daniel	daniel	PROPN
iajs-3148	159	2	.	.	PUNCT
iajs-3148	160	1	w.w	w.w	PROPN
iajs-3148	160	2	.	.	PROPN
iajs-3148	160	3	;	;	PUNCT
iajs-3148	160	4	cross	cross	PROPN
iajs-3148	160	5	,	,	PUNCT
iajs-3148	160	6	c.l	c.l	PROPN
iajs-3148	160	7	.	.	PROPN
iajs-3148	160	8	biostatistics	biostatistics	PROPN
iajs-3148	160	9	,	,	PUNCT
iajs-3148	160	10	a	a	DET
iajs-3148	160	11	foundation	foundation	NOUN
iajs-3148	160	12	for	for	ADP
iajs-3148	160	13	analysis	analysis	NOUN
iajs-3148	160	14	in	in	ADP
iajs-3148	160	15	the	the	DET
iajs-3148	160	16	health	health	NOUN
iajs-3148	160	17	sciences	sciences	PROPN
iajs-3148	160	18	.	.	PUNCT
iajs-3148	161	1	journal	journal	PROPN
iajs-3148	161	2	of	of	ADP
iajs-3148	161	3	john	john	PROPN
iajs-3148	161	4	wiely	wiely	ADV
iajs-3148	161	5	and	and	CCONJ
iajs-3148	161	6	sons	son	NOUN
iajs-3148	161	7	2013	2013	NUM
iajs-3148	161	8	;	;	PUNCT
iajs-3148	161	9	958	958	NUM
iajs-3148	161	10	.	.	X
iajs-3148	161	11	21	21	NUM
iajs-3148	161	12	.	.	PUNCT
iajs-3148	162	1	yost	yost	PROPN
iajs-3148	162	2	,	,	PUNCT
iajs-3148	162	3	j.	j.	PROPN
iajs-3148	162	4	;	;	PUNCT
iajs-3148	162	5	gudjonsson	gudjonsson	PROPN
iajs-3148	162	6	,	,	PUNCT
iajs-3148	162	7	j.e	j.e	PROPN
iajs-3148	162	8	.	.	PUNCT
iajs-3148	163	1	the	the	DET
iajs-3148	163	2	role	role	NOUN
iajs-3148	163	3	of	of	ADP
iajs-3148	163	4	tnf	tnf	PROPN
iajs-3148	163	5	inhibitors	inhibitor	NOUN
iajs-3148	163	6	in	in	ADP
iajs-3148	163	7	psoriasis	psoriasis	NOUN
iajs-3148	163	8	therapy	therapy	NOUN
iajs-3148	163	9	.	.	PUNCT
iajs-3148	164	1	new	new	ADJ
iajs-3148	164	2	implications	implication	NOUN
iajs-3148	164	3	for	for	ADP
iajs-3148	164	4	associated	associate	VERB
iajs-3148	164	5	comorbidities	comorbiditie	NOUN
iajs-3148	164	6	2009	2009	NUM
iajs-3148	164	7	;	;	PUNCT
iajs-3148	164	8	f1000	f1000	NUM
iajs-3148	164	9	medicine	medicine	NOUN
iajs-3148	164	10	reports	report	VERB
iajs-3148	164	11	1	1	NUM
iajs-3148	164	12	.	.	NOUN
iajs-3148	164	13	22	22	NUM
iajs-3148	164	14	.	.	PUNCT
iajs-3148	165	1	mizutani	mizutani	PROPN
iajs-3148	165	2	,	,	PUNCT
iajs-3148	165	3	h.	h.	PROPN
iajs-3148	165	4	;	;	PUNCT
iajs-3148	165	5	ohmoto	ohmoto	NOUN
iajs-3148	165	6	,	,	PUNCT
iajs-3148	165	7	y.	y.	PROPN
iajs-3148	165	8	;	;	PUNCT
iajs-3148	165	9	mizutani	mizutani	PROPN
iajs-3148	165	10	,	,	PUNCT
iajs-3148	165	11	t.	t.	PROPN
iajs-3148	165	12	;	;	PUNCT
iajs-3148	165	13	murata	murata	PROPN
iajs-3148	165	14	,	,	PUNCT
iajs-3148	165	15	m.	m.	NOUN
iajs-3148	165	16	;	;	PUNCT
iajs-3148	165	17	shimizu	shimizu	PROPN
iajs-3148	165	18	,	,	PUNCT
iajs-3148	165	19	m.	m.	NOUN
iajs-3148	165	20	role	role	NOUN
iajs-3148	165	21	of	of	ADP
iajs-3148	165	22	increased	increase	VERB
iajs-3148	165	23	production	production	NOUN
iajs-3148	165	24	of	of	ADP
iajs-3148	165	25	monocytes	monocyte	NOUN
iajs-3148	165	26	tnf	tnf	PROPN
iajs-3148	165	27	-	-	PUNCT
iajs-3148	165	28	α	α	PROPN
iajs-3148	165	29	,	,	PUNCT
iajs-3148	165	30	il-1β	il-1β	PROPN
iajs-3148	165	31	and	and	CCONJ
iajs-3148	165	32	il-6	il-6	NOUN
iajs-3148	165	33	in	in	ADP
iajs-3148	165	34	psoriasis	psoriasis	NOUN
iajs-3148	165	35	:	:	PUNCT
iajs-3148	165	36	relation	relation	NOUN
iajs-3148	165	37	to	to	ADP
iajs-3148	165	38	focal	focal	ADJ
iajs-3148	165	39	infection	infection	NOUN
iajs-3148	165	40	,	,	PUNCT
iajs-3148	165	41	disease	disease	NOUN
iajs-3148	165	42	activity	activity	NOUN
iajs-3148	165	43	and	and	CCONJ
iajs-3148	165	44	responses	response	NOUN
iajs-3148	165	45	to	to	ADP
iajs-3148	165	46	treatments	treatment	NOUN
iajs-3148	165	47	.	.	PUNCT
iajs-3148	166	1	j.	j.	PROPN
iajs-3148	166	2	dermatol	dermatol	PROPN
iajs-3148	166	3	.	.	PUNCT
iajs-3148	167	1	sci	sci	PROPN
iajs-3148	167	2	.	.	PROPN
iajs-3148	167	3	1997	1997	NUM
iajs-3148	167	4	;	;	PUNCT
iajs-3148	167	5	14	14	NUM
iajs-3148	167	6	,	,	PUNCT
iajs-3148	167	7	2,145	2,145	NUM
iajs-3148	167	8	-	-	SYM
iajs-3148	167	9	153	153	NUM
iajs-3148	167	10	.	.	PUNCT
iajs-3148	167	11	23	23	NUM
iajs-3148	167	12	.	.	PUNCT
iajs-3148	168	1	uyemura	uyemura	ADJ
iajs-3148	168	2	,	,	PUNCT
iajs-3148	168	3	k.	k.	PROPN
iajs-3148	168	4	;	;	PUNCT
iajs-3148	168	5	yamamura	yamamura	NOUN
iajs-3148	168	6	,	,	PUNCT
iajs-3148	168	7	m.	m.	NOUN
iajs-3148	168	8	;	;	PUNCT
iajs-3148	168	9	fivenson	fivenson	PROPN
iajs-3148	168	10	,	,	PUNCT
iajs-3148	168	11	d.f	d.f	PROPN
iajs-3148	168	12	.	.	PROPN
iajs-3148	168	13	;	;	PUNCT
iajs-3148	168	14	modlin	modlin	PROPN
iajs-3148	168	15	,	,	PUNCT
iajs-3148	168	16	r.l	r.l	PROPN
iajs-3148	168	17	.	.	PROPN
iajs-3148	168	18	;	;	PUNCT
iajs-3148	168	19	nickoloff	nickoloff	PROPN
iajs-3148	168	20	,	,	PUNCT
iajs-3148	168	21	b.j	b.j	PROPN
iajs-3148	168	22	;	;	PUNCT
iajs-3148	168	23	the	the	DET
iajs-3148	168	24	cytokine	cytokine	ADJ
iajs-3148	168	25	network	network	NOUN
iajs-3148	168	26	in	in	ADP
iajs-3148	168	27	lesional	lesional	ADJ
iajs-3148	168	28	and	and	CCONJ
iajs-3148	168	29	lesion	lesion	NOUN
iajs-3148	168	30	-	-	PUNCT
iajs-3148	168	31	free	free	ADJ
iajs-3148	168	32	psoriatic	psoriatic	ADJ
iajs-3148	168	33	skin	skin	NOUN
iajs-3148	168	34	is	be	AUX
iajs-3148	168	35	characterized	characterize	VERB
iajs-3148	168	36	by	by	ADP
iajs-3148	168	37	a	a	DET
iajs-3148	168	38	t	t	PROPN
iajs-3148	168	39	-	-	PUNCT
iajs-3148	168	40	helper	helper	NOUN
iajs-3148	168	41	type	type	NOUN
iajs-3148	168	42	1	1	NUM
iajs-3148	168	43	cellmediated	cellmediated	ADJ
iajs-3148	168	44	response	response	NOUN
iajs-3148	168	45	.	.	PUNCT
iajs-3148	169	1	j.	j.	PROPN
iajs-3148	169	2	investig	investig	PROPN
iajs-3148	169	3	.	.	PROPN
iajs-3148	169	4	dermatol	dermatol	PROPN
iajs-3148	169	5	.	.	PUNCT
iajs-3148	169	6	,	,	PUNCT
iajs-3148	169	7	1993	1993	NUM
iajs-3148	169	8	;	;	PUNCT
iajs-3148	169	9	101	101	NUM
iajs-3148	169	10	,	,	PUNCT
iajs-3148	169	11	5,701	5,701	NUM
iajs-3148	169	12	-	-	SYM
iajs-3148	169	13	705	705	NUM
iajs-3148	169	14	.	.	NUM
iajs-3148	170	1	24	24	NUM
iajs-3148	170	2	.	.	PUNCT
iajs-3148	170	3	de	de	X
iajs-3148	170	4	rie	rie	X
iajs-3148	170	5	,	,	PUNCT
iajs-3148	170	6	m.a	m.a	PROPN
iajs-3148	170	7	.	.	PROPN
iajs-3148	170	8	;	;	PUNCT
iajs-3148	170	9	goedkoop	goedkoop	PROPN
iajs-3148	170	10	,	,	PUNCT
iajs-3148	170	11	a.y	a.y	PROPN
iajs-3148	170	12	.	.	PROPN
iajs-3148	170	13	;	;	PUNCT
iajs-3148	170	14	bos	bos	PROPN
iajs-3148	170	15	,	,	PUNCT
iajs-3148	170	16	j.d	j.d	PROPN
iajs-3148	170	17	.	.	PROPN
iajs-3148	170	18	overview	overview	NOUN
iajs-3148	170	19	of	of	ADP
iajs-3148	170	20	psoriasis	psoriasis	NOUN
iajs-3148	170	21	.	.	PUNCT
iajs-3148	171	1	j.	j.	PROPN
iajs-3148	171	2	dermatol	dermatol	PROPN
iajs-3148	171	3	.	.	PUNCT
iajs-3148	172	1	therapy	therapy	NOUN
iajs-3148	172	2	,	,	PUNCT
iajs-3148	172	3	2004	2004	NUM
iajs-3148	172	4	;	;	PUNCT
iajs-3148	172	5	17	17	NUM
iajs-3148	172	6	,	,	PUNCT
iajs-3148	172	7	5	5	NUM
iajs-3148	172	8	,	,	PUNCT
iajs-3148	172	9	341	341	NUM
iajs-3148	172	10	-	-	SYM
iajs-3148	172	11	349	349	NUM
iajs-3148	172	12	.	.	PUNCT
iajs-3148	173	1	25	25	NUM
iajs-3148	173	2	.	.	PUNCT
iajs-3148	174	1	hong	hong	PROPN
iajs-3148	174	2	,	,	PUNCT
iajs-3148	174	3	j.j	j.j	PROPN
iajs-3148	174	4	.	.	PROPN
iajs-3148	174	5	;	;	PUNCT
iajs-3148	174	6	hadeler	hadeler	NOUN
iajs-3148	174	7	,	,	PUNCT
iajs-3148	174	8	e.k	e.k	PROPN
iajs-3148	174	9	.	.	PROPN
iajs-3148	174	10	;	;	PUNCT
iajs-3148	174	11	mosca	mosca	PROPN
iajs-3148	174	12	,	,	PUNCT
iajs-3148	174	13	m.l	m.l	PROPN
iajs-3148	174	14	.	.	PROPN
iajs-3148	174	15	;	;	PUNCT
iajs-3148	174	16	brownstone	brownstone	PROPN
iajs-3148	174	17	,	,	PUNCT
iajs-3148	174	18	n.d	n.d	PROPN
iajs-3148	174	19	.	.	PROPN
iajs-3148	174	20	;	;	PUNCT
iajs-3148	174	21	bhutani	bhutani	NOUN
iajs-3148	174	22	,	,	PUNCT
iajs-3148	174	23	t.	t.	PROPN
iajs-3148	174	24	liao	liao	PROPN
iajs-3148	174	25	,	,	PUNCT
iajs-3148	174	26	w.j	w.j	PROPN
iajs-3148	174	27	.	.	PROPN
iajs-3148	174	28	tnf	tnf	PROPN
iajs-3148	174	29	-	-	PUNCT
iajs-3148	174	30	alpha	alpha	NOUN
iajs-3148	174	31	inhibitors	inhibitor	NOUN
iajs-3148	174	32	and	and	CCONJ
iajs-3148	174	33	ustekinumab	ustekinumab	NOUN
iajs-3148	174	34	for	for	ADP
iajs-3148	174	35	the	the	DET
iajs-3148	174	36	treatment	treatment	NOUN
iajs-3148	174	37	of	of	ADP
iajs-3148	174	38	psoriasis	psoriasis	NOUN
iajs-3148	174	39	:	:	PUNCT
iajs-3148	174	40	therapeutic	therapeutic	ADJ
iajs-3148	174	41	utility	utility	NOUN
iajs-3148	174	42	in	in	ADP
iajs-3148	174	43	the	the	DET
iajs-3148	174	44	era	era	NOUN
iajs-3148	174	45	of	of	ADP
iajs-3148	174	46	il-17	il-17	NUM
iajs-3148	174	47	and	and	CCONJ
iajs-3148	174	48	il-23	il-23	VERB
iajs-3148	174	49	inhibitors	inhibitor	NOUN
iajs-3148	174	50	.	.	PUNCT
iajs-3148	175	1	j.	j.	PROPN
iajs-3148	175	2	psoriasis	psoriasis	NOUN
iajs-3148	175	3	psoriatic	psoriatic	ADJ
iajs-3148	175	4	arthritis	arthritis	NOUN
iajs-3148	175	5	,	,	PUNCT
iajs-3148	175	6	2022	2022	NUM
iajs-3148	175	7	;	;	PUNCT
iajs-3148	175	8	7	7	NUM
iajs-3148	175	9	,	,	PUNCT
iajs-3148	175	10	2	2	NUM
iajs-3148	175	11	,	,	PUNCT
iajs-3148	175	12	79	79	NUM
iajs-3148	175	13	-	-	SYM
iajs-3148	175	14	92	92	NUM
iajs-3148	175	15	.	.	PUNCT
iajs-3148	176	1	26	26	NUM
iajs-3148	176	2	.	.	PUNCT
iajs-3148	176	3	domm	domm	NOUN
iajs-3148	176	4	.	.	PUNCT
iajs-3148	177	1	s.	s.	PROPN
iajs-3148	177	2	;	;	PUNCT
iajs-3148	177	3	cinatl	cinatl	PROPN
iajs-3148	177	4	.	.	PUNCT
iajs-3148	178	1	j.	j.	PROPN
iajs-3148	178	2	;	;	PUNCT
iajs-3148	178	3	mrowietz	mrowietz	ADJ
iajs-3148	178	4	.	.	PUNCT
iajs-3148	179	1	u.	u.	PROPN
iajs-3148	179	2	;	;	PUNCT
iajs-3148	179	3	the	the	DET
iajs-3148	179	4	impact	impact	NOUN
iajs-3148	179	5	of	of	ADP
iajs-3148	179	6	treatment	treatment	NOUN
iajs-3148	179	7	with	with	ADP
iajs-3148	179	8	tumour	tumour	NOUN
iajs-3148	179	9	necrosis	necrosis	NOUN
iajs-3148	179	10	factor	factor	NOUN
iajs-3148	179	11	-	-	PUNCT
iajs-3148	179	12	alpha	alpha	NOUN
iajs-3148	179	13	antagonists	antagonist	NOUN
iajs-3148	179	14	on	on	ADP
iajs-3148	179	15	the	the	DET
iajs-3148	179	16	course	course	NOUN
iajs-3148	179	17	of	of	ADP
iajs-3148	179	18	chronic	chronic	ADJ
iajs-3148	179	19	viral	viral	ADJ
iajs-3148	179	20	infections	infection	NOUN
iajs-3148	179	21	:	:	PUNCT
iajs-3148	179	22	a	a	DET
iajs-3148	179	23	review	review	NOUN
iajs-3148	179	24	of	of	ADP
iajs-3148	179	25	the	the	DET
iajs-3148	179	26	literature	literature	NOUN
iajs-3148	179	27	.	.	PUNCT
iajs-3148	180	1	br	br	PROPN
iajs-3148	180	2	.	.	PUNCT
iajs-3148	181	1	j.	j.	PROPN
iajs-3148	181	2	dermatol	dermatol	PROPN
iajs-3148	181	3	.	.	PUNCT
iajs-3148	181	4	,	,	PUNCT
iajs-3148	181	5	2008	2008	NUM
iajs-3148	181	6	;	;	PUNCT
iajs-3148	181	7	159	159	NUM
iajs-3148	181	8	,	,	PUNCT
iajs-3148	181	9	6	6	NUM
iajs-3148	181	10	,	,	PUNCT
iajs-3148	181	11	1217–1228	1217–1228	NUM
iajs-3148	181	12	.	.	PROPN
iajs-3148	182	1	27	27	NUM
iajs-3148	182	2	.	.	PUNCT
iajs-3148	183	1	myers	myers	PROPN
iajs-3148	183	2	,	,	PUNCT
iajs-3148	183	3	b.	b.	PROPN
iajs-3148	183	4	;	;	PUNCT
iajs-3148	183	5	thibodeaux	thibodeaux	PROPN
iajs-3148	183	6	,	,	PUNCT
iajs-3148	183	7	q.	q.	PROPN
iajs-3148	183	8	;	;	PUNCT
iajs-3148	183	9	reddy	reddy	PROPN
iajs-3148	183	10	.	.	PUNCT
iajs-3148	184	1	v.	v.	ADP
iajs-3148	184	2	biologic	biologic	ADJ
iajs-3148	184	3	treatment	treatment	NOUN
iajs-3148	184	4	of	of	ADP
iajs-3148	184	5	4	4	NUM
iajs-3148	184	6	hiv	hiv	NOUN
iajs-3148	184	7	-	-	PUNCT
iajs-3148	184	8	positive	positive	ADJ
iajs-3148	184	9	patients	patient	NOUN
iajs-3148	184	10	:	:	PUNCT
iajs-3148	184	11	a	a	DET
iajs-3148	184	12	case	case	NOUN
iajs-3148	184	13	series	series	NOUN
iajs-3148	184	14	and	and	CCONJ
iajs-3148	184	15	literature	literature	PROPN
iajs-3148	184	16	review	review	PROPN
iajs-3148	184	17	.	.	PUNCT
iajs-3148	185	1	j.	j.	PROPN
iajs-3148	185	2	psoriasis	psoriasis	NOUN
iajs-3148	185	3	psoriatic	psoriatic	ADJ
iajs-3148	185	4	arthritis	arthritis	NOUN
iajs-3148	185	5	,	,	PUNCT
iajs-3148	185	6	2021	2021	NUM
iajs-3148	185	7	;	;	PUNCT
iajs-3148	185	8	6	6	NUM
iajs-3148	185	9	,	,	PUNCT
iajs-3148	185	10	1	1	NUM
iajs-3148	185	11	,	,	PUNCT
iajs-3148	185	12	19–26	19–26	NUM
iajs-3148	185	13	.	.	PUNCT
iajs-3148	186	1	28	28	NUM
iajs-3148	186	2	.	.	PUNCT
iajs-3148	187	1	arican	arican	PROPN
iajs-3148	187	2	,	,	PUNCT
iajs-3148	187	3	o.	o.	PROPN
iajs-3148	187	4	;	;	PUNCT
iajs-3148	187	5	aral	aral	PROPN
iajs-3148	187	6	,	,	PUNCT
iajs-3148	187	7	m.	m.	NOUN
iajs-3148	187	8	;	;	PUNCT
iajs-3148	187	9	sasmaz	sasmaz	PROPN
iajs-3148	187	10	,	,	PUNCT
iajs-3148	187	11	s.	s.	PROPN
iajs-3148	187	12	;	;	PUNCT
iajs-3148	187	13	ciragil	ciragil	NOUN
iajs-3148	187	14	,	,	PUNCT
iajs-3148	187	15	p.	p.	NOUN
iajs-3148	187	16	serum	serum	NOUN
iajs-3148	187	17	levels	level	NOUN
iajs-3148	187	18	of	of	ADP
iajs-3148	187	19	tnf	tnf	PROPN
iajs-3148	187	20	-	-	PUNCT
iajs-3148	187	21	alpha	alpha	NOUN
iajs-3148	187	22	,	,	PUNCT
iajs-3148	187	23	ifn	ifn	PROPN
iajs-3148	187	24	-	-	PUNCT
iajs-3148	187	25	gamma	gamma	NOUN
iajs-3148	187	26	,	,	PUNCT
iajs-3148	187	27	il-6	il-6	NOUN
iajs-3148	187	28	,	,	PUNCT
iajs-3148	187	29	il-8	il-8	NOUN
iajs-3148	187	30	,	,	PUNCT
iajs-3148	187	31	il-12	il-12	NOUN
iajs-3148	187	32	,	,	PUNCT
iajs-3148	187	33	il-17	il-17	X
iajs-3148	187	34	,	,	PUNCT
iajs-3148	187	35	and	and	CCONJ
iajs-3148	187	36	il-18	il-18	ADP
iajs-3148	187	37	in	in	ADP
iajs-3148	187	38	patients	patient	NOUN
iajs-3148	187	39	with	with	ADP
iajs-3148	187	40	active	active	ADJ
iajs-3148	187	41	psoriasis	psoriasis	NOUN
iajs-3148	187	42	and	and	CCONJ
iajs-3148	187	43	correlation	correlation	NOUN
iajs-3148	187	44	with	with	ADP
iajs-3148	187	45	disease	disease	NOUN
iajs-3148	187	46	severity	severity	NOUN
iajs-3148	187	47	.	.	PUNCT
iajs-3148	188	1	j.	j.	PROPN
iajs-3148	188	2	mediators	mediators	PROPN
iajs-3148	188	3	inflamm	inflamm	PROPN
iajs-3148	188	4	.	.	PUNCT
iajs-3148	188	5	,	,	PUNCT
iajs-3148	188	6	2005	2005	NUM
iajs-3148	188	7	;	;	PUNCT
iajs-3148	188	8	2005	2005	NUM
iajs-3148	188	9	,	,	PUNCT
iajs-3148	188	10	5	5	NUM
iajs-3148	188	11	,	,	PUNCT
iajs-3148	188	12	273–279	273–279	NUM
iajs-3148	188	13	.	.	PUNCT
iajs-3148	189	1	29	29	NUM
iajs-3148	189	2	.	.	PUNCT
iajs-3148	189	3	abanmi	abanmi	PROPN
iajs-3148	189	4	,	,	PUNCT
iajs-3148	189	5	a.	a.	NOUN
iajs-3148	189	6	;	;	PUNCT
iajs-3148	189	7	al	al	PROPN
iajs-3148	189	8	-	-	PUNCT
iajs-3148	189	9	harthi	harthi	PROPN
iajs-3148	189	10	,	,	PUNCT
iajs-3148	189	11	f.	f.	PROPN
iajs-3148	189	12	;	;	PUNCT
iajs-3148	189	13	al	al	PROPN
iajs-3148	189	14	-	-	PUNCT
iajs-3148	189	15	agla	agla	PROPN
iajs-3148	189	16	,	,	PUNCT
iajs-3148	189	17	r.	r.	PROPN
iajs-3148	189	18	serum	serum	PROPN
iajs-3148	189	19	levels	level	NOUN
iajs-3148	189	20	of	of	ADP
iajs-3148	189	21	proinflammatory	proinflammatory	ADJ
iajs-3148	189	22	cytokines	cytokine	NOUN
iajs-3148	189	23	in	in	ADP
iajs-3148	189	24	psoriasis	psoriasis	NOUN
iajs-3148	189	25	patients	patient	NOUN
iajs-3148	189	26	from	from	ADP
iajs-3148	189	27	saudi	saudi	PROPN
iajs-3148	189	28	arabia	arabia	PROPN
iajs-3148	189	29	.	.	PUNCT
iajs-3148	190	1	int	int	NOUN
iajs-3148	190	2	.	.	PUNCT
iajs-3148	191	1	j.	j.	PROPN
iajs-3148	191	2	dermatol	dermatol	PROPN
iajs-3148	191	3	.	.	PUNCT
iajs-3148	191	4	,	,	PUNCT
iajs-3148	191	5	2005	2005	NUM
iajs-3148	191	6	;	;	PUNCT
iajs-3148	191	7	44	44	NUM
iajs-3148	191	8	,	,	PUNCT
iajs-3148	191	9	1	1	NUM
iajs-3148	191	10	,	,	PUNCT
iajs-3148	191	11	82–83	82–83	NUM
iajs-3148	191	12	.	.	NOUN
iajs-3148	191	13	30	30	NUM
iajs-3148	191	14	.	.	X
iajs-3148	192	1	roussaki	roussaki	NOUN
iajs-3148	192	2	-	-	PUNCT
iajs-3148	192	3	schulze	schulze	NOUN
iajs-3148	192	4	.	.	PUNCT
iajs-3148	193	1	av	av	PROPN
iajs-3148	193	2	.	.	PUNCT
iajs-3148	193	3	;	;	PUNCT
iajs-3148	194	1	kouskoukis	kouskoukis	PROPN
iajs-3148	194	2	.	.	PUNCT
iajs-3148	195	1	c.	c.	PROPN
iajs-3148	195	2	;	;	PUNCT
iajs-3148	195	3	petinaki	petinaki	PROPN
iajs-3148	195	4	.	.	PUNCT
iajs-3148	196	1	e.	e.	PROPN
iajs-3148	196	2	evaluation	evaluation	PROPN
iajs-3148	196	3	of	of	ADP
iajs-3148	196	4	cytokine	cytokine	ADJ
iajs-3148	196	5	serum	serum	NOUN
iajs-3148	196	6	levels	level	NOUN
iajs-3148	196	7	in	in	ADP
iajs-3148	196	8	patients	patient	NOUN
iajs-3148	196	9	with	with	ADP
iajs-3148	196	10	plaque	plaque	NOUN
iajs-3148	196	11	-	-	PUNCT
iajs-3148	196	12	type	type	NOUN
iajs-3148	196	13	psoriasis	psoriasis	NOUN
iajs-3148	196	14	.	.	PUNCT
iajs-3148	197	1	int	int	NOUN
iajs-3148	197	2	.	.	PUNCT
iajs-3148	198	1	j.	j.	PROPN
iajs-3148	198	2	clin	clin	PROPN
iajs-3148	198	3	.	.	PUNCT
iajs-3148	199	1	pharmacol	pharmacol	PROPN
iajs-3148	199	2	.	.	PUNCT
iajs-3148	200	1	res	re	NOUN
iajs-3148	200	2	.	.	PROPN
iajs-3148	200	3	,	,	PUNCT
iajs-3148	200	4	2005	2005	NUM
iajs-3148	200	5	;	;	PUNCT
iajs-3148	200	6	25	25	NUM
iajs-3148	200	7	,	,	PUNCT
iajs-3148	200	8	4	4	NUM
iajs-3148	200	9	,	,	PUNCT
iajs-3148	200	10	169–73	169–73	NUM
iajs-3148	200	11	.	.	PUNCT
iajs-3148	201	1	31	31	NUM
iajs-3148	201	2	.	.	PUNCT
iajs-3148	201	3	fotiadou	fotiadou	PROPN
iajs-3148	201	4	,	,	PUNCT
iajs-3148	201	5	c.	c.	PROPN
iajs-3148	201	6	;	;	PUNCT
iajs-3148	201	7	lazaridou	lazaridou	PROPN
iajs-3148	201	8	,	,	PUNCT
iajs-3148	201	9	e.	e.	PROPN
iajs-3148	201	10	;	;	PUNCT
iajs-3148	201	11	sotiriou	sotiriou	PROPN
iajs-3148	201	12	,	,	PUNCT
iajs-3148	201	13	e.	e.	PROPN
iajs-3148	201	14	;	;	PUNCT
iajs-3148	201	15	ioannides	ioannide	NOUN
iajs-3148	201	16	,	,	PUNCT
iajs-3148	201	17	d.	d.	NOUN
iajs-3148	201	18	targeting	target	VERB
iajs-3148	201	19	il-23	il-23	NOUN
iajs-3148	201	20	in	in	ADP
iajs-3148	201	21	psoriasis	psoriasis	NOUN
iajs-3148	201	22	:	:	PUNCT
iajs-3148	201	23	current	current	ADJ
iajs-3148	201	24	perspectives	perspective	NOUN
iajs-3148	201	25	.	.	PUNCT
iajs-3148	202	1	j.	j.	PROPN
iajs-3148	202	2	psoriasis	psoriasis	NOUN
iajs-3148	202	3	(	(	PUNCT
iajs-3148	202	4	auckl	auckl	NOUN
iajs-3148	202	5	)	)	PUNCT
iajs-3148	202	6	,	,	PUNCT
iajs-3148	202	7	2018	2018	NUM
iajs-3148	202	8	;	;	PUNCT
iajs-3148	202	9	8	8	NUM
iajs-3148	202	10	,	,	PUNCT
iajs-3148	202	11	1	1	NUM
iajs-3148	202	12	,	,	PUNCT
iajs-3148	202	13	1	1	NUM
iajs-3148	202	14	-	-	SYM
iajs-3148	202	15	5	5	NUM
iajs-3148	202	16	.	.	NOUN
iajs-3148	202	17	32	32	NUM
iajs-3148	202	18	.	.	PUNCT
iajs-3148	203	1	dattola	dattola	PROPN
iajs-3148	203	2	,	,	PUNCT
iajs-3148	203	3	a.	a.	NOUN
iajs-3148	203	4	;	;	PUNCT
iajs-3148	203	5	silvestri	silvestri	ADJ
iajs-3148	203	6	,	,	PUNCT
iajs-3148	203	7	m.	m.	NOUN
iajs-3148	203	8	;	;	PUNCT
iajs-3148	203	9	tamburi	tamburi	PROPN
iajs-3148	203	10	,	,	PUNCT
iajs-3148	203	11	f.	f.	PROPN
iajs-3148	203	12	;	;	PUNCT
iajs-3148	203	13	amoruso	amoruso	PROPN
iajs-3148	203	14	,	,	PUNCT
iajs-3148	203	15	g.	g.	PROPN
iajs-3148	203	16	f.	f.	PROPN
iajs-3148	203	17	;	;	PUNCT
iajs-3148	203	18	bennardo	bennardo	PROPN
iajs-3148	203	19	,	,	PUNCT
iajs-3148	203	20	l.	l.	PROPN
iajs-3148	203	21	;	;	PUNCT
iajs-3148	203	22	nisticò	nisticò	NOUN
iajs-3148	203	23	.	.	PUNCT
iajs-3148	204	1	s.p	s.p	PROPN
iajs-3148	204	2	.	.	PUNCT
iajs-3148	204	3	emerging	emerge	VERB
iajs-3148	204	4	role	role	NOUN
iajs-3148	204	5	of	of	ADP
iajs-3148	204	6	anti‐il23	anti‐il23	X
iajs-3148	204	7	in	in	ADP
iajs-3148	204	8	the	the	DET
iajs-3148	204	9	treatment	treatment	NOUN
iajs-3148	204	10	of	of	ADP
iajs-3148	204	11	psoriasis	psoriasis	NOUN
iajs-3148	204	12	:	:	PUNCT
iajs-3148	204	13	when	when	SCONJ
iajs-3148	204	14	humanized	humanize	VERB
iajs-3148	204	15	is	be	AUX
iajs-3148	204	16	very	very	ADV
iajs-3148	204	17	promising	promising	ADJ
iajs-3148	204	18	.	.	PUNCT
iajs-3148	205	1	j.	j.	PROPN
iajs-3148	205	2	dermatologic	dermatologic	PROPN
iajs-3148	205	3	therapy	therapy	NOUN
iajs-3148	205	4	2020	2020	NUM
iajs-3148	205	5	;	;	PUNCT
iajs-3148	205	6	33	33	NUM
iajs-3148	205	7	,	,	PUNCT
iajs-3148	205	8	6	6	NUM
iajs-3148	205	9	,	,	PUNCT
iajs-3148	205	10	14504	14504	NUM
iajs-3148	205	11	33	33	NUM
iajs-3148	205	12	.	.	PUNCT
iajs-3148	206	1	wolk	wolk	PROPN
iajs-3148	206	2	,	,	PUNCT
iajs-3148	206	3	k.	k.	PROPN
iajs-3148	206	4	;	;	PUNCT
iajs-3148	206	5	witte	witte	PROPN
iajs-3148	206	6	,	,	PUNCT
iajs-3148	206	7	e.	e.	PROPN
iajs-3148	206	8	;	;	PUNCT
iajs-3148	206	9	wallace	wallace	PROPN
iajs-3148	206	10	,	,	PUNCT
iajs-3148	206	11	e.	e.	PROPN
iajs-3148	206	12	;	;	PUNCT
iajs-3148	206	13	döcke	döcke	PROPN
iajs-3148	206	14	,	,	PUNCT
iajs-3148	206	15	w.d	w.d	PROPN
iajs-3148	206	16	.	.	PROPN
iajs-3148	206	17	;	;	PUNCT
iajs-3148	206	18	kunz	kunz	PROPN
iajs-3148	206	19	,	,	PUNCT
iajs-3148	206	20	s.	s.	PROPN
iajs-3148	206	21	;	;	PUNCT
iajs-3148	206	22	asadullah	asadullah	PROPN
iajs-3148	206	23	,	,	PUNCT
iajs-3148	206	24	k.	k.	PROPN
iajs-3148	206	25	;	;	PUNCT
iajs-3148	206	26	volk	volk	PROPN
iajs-3148	206	27	,	,	PUNCT
iajs-3148	206	28	h.d	h.d	PROPN
iajs-3148	206	29	.	.	PROPN
iajs-3148	206	30	;	;	PUNCT
iajs-3148	206	31	sterry	sterry	PROPN
iajs-3148	206	32	,	,	PUNCT
iajs-3148	206	33	w.	w.	PROPN
iajs-3148	206	34	;	;	PUNCT
iajs-3148	206	35	sabat	sabat	PROPN
iajs-3148	206	36	,	,	PUNCT
iajs-3148	206	37	r.	r.	PROPN
iajs-3148	206	38	il‐22	il‐22	PROPN
iajs-3148	206	39	regulates	regulate	VERB
iajs-3148	206	40	the	the	DET
iajs-3148	206	41	expression	expression	NOUN
iajs-3148	206	42	of	of	ADP
iajs-3148	206	43	genes	gene	NOUN
iajs-3148	206	44	responsible	responsible	ADJ
iajs-3148	206	45	for	for	ADP
iajs-3148	206	46	antimicrobial	antimicrobial	ADJ
iajs-3148	206	47	defense	defense	NOUN
iajs-3148	206	48	,	,	PUNCT
iajs-3148	206	49	cellular	cellular	ADJ
iajs-3148	206	50	differentiation	differentiation	NOUN
iajs-3148	206	51	,	,	PUNCT
iajs-3148	206	52	and	and	CCONJ
iajs-3148	206	53	mobility	mobility	NOUN
iajs-3148	206	54	in	in	ADP
iajs-3148	206	55	keratinocytes	keratinocyte	NOUN
iajs-3148	206	56	:	:	PUNCT
iajs-3148	206	57	a	a	DET
iajs-3148	206	58	potential	potential	ADJ
iajs-3148	206	59	role	role	NOUN
iajs-3148	206	60	in	in	ADP
iajs-3148	206	61	psoriasis	psoriasis	NOUN
iajs-3148	206	62	.	.	PUNCT
iajs-3148	207	1	europ	europ	NOUN
iajs-3148	207	2	.	.	PUNCT
iajs-3148	208	1	j.	j.	PROPN
iajs-3148	208	2	immunol	immunol	PROPN
iajs-3148	208	3	.	.	PROPN
iajs-3148	208	4	,	,	PUNCT
iajs-3148	208	5	2006	2006	NUM
iajs-3148	208	6	;	;	PUNCT
iajs-3148	208	7	36	36	NUM
iajs-3148	208	8	,	,	PUNCT
iajs-3148	208	9	5	5	NUM
iajs-3148	208	10	,	,	PUNCT
iajs-3148	208	11	1309	1309	NUM
iajs-3148	208	12	-	-	SYM
iajs-3148	208	13	1323	1323	NUM
iajs-3148	208	14	.	.	PUNCT
iajs-3148	209	1	34	34	NUM
iajs-3148	209	2	.	.	PUNCT
iajs-3148	210	1	takahashi	takahashi	PROPN
iajs-3148	210	2	,	,	PUNCT
iajs-3148	210	3	h.	h.	PROPN
iajs-3148	210	4	;	;	PUNCT
iajs-3148	210	5	tsuji	tsuji	PROPN
iajs-3148	210	6	,	,	PUNCT
iajs-3148	210	7	h.	h.	PROPN
iajs-3148	210	8	;	;	PUNCT
iajs-3148	210	9	hashimoto	hashimoto	NOUN
iajs-3148	210	10	,	,	PUNCT
iajs-3148	210	11	y.	y.	PROPN
iajs-3148	210	12	;	;	PUNCT
iajs-3148	210	13	ishida	ishida	PROPN
iajs-3148	210	14	-	-	PUNCT
iajs-3148	210	15	yamamoto	yamamoto	PROPN
iajs-3148	210	16	,	,	PUNCT
iajs-3148	210	17	a.	a.	NOUN
iajs-3148	210	18	;	;	PUNCT
iajs-3148	210	19	iizuka	iizuka	PROPN
iajs-3148	210	20	,	,	PUNCT
iajs-3148	210	21	h.	h.	PROPN
iajs-3148	210	22	serum	serum	PROPN
iajs-3148	210	23	cytokines	cytokine	NOUN
iajs-3148	210	24	and	and	CCONJ
iajs-3148	210	25	growth	growth	NOUN
iajs-3148	210	26	factor	factor	NOUN
iajs-3148	210	27	levels	level	NOUN
iajs-3148	210	28	in	in	ADP
iajs-3148	210	29	japanese	japanese	ADJ
iajs-3148	210	30	patients	patient	NOUN
iajs-3148	210	31	with	with	ADP
iajs-3148	210	32	psoriasis	psoriasis	NOUN
iajs-3148	210	33	.	.	PUNCT
iajs-3148	211	1	clin	clin	PROPN
iajs-3148	211	2	.	.	PUNCT
iajs-3148	212	1	exper	exper	PROPN
iajs-3148	212	2	.	.	PUNCT
iajs-3148	213	1	dermatol	dermatol	PROPN
iajs-3148	213	2	,	,	PUNCT
iajs-3148	213	3	exper	exper	PROPN
iajs-3148	213	4	.	.	PUNCT
iajs-3148	214	1	dermatol	dermatol	PROPN
iajs-3148	214	2	.	.	PUNCT
iajs-3148	214	3	,	,	PUNCT
iajs-3148	214	4	2010	2010	NUM
iajs-3148	214	5	;	;	PUNCT
iajs-3148	214	6	35	35	NUM
iajs-3148	214	7	,	,	PUNCT
iajs-3148	214	8	6	6	NUM
iajs-3148	214	9	,	,	PUNCT
iajs-3148	214	10	645	645	NUM
iajs-3148	214	11	-	-	SYM
iajs-3148	214	12	649	649	NUM
iajs-3148	214	13	.	.	NOUN
iajs-3148	215	1	35	35	NUM
iajs-3148	215	2	.	.	PUNCT
iajs-3148	215	3	vähävihu	vähävihu	PROPN
iajs-3148	215	4	,	,	PUNCT
iajs-3148	215	5	k.	k.	PROPN
iajs-3148	215	6	;	;	PUNCT
iajs-3148	215	7	ala	ala	PROPN
iajs-3148	215	8	-	-	PUNCT
iajs-3148	215	9	houhala	houhala	PROPN
iajs-3148	215	10	,	,	PUNCT
iajs-3148	215	11	m.	m.	NOUN
iajs-3148	215	12	;	;	PUNCT
iajs-3148	215	13	peric	peric	NOUN
iajs-3148	215	14	,	,	PUNCT
iajs-3148	215	15	m.	m.	NOUN
iajs-3148	215	16	;	;	PUNCT
iajs-3148	215	17	karisola	karisola	PROPN
iajs-3148	215	18	,	,	PUNCT
iajs-3148	215	19	p.	p.	PROPN
iajs-3148	215	20	;	;	PUNCT
iajs-3148	215	21	kautiainen	kautiainen	PROPN
iajs-3148	215	22	,	,	PUNCT
iajs-3148	215	23	h.	h.	PROPN
iajs-3148	215	24	;	;	PUNCT
iajs-3148	215	25	hasan	hasan	PROPN
iajs-3148	215	26	,	,	PUNCT
iajs-3148	215	27	t.	t.	PROPN
iajs-3148	215	28	;	;	PUNCT
iajs-3148	215	29	snellman	snellman	PROPN
iajs-3148	215	30	,	,	PUNCT
iajs-3148	215	31	e.	e.	PROPN
iajs-3148	215	32	;	;	PUNCT
iajs-3148	215	33	alenius	alenius	PROPN
iajs-3148	215	34	,	,	PUNCT
iajs-3148	215	35	h.	h.	PROPN
iajs-3148	215	36	;	;	PUNCT
iajs-3148	215	37	schauber	schauber	PROPN
iajs-3148	215	38	,	,	PUNCT
iajs-3148	215	39	j.	j.	PROPN
iajs-3148	215	40	;	;	PUNCT
iajs-3148	215	41	reunala	reunala	PROPN
iajs-3148	215	42	,	,	PUNCT
iajs-3148	215	43	t.	t.	PROPN
iajs-3148	215	44	narrowband	narrowband	PROPN
iajs-3148	216	1	ultraviolet	ultraviolet	PROPN
iajs-3148	216	2	b	b	PROPN
iajs-3148	216	3	treatment	treatment	NOUN
iajs-3148	216	4	improves	improve	VERB
iajs-3148	216	5	ihjpas	ihjpa	NOUN
iajs-3148	216	6	.	.	PUNCT
iajs-3148	217	1	37	37	NUM
iajs-3148	217	2	(	(	PUNCT
iajs-3148	217	3	1	1	NUM
iajs-3148	217	4	)	)	PUNCT
iajs-3148	217	5	2024	2024	NUM
iajs-3148	217	6	84	84	NUM
iajs-3148	217	7	vitamin	vitamin	NOUN
iajs-3148	217	8	d	d	NOUN
iajs-3148	217	9	balance	balance	NOUN
iajs-3148	217	10	and	and	CCONJ
iajs-3148	217	11	alters	alter	VERB
iajs-3148	217	12	antimicrobial	antimicrobial	ADJ
iajs-3148	217	13	peptide	peptide	NOUN
iajs-3148	217	14	expression	expression	NOUN
iajs-3148	217	15	in	in	ADP
iajs-3148	217	16	skin	skin	NOUN
iajs-3148	217	17	lesions	lesion	NOUN
iajs-3148	217	18	of	of	ADP
iajs-3148	217	19	psoriasis	psoriasis	NOUN
iajs-3148	217	20	and	and	CCONJ
iajs-3148	217	21	atopic	atopic	NOUN
iajs-3148	217	22	dermatitis	dermatitis	NOUN
iajs-3148	217	23	.	.	PUNCT
iajs-3148	218	1	br	br	PROPN
iajs-3148	218	2	.	.	PUNCT
iajs-3148	219	1	j.	j.	PROPN
iajs-3148	219	2	dermatol	dermatol	PROPN
iajs-3148	219	3	.	.	PUNCT
iajs-3148	219	4	,	,	PUNCT
iajs-3148	219	5	2010	2010	NUM
iajs-3148	219	6	;	;	PUNCT
iajs-3148	219	7	163	163	NUM
iajs-3148	219	8	,	,	PUNCT
iajs-3148	219	9	2	2	NUM
iajs-3148	219	10	,	,	PUNCT
iajs-3148	219	11	321	321	NUM
iajs-3148	219	12	-	-	SYM
iajs-3148	219	13	328	328	NUM
iajs-3148	219	14	.	.	PUNCT
iajs-3148	220	1	36	36	NUM
iajs-3148	220	2	.	.	PUNCT
iajs-3148	221	1	coimbra	coimbra	PROPN
iajs-3148	221	2	,	,	PUNCT
iajs-3148	221	3	s.	s.	PROPN
iajs-3148	221	4	;	;	PUNCT
iajs-3148	221	5	oliveira	oliveira	PROPN
iajs-3148	221	6	,	,	PUNCT
iajs-3148	221	7	h.	h.	PROPN
iajs-3148	221	8	;	;	PUNCT
iajs-3148	221	9	reis	reis	NOUN
iajs-3148	221	10	,	,	PUNCT
iajs-3148	221	11	f.	f.	PROPN
iajs-3148	221	12	;	;	PUNCT
iajs-3148	221	13	belo	belo	PROPN
iajs-3148	221	14	,	,	PUNCT
iajs-3148	221	15	l.	l.	PROPN
iajs-3148	221	16	;	;	PUNCT
iajs-3148	221	17	rocha	rocha	PROPN
iajs-3148	221	18	,	,	PUNCT
iajs-3148	221	19	s.	s.	PROPN
iajs-3148	221	20	;	;	PUNCT
iajs-3148	221	21	quintanilha	quintanilha	NOUN
iajs-3148	221	22	,	,	PUNCT
iajs-3148	221	23	a.	a.	NOUN
iajs-3148	221	24	;	;	PUNCT
iajs-3148	221	25	santos‐silva	santos‐silva	PROPN
iajs-3148	221	26	.	.	PUNCT
iajs-3148	222	1	a.	a.	NOUN
iajs-3148	222	2	interleukin	interleukin	NOUN
iajs-3148	222	3	(	(	PUNCT
iajs-3148	222	4	il)‐22	il)‐22	ADJ
iajs-3148	222	5	,	,	PUNCT
iajs-3148	222	6	il‐17	il‐17	ADJ
iajs-3148	222	7	,	,	PUNCT
iajs-3148	222	8	il‐23	il‐23	PROPN
iajs-3148	222	9	,	,	PUNCT
iajs-3148	222	10	il‐8	il‐8	NOUN
iajs-3148	222	11	,	,	PUNCT
iajs-3148	222	12	vascular	vascular	ADJ
iajs-3148	222	13	endothelial	endothelial	ADJ
iajs-3148	222	14	growth	growth	NOUN
iajs-3148	222	15	factor	factor	NOUN
iajs-3148	222	16	and	and	CCONJ
iajs-3148	222	17	tumour	tumour	NOUN
iajs-3148	222	18	necrosis	necrosis	NOUN
iajs-3148	222	19	factor‐α	factor‐α	NOUN
iajs-3148	222	20	levels	level	NOUN
iajs-3148	222	21	in	in	ADP
iajs-3148	222	22	patients	patient	NOUN
iajs-3148	222	23	with	with	ADP
iajs-3148	222	24	psoriasis	psoriasis	NOUN
iajs-3148	222	25	before	before	ADV
iajs-3148	222	26	,	,	PUNCT
iajs-3148	222	27	during	during	ADP
iajs-3148	222	28	and	and	CCONJ
iajs-3148	222	29	after	after	ADP
iajs-3148	222	30	psoralen	psoralen	NOUN
iajs-3148	222	31	–	–	PUNCT
iajs-3148	222	32	ultraviolet	ultraviolet	NOUN
iajs-3148	222	33	a	a	PRON
iajs-3148	222	34	and	and	CCONJ
iajs-3148	222	35	narrowband	narrowband	PROPN
iajs-3148	222	36	ultraviolet	ultraviolet	PROPN
iajs-3148	222	37	b	b	PROPN
iajs-3148	222	38	therapy	therapy	NOUN
iajs-3148	222	39	.	.	PUNCT
iajs-3148	223	1	br	br	PROPN
iajs-3148	223	2	.	.	PUNCT
iajs-3148	224	1	j.	j.	PROPN
iajs-3148	224	2	dermatology	dermatology	PROPN
iajs-3148	224	3	2010,163	2010,163	NUM
iajs-3148	224	4	,	,	PUNCT
iajs-3148	224	5	6	6	NUM
iajs-3148	224	6	,	,	PUNCT
iajs-3148	224	7	1282	1282	NUM
iajs-3148	224	8	-	-	SYM
iajs-3148	224	9	1290	1290	NUM
iajs-3148	224	10	.	.	PUNCT
iajs-3148	225	1	37	37	NUM
iajs-3148	225	2	.	.	PUNCT
iajs-3148	225	3	girolomoni	girolomoni	PROPN
iajs-3148	225	4	,	,	PUNCT
iajs-3148	225	5	g.	g.	NOUN
iajs-3148	225	6	;	;	PUNCT
iajs-3148	225	7	strohal	strohal	PROPN
iajs-3148	225	8	,	,	PUNCT
iajs-3148	225	9	r.	r.	PROPN
iajs-3148	225	10	;	;	PUNCT
iajs-3148	225	11	puig	puig	PROPN
iajs-3148	225	12	,	,	PUNCT
iajs-3148	225	13	l.	l.	PROPN
iajs-3148	225	14	;	;	PUNCT
iajs-3148	225	15	bachelez	bachelez	PROPN
iajs-3148	225	16	,	,	PUNCT
iajs-3148	225	17	h.	h.	PROPN
iajs-3148	225	18	;	;	PUNCT
iajs-3148	225	19	barker	barker	PROPN
iajs-3148	225	20	,	,	PUNCT
iajs-3148	225	21	j.	j.	PROPN
iajs-3148	225	22	;	;	PUNCT
iajs-3148	225	23	boehncke	boehncke	NOUN
iajs-3148	225	24	,	,	PUNCT
iajs-3148	225	25	w.h	w.h	PROPN
iajs-3148	225	26	.	.	PROPN
iajs-3148	225	27	;	;	PUNCT
iajs-3148	225	28	prinz	prinz	PROPN
iajs-3148	225	29	j.	j.	PROPN
iajs-3148	225	30	c.	c.	PROPN
iajs-3148	225	31	the	the	DET
iajs-3148	225	32	role	role	NOUN
iajs-3148	225	33	of	of	ADP
iajs-3148	225	34	il‐23	il‐23	PROPN
iajs-3148	225	35	and	and	CCONJ
iajs-3148	225	36	the	the	DET
iajs-3148	225	37	il‐23	il‐23	PROPN
iajs-3148	225	38	/	/	SYM
iajs-3148	225	39	th	th	PROPN
iajs-3148	225	40	17	17	NUM
iajs-3148	225	41	immune	immune	ADJ
iajs-3148	225	42	axis	axis	NOUN
iajs-3148	225	43	in	in	ADP
iajs-3148	225	44	the	the	DET
iajs-3148	225	45	pathogenesis	pathogenesis	NOUN
iajs-3148	225	46	and	and	CCONJ
iajs-3148	225	47	treatment	treatment	NOUN
iajs-3148	225	48	of	of	ADP
iajs-3148	225	49	psoriasis	psoriasis	NOUN
iajs-3148	225	50	.	.	PUNCT
iajs-3148	226	1	j.	j.	PROPN
iajs-3148	226	2	europ	europ	PROPN
iajs-3148	226	3	.	.	PUNCT
iajs-3148	227	1	acad	acad	PROPN
iajs-3148	227	2	.	.	PUNCT
iajs-3148	228	1	dermatol	dermatol	NOUN
iajs-3148	228	2	.	.	PUNCT
iajs-3148	229	1	venereol	venereol	PROPN
iajs-3148	229	2	.	.	PUNCT
iajs-3148	230	1	,	,	PUNCT
iajs-3148	231	1	2017	2017	NUM
iajs-3148	231	2	;	;	PUNCT
iajs-3148	231	3	31	31	NUM
iajs-3148	231	4	,	,	PUNCT
iajs-3148	231	5	10	10	NUM
iajs-3148	231	6	,	,	PUNCT
iajs-3148	231	7	1616	1616	NUM
iajs-3148	231	8	-	-	SYM
iajs-3148	231	9	1626	1626	NUM
iajs-3148	231	10	.	.	PUNCT
iajs-3148	232	1	38	38	NUM
iajs-3148	232	2	.	.	PUNCT
iajs-3148	233	1	curtis	curtis	PROPN
iajs-3148	233	2	.	.	PUNCT
iajs-3148	234	1	m.m	m.m	PROPN
iajs-3148	234	2	.	.	PROPN
iajs-3148	234	3	;	;	PUNCT
iajs-3148	234	4	way	way	NOUN
iajs-3148	234	5	.	.	PUNCT
iajs-3148	235	1	s.s	s.s	PROPN
iajs-3148	235	2	.	.	PROPN
iajs-3148	235	3	;	;	PUNCT
iajs-3148	235	4	interleukin-17	interleukin-17	PROPN
iajs-3148	235	5	in	in	ADP
iajs-3148	235	6	host	host	NOUN
iajs-3148	235	7	defence	defence	NOUN
iajs-3148	235	8	against	against	ADP
iajs-3148	235	9	bacterial	bacterial	ADJ
iajs-3148	235	10	,	,	PUNCT
iajs-3148	235	11	mycobacterial	mycobacterial	ADJ
iajs-3148	235	12	and	and	CCONJ
iajs-3148	235	13	fungal	fungal	ADJ
iajs-3148	235	14	pathogens	pathogen	NOUN
iajs-3148	235	15	.	.	PUNCT
iajs-3148	236	1	j.	j.	PROPN
iajs-3148	236	2	immunol	immunol	PROPN
iajs-3148	236	3	.	.	PUNCT
iajs-3148	237	1	2009	2009	NUM
iajs-3148	237	2	;	;	PUNCT
iajs-3148	237	3	126	126	NUM
iajs-3148	237	4	,	,	PUNCT
iajs-3148	237	5	177	177	NUM
iajs-3148	237	6	-	-	SYM
iajs-3148	237	7	185	185	NUM
iajs-3148	237	8	.	.	PUNCT
iajs-3148	238	1	39	39	NUM
iajs-3148	238	2	.	.	PUNCT
iajs-3148	239	1	langrish	langrish	PROPN
iajs-3148	239	2	,	,	PUNCT
iajs-3148	239	3	c.l	c.l	PROPN
iajs-3148	239	4	.	.	PROPN
iajs-3148	239	5	;	;	PUNCT
iajs-3148	240	1	chen	chen	PROPN
iajs-3148	240	2	,	,	PUNCT
iajs-3148	240	3	y.	y.	PROPN
iajs-3148	240	4	;	;	PUNCT
iajs-3148	240	5	blumenschein	blumenschein	ADJ
iajs-3148	240	6	,	,	PUNCT
iajs-3148	240	7	w.m	w.m	PROPN
iajs-3148	240	8	.	.	PROPN
iajs-3148	240	9	;	;	PUNCT
iajs-3148	240	10	mattson	mattson	PROPN
iajs-3148	240	11	,	,	PUNCT
iajs-3148	240	12	j.	j.	PROPN
iajs-3148	240	13	;	;	PUNCT
iajs-3148	240	14	basham	basham	PROPN
iajs-3148	240	15	,	,	PUNCT
iajs-3148	240	16	b.	b.	PROPN
iajs-3148	240	17	;	;	PUNCT
iajs-3148	240	18	sedgwick	sedgwick	PROPN
iajs-3148	240	19	,	,	PUNCT
iajs-3148	240	20	j.d	j.d	PROPN
iajs-3148	240	21	.	.	PROPN
iajs-3148	240	22	;	;	PUNCT
iajs-3148	240	23	mcclanahan	mcclanahan	PROPN
iajs-3148	240	24	,	,	PUNCT
iajs-3148	240	25	t.	t.	PROPN
iajs-3148	240	26	;	;	PUNCT
iajs-3148	240	27	kastelein	kastelein	PROPN
iajs-3148	240	28	,	,	PUNCT
iajs-3148	240	29	r.a	r.a	PROPN
iajs-3148	240	30	.	.	PROPN
iajs-3148	240	31	;	;	PUNCT
iajs-3148	240	32	cua	cua	VERB
iajs-3148	240	33	,	,	PUNCT
iajs-3148	240	34	d.	d.	PROPN
iajs-3148	240	35	j.	j.	PROPN
iajs-3148	240	36	il-23	il-23	PROPN
iajs-3148	240	37	drives	drive	VERB
iajs-3148	240	38	a	a	DET
iajs-3148	240	39	pathogenic	pathogenic	ADJ
iajs-3148	240	40	t	t	NOUN
iajs-3148	240	41	cell	cell	NOUN
iajs-3148	240	42	population	population	NOUN
iajs-3148	240	43	that	that	PRON
iajs-3148	240	44	induces	induce	VERB
iajs-3148	240	45	autoimmune	autoimmune	ADJ
iajs-3148	240	46	inflammation	inflammation	NOUN
iajs-3148	240	47	.	.	PUNCT
iajs-3148	241	1	j.	j.	PROPN
iajs-3148	241	2	exper	exper	PROPN
iajs-3148	241	3	.	.	PUNCT
iajs-3148	241	4	med	med	PROPN
iajs-3148	241	5	.	.	PROPN
iajs-3148	241	6	,	,	PUNCT
iajs-3148	241	7	2005	2005	NUM
iajs-3148	241	8	;	;	PUNCT
iajs-3148	241	9	201	201	NUM
iajs-3148	241	10	,	,	PUNCT
iajs-3148	241	11	2	2	NUM
iajs-3148	241	12	,	,	PUNCT
iajs-3148	241	13	233	233	NUM
iajs-3148	241	14	-	-	SYM
iajs-3148	241	15	240	240	NUM
iajs-3148	241	16	.	.	NUM
iajs-3148	242	1	40	40	NUM
iajs-3148	242	2	.	.	PUNCT
iajs-3148	243	1	dapavo	dapavo	PROPN
iajs-3148	243	2	,	,	PUNCT
iajs-3148	243	3	p.	p.	NOUN
iajs-3148	243	4	;	;	PUNCT
iajs-3148	243	5	siliquini	siliquini	PROPN
iajs-3148	243	6	,	,	PUNCT
iajs-3148	243	7	n.	n.	NOUN
iajs-3148	243	8	;	;	PUNCT
iajs-3148	243	9	mastorino	mastorino	PROPN
iajs-3148	243	10	,	,	PUNCT
iajs-3148	243	11	l.	l.	PROPN
iajs-3148	243	12	;	;	PUNCT
iajs-3148	243	13	avallone	avallone	NOUN
iajs-3148	243	14	,	,	PUNCT
iajs-3148	243	15	g.	g.	PROPN
iajs-3148	243	16	;	;	PUNCT
iajs-3148	243	17	merli	merli	NOUN
iajs-3148	243	18	,	,	PUNCT
iajs-3148	243	19	m.	m.	NOUN
iajs-3148	243	20	;	;	PUNCT
iajs-3148	244	1	agostini	agostini	PROPN
iajs-3148	244	2	,	,	PUNCT
iajs-3148	244	3	a.	a.	PROPN
iajs-3148	244	4	;	;	PUNCT
iajs-3148	244	5	ribero	ribero	PROPN
iajs-3148	244	6	s	s	PROPN
iajs-3148	244	7	;	;	PUNCT
iajs-3148	244	8	efficacy	efficacy	NOUN
iajs-3148	244	9	,	,	PUNCT
iajs-3148	244	10	safety	safety	NOUN
iajs-3148	244	11	,	,	PUNCT
iajs-3148	244	12	and	and	CCONJ
iajs-3148	244	13	drug	drug	NOUN
iajs-3148	244	14	survival	survival	NOUN
iajs-3148	244	15	of	of	ADP
iajs-3148	244	16	il-23	il-23	NOUN
iajs-3148	244	17	,	,	PUNCT
iajs-3148	244	18	il-17	il-17	X
iajs-3148	244	19	,	,	PUNCT
iajs-3148	244	20	and	and	CCONJ
iajs-3148	244	21	tnf	tnf	PROPN
iajs-3148	244	22	-	-	PUNCT
iajs-3148	244	23	alpha	alpha	NOUN
iajs-3148	244	24	inhibitors	inhibitor	NOUN
iajs-3148	244	25	for	for	ADP
iajs-3148	244	26	psoriasis	psoriasis	NOUN
iajs-3148	244	27	treatment	treatment	NOUN
iajs-3148	244	28	:	:	PUNCT
iajs-3148	244	29	a	a	DET
iajs-3148	244	30	retrospective	retrospective	ADJ
iajs-3148	244	31	study	study	NOUN
iajs-3148	244	32	.	.	PUNCT
iajs-3148	245	1	j.	j.	PROPN
iajs-3148	245	2	dermatol	dermatol	PROPN
iajs-3148	245	3	.	.	PUNCT
iajs-3148	246	1	treat	treat	NOUN
iajs-3148	246	2	.	.	PUNCT
iajs-3148	247	1	2022	2022	NUM
iajs-3148	247	2	;	;	PUNCT
iajs-3148	247	3	33	33	NUM
iajs-3148	247	4	,	,	PUNCT
iajs-3148	247	5	4	4	NUM
iajs-3148	247	6	,	,	PUNCT
iajs-3148	247	7	2352	2352	NUM
iajs-3148	247	8	-	-	SYM
iajs-3148	247	9	2357	2357	NUM
iajs-3148	247	10	.	.	PUNCT
iajs-3148	248	1	41	41	NUM
iajs-3148	248	2	.	.	PUNCT
iajs-3148	249	1	dunphy	dunphy	PROPN
iajs-3148	249	2	,	,	PUNCT
iajs-3148	249	3	s.e	s.e	PROPN
iajs-3148	249	4	.	.	PROPN
iajs-3148	249	5	;	;	PUNCT
iajs-3148	249	6	sweeney	sweeney	PROPN
iajs-3148	249	7	,	,	PUNCT
iajs-3148	249	8	c.m	c.m	PROPN
iajs-3148	249	9	.	.	PROPN
iajs-3148	249	10	;	;	PUNCT
iajs-3148	249	11	kelly	kelly	PROPN
iajs-3148	249	12	,	,	PUNCT
iajs-3148	249	13	g.	g.	PROPN
iajs-3148	249	14	;	;	PUNCT
iajs-3148	249	15	tobin	tobin	PROPN
iajs-3148	249	16	,	,	PUNCT
iajs-3148	249	17	a.m.	a.m.	ADV
iajs-3148	249	18	;	;	PUNCT
iajs-3148	249	19	kirby	kirby	PROPN
iajs-3148	249	20	,	,	PUNCT
iajs-3148	249	21	b.	b.	PROPN
iajs-3148	249	22	;	;	PUNCT
iajs-3148	249	23	gardiner	gardiner	PROPN
iajs-3148	249	24	,	,	PUNCT
iajs-3148	249	25	c.m	c.m	PROPN
iajs-3148	249	26	.	.	PROPN
iajs-3148	249	27	natural	natural	ADJ
iajs-3148	249	28	killer	killer	NOUN
iajs-3148	249	29	cells	cell	NOUN
iajs-3148	249	30	from	from	ADP
iajs-3148	249	31	psoriasis	psoriasis	NOUN
iajs-3148	249	32	vulgaris	vulgaris	NOUN
iajs-3148	249	33	patients	patient	NOUN
iajs-3148	249	34	have	have	AUX
iajs-3148	249	35	reduced	reduce	VERB
iajs-3148	249	36	levels	level	NOUN
iajs-3148	249	37	of	of	ADP
iajs-3148	249	38	cytotoxicity	cytotoxicity	NOUN
iajs-3148	249	39	associated	associate	VERB
iajs-3148	249	40	degranulation	degranulation	NOUN
iajs-3148	249	41	and	and	CCONJ
iajs-3148	249	42	cytokine	cytokine	ADJ
iajs-3148	249	43	production	production	NOUN
iajs-3148	249	44	.	.	PUNCT
iajs-3148	250	1	j.	j.	PROPN
iajs-3148	250	2	clin	clin	PROPN
iajs-3148	250	3	.	.	PUNCT
iajs-3148	251	1	immunol	immunol	PROPN
iajs-3148	251	2	.	.	PROPN
iajs-3148	251	3	,	,	PUNCT
iajs-3148	251	4	2017	2017	NUM
iajs-3148	251	5	;	;	PUNCT
iajs-3148	251	6	177	177	NUM
iajs-3148	251	7	,	,	PUNCT
iajs-3148	251	8	43	43	NUM
iajs-3148	251	9	-	-	SYM
iajs-3148	251	10	49	49	NUM
iajs-3148	251	11	.	.	PUNCT
iajs-3148	252	1	42	42	NUM
iajs-3148	252	2	.	.	PUNCT
iajs-3148	253	1	tassiulas	tassiula	NOUN
iajs-3148	253	2	,	,	PUNCT
iajs-3148	253	3	i.	i.	NOUN
iajs-3148	253	4	;	;	PUNCT
iajs-3148	253	5	duncan	duncan	PROPN
iajs-3148	253	6	,	,	PUNCT
iajs-3148	253	7	s.r	s.r	PROPN
iajs-3148	253	8	.	.	PROPN
iajs-3148	253	9	;	;	PUNCT
iajs-3148	253	10	centola	centola	PROPN
iajs-3148	253	11	,	,	PUNCT
iajs-3148	253	12	m.	m.	NOUN
iajs-3148	253	13	;	;	PUNCT
iajs-3148	253	14	theofilopoulos	theofilopoulos	PROPN
iajs-3148	253	15	,	,	PUNCT
iajs-3148	253	16	a.n	a.n	PROPN
iajs-3148	253	17	.	.	PROPN
iajs-3148	253	18	;	;	PUNCT
iajs-3148	253	19	boumpas	boumpas	PROPN
iajs-3148	253	20	,	,	PUNCT
iajs-3148	253	21	d.t	d.t	PROPN
iajs-3148	253	22	.	.	PROPN
iajs-3148	253	23	clonal	clonal	ADJ
iajs-3148	253	24	characteristics	characteristic	NOUN
iajs-3148	253	25	of	of	ADP
iajs-3148	253	26	t	t	NOUN
iajs-3148	253	27	cell	cell	NOUN
iajs-3148	253	28	infiltrates	infiltrate	NOUN
iajs-3148	253	29	in	in	ADP
iajs-3148	253	30	skin	skin	NOUN
iajs-3148	253	31	and	and	CCONJ
iajs-3148	253	32	synovium	synovium	NOUN
iajs-3148	253	33	of	of	ADP
iajs-3148	253	34	patients	patient	NOUN
iajs-3148	253	35	with	with	ADP
iajs-3148	253	36	psoriatic	psoriatic	ADJ
iajs-3148	253	37	arthritis	arthritis	NOUN
iajs-3148	253	38	.	.	PUNCT
iajs-3148	254	1	j.	j.	PROPN
iajs-3148	254	2	human	human	PROPN
iajs-3148	254	3	immunol	immunol	PROPN
iajs-3148	254	4	.	.	PUNCT
iajs-3148	254	5	,	,	PUNCT
iajs-3148	254	6	1999	1999	NUM
iajs-3148	254	7	;	;	PUNCT
iajs-3148	254	8	60	60	NUM
iajs-3148	254	9	,	,	PUNCT
iajs-3148	254	10	6	6	NUM
iajs-3148	254	11	,	,	PUNCT
iajs-3148	254	12	479	479	NUM
iajs-3148	254	13	-	-	SYM
iajs-3148	254	14	491	491	NUM
iajs-3148	254	15	.	.	PUNCT
iajs-3148	255	1	43	43	NUM
iajs-3148	255	2	.	.	PUNCT
iajs-3148	256	1	danning	danning	PROPN
iajs-3148	256	2	,	,	PUNCT
iajs-3148	256	3	c.l	c.l	PROPN
iajs-3148	256	4	.	.	PROPN
iajs-3148	256	5	;	;	PUNCT
iajs-3148	256	6	illei	illei	NOUN
iajs-3148	256	7	,	,	PUNCT
iajs-3148	256	8	g.g	g.g	PROPN
iajs-3148	256	9	.	.	PROPN
iajs-3148	256	10	;	;	PUNCT
iajs-3148	256	11	hitchon	hitchon	PROPN
iajs-3148	256	12	,	,	PUNCT
iajs-3148	256	13	c.	c.	PROPN
iajs-3148	256	14	;	;	PUNCT
iajs-3148	256	15	greer	greer	PROPN
iajs-3148	256	16	,	,	PUNCT
iajs-3148	256	17	m.r	m.r	PROPN
iajs-3148	256	18	.	.	PROPN
iajs-3148	256	19	;	;	PUNCT
iajs-3148	256	20	boumpas	boumpas	PROPN
iajs-3148	256	21	,	,	PUNCT
iajs-3148	256	22	d.	d.	PROPN
iajs-3148	256	23	t.	t.	PROPN
iajs-3148	256	24	;	;	PUNCT
iajs-3148	256	25	mcinnes	mcinnes	PROPN
iajs-3148	256	26	,	,	PUNCT
iajs-3148	256	27	i.b	i.b	PROPN
iajs-3148	256	28	;	;	PUNCT
iajs-3148	256	29	macrophage‐derived	macrophage‐derive	VERB
iajs-3148	256	30	cytokine	cytokine	ADJ
iajs-3148	256	31	and	and	CCONJ
iajs-3148	256	32	nuclear	nuclear	ADJ
iajs-3148	256	33	factor	factor	NOUN
iajs-3148	256	34	κb	κb	NOUN
iajs-3148	256	35	p65	p65	NOUN
iajs-3148	256	36	expression	expression	NOUN
iajs-3148	256	37	in	in	ADP
iajs-3148	256	38	synovial	synovial	ADJ
iajs-3148	256	39	membrane	membrane	NOUN
iajs-3148	256	40	and	and	CCONJ
iajs-3148	256	41	skin	skin	NOUN
iajs-3148	256	42	of	of	ADP
iajs-3148	256	43	patients	patient	NOUN
iajs-3148	256	44	with	with	ADP
iajs-3148	256	45	psoriatic	psoriatic	ADJ
iajs-3148	256	46	arthritis	arthritis	NOUN
iajs-3148	256	47	.	.	PUNCT
iajs-3148	257	1	arthritis	arthritis	NOUN
iajs-3148	257	2	rheumat	rheumat	NOUN
iajs-3148	257	3	.	.	PUNCT
iajs-3148	258	1	official	official	ADJ
iajs-3148	258	2	j.	j.	PROPN
iajs-3148	258	3	am	am	PROPN
iajs-3148	258	4	.	.	PUNCT
iajs-3148	259	1	coll	coll	PROPN
iajs-3148	259	2	.	.	PUNCT
iajs-3148	260	1	rheumatol	rheumatol	PROPN
iajs-3148	260	2	.	.	PUNCT
iajs-3148	260	3	,	,	PUNCT
iajs-3148	260	4	2000	2000	NUM
iajs-3148	260	5	,	,	PUNCT
iajs-3148	260	6	43	43	NUM
iajs-3148	260	7	,	,	PUNCT
iajs-3148	260	8	6	6	NUM
iajs-3148	260	9	,	,	PUNCT
iajs-3148	260	10	1244	1244	NUM
iajs-3148	260	11	-	-	SYM
iajs-3148	260	12	1256	1256	NUM
iajs-3148	260	13	.	.	PUNCT
iajs-3148	261	1	44	44	NUM
iajs-3148	261	2	.	.	PUNCT
iajs-3148	262	1	dunphy	dunphy	PROPN
iajs-3148	262	2	,	,	PUNCT
iajs-3148	262	3	s.e	s.e	PROPN
iajs-3148	262	4	.	.	PROPN
iajs-3148	262	5	;	;	PUNCT
iajs-3148	262	6	sweeney	sweeney	PROPN
iajs-3148	262	7	,	,	PUNCT
iajs-3148	262	8	c.m	c.m	PROPN
iajs-3148	262	9	.	.	PROPN
iajs-3148	262	10	;	;	PUNCT
iajs-3148	262	11	kelly	kelly	PROPN
iajs-3148	262	12	,	,	PUNCT
iajs-3148	262	13	g.	g.	PROPN
iajs-3148	262	14	;	;	PUNCT
iajs-3148	262	15	tobin	tobin	PROPN
iajs-3148	262	16	,	,	PUNCT
iajs-3148	262	17	a.m.	a.m.	ADV
iajs-3148	262	18	;	;	PUNCT
iajs-3148	262	19	kirby	kirby	PROPN
iajs-3148	262	20	,	,	PUNCT
iajs-3148	262	21	b.	b.	PROPN
iajs-3148	262	22	;	;	PUNCT
iajs-3148	262	23	gardiner	gardiner	PROPN
iajs-3148	262	24	c.m	c.m	PROPN
iajs-3148	262	25	.	.	PROPN
iajs-3148	262	26	natural	natural	ADJ
iajs-3148	262	27	killer	killer	NOUN
iajs-3148	262	28	cells	cell	NOUN
iajs-3148	262	29	from	from	ADP
iajs-3148	262	30	psoriasis	psoriasis	NOUN
iajs-3148	262	31	vulgaris	vulgaris	NOUN
iajs-3148	262	32	patients	patient	NOUN
iajs-3148	262	33	have	have	AUX
iajs-3148	262	34	reduced	reduce	VERB
iajs-3148	262	35	levels	level	NOUN
iajs-3148	262	36	of	of	ADP
iajs-3148	262	37	cytotoxicity	cytotoxicity	NOUN
iajs-3148	262	38	associated	associate	VERB
iajs-3148	262	39	degranulation	degranulation	NOUN
iajs-3148	262	40	and	and	CCONJ
iajs-3148	262	41	cytokine	cytokine	ADJ
iajs-3148	262	42	production	production	NOUN
iajs-3148	262	43	.	.	PUNCT
iajs-3148	263	1	j.	j.	PROPN
iajs-3148	263	2	clin	clin	PROPN
iajs-3148	263	3	.	.	PUNCT
iajs-3148	264	1	immunol	immunol	PROPN
iajs-3148	264	2	.	.	PROPN
iajs-3148	264	3	,	,	PUNCT
iajs-3148	264	4	2017	2017	NUM
iajs-3148	264	5	;	;	PUNCT
iajs-3148	264	6	177	177	NUM
iajs-3148	264	7	,	,	PUNCT
iajs-3148	264	8	43	43	NUM
iajs-3148	264	9	-	-	SYM
iajs-3148	264	10	49	49	NUM
iajs-3148	264	11	.	.	PUNCT
iajs-3148	265	1	45	45	NUM
iajs-3148	265	2	.	.	PUNCT
iajs-3148	265	3	kalinina	kalinina	PROPN
iajs-3148	265	4	,	,	PUNCT
iajs-3148	265	5	o.	o.	PROPN
iajs-3148	265	6	;	;	PUNCT
iajs-3148	265	7	golovkin	golovkin	NOUN
iajs-3148	265	8	,	,	PUNCT
iajs-3148	265	9	a.	a.	NOUN
iajs-3148	265	10	;	;	PUNCT
iajs-3148	265	11	zaikova	zaikova	PROPN
iajs-3148	265	12	,	,	PUNCT
iajs-3148	265	13	e.	e.	PROPN
iajs-3148	265	14	;	;	PUNCT
iajs-3148	265	15	aquino	aquino	PROPN
iajs-3148	265	16	,	,	PUNCT
iajs-3148	265	17	a.	a.	NOUN
iajs-3148	265	18	;	;	PUNCT
iajs-3148	265	19	bezrukikh	bezrukikh	NOUN
iajs-3148	265	20	,	,	PUNCT
iajs-3148	265	21	v.	v.	ADV
iajs-3148	265	22	;	;	PUNCT
iajs-3148	265	23	melnik	melnik	X
iajs-3148	265	24	,	,	PUNCT
iajs-3148	265	25	o.	o.	PROPN
iajs-3148	265	26	;	;	PUNCT
iajs-3148	265	27	shlyakhto	shlyakhto	NOUN
iajs-3148	265	28	,	,	PUNCT
iajs-3148	265	29	e.	e.	PROPN
iajs-3148	265	30	cytokine	cytokine	PROPN
iajs-3148	265	31	storm	storm	NOUN
iajs-3148	265	32	signature	signature	NOUN
iajs-3148	265	33	in	in	ADP
iajs-3148	265	34	patients	patient	NOUN
iajs-3148	265	35	with	with	ADP
iajs-3148	265	36	moderate	moderate	ADJ
iajs-3148	265	37	and	and	CCONJ
iajs-3148	265	38	severe	severe	ADJ
iajs-3148	265	39	covid-19	covid-19	PROPN
iajs-3148	265	40	.	.	PUNCT
iajs-3148	265	41	int	int	PROPN
iajs-3148	265	42	.	.	PUNCT
iajs-3148	266	1	j.	j.	PROPN
iajs-3148	266	2	mol	mol	PROPN
iajs-3148	266	3	.	.	PUNCT
iajs-3148	267	1	sci	sci	PROPN
iajs-3148	267	2	.	.	PROPN
iajs-3148	267	3	,	,	PUNCT
iajs-3148	267	4	2022	2022	NUM
iajs-3148	267	5	;	;	PUNCT
iajs-3148	267	6	23	23	NUM
iajs-3148	267	7	,	,	PUNCT
iajs-3148	267	8	16	16	NUM
iajs-3148	267	9	,	,	PUNCT
iajs-3148	267	10	8879	8879	NUM
iajs-3148	267	11	.	.	PUNCT
iajs-3148	268	1	46	46	NUM
iajs-3148	268	2	.	.	PUNCT
iajs-3148	269	1	mcinnes	mcinne	NOUN
iajs-3148	269	2	.	.	PUNCT
iajs-3148	270	1	i.b	i.b	PROPN
iajs-3148	270	2	.	.	PROPN
iajs-3148	270	3	;	;	PUNCT
iajs-3148	271	1	liew	liew	PROPN
iajs-3148	271	2	.	.	PUNCT
iajs-3148	272	1	f.y	f.y	PROPN
iajs-3148	272	2	.	.	PROPN
iajs-3148	272	3	interleukin	interleukin	PROPN
iajs-3148	272	4	15	15	NUM
iajs-3148	272	5	:	:	PUNCT
iajs-3148	272	6	a	a	DET
iajs-3148	272	7	proinflammatory	proinflammatory	ADJ
iajs-3148	272	8	role	role	NOUN
iajs-3148	272	9	in	in	ADP
iajs-3148	272	10	rheumatoid	rheumatoid	NOUN
iajs-3148	272	11	arthritis	arthritis	NOUN
iajs-3148	272	12	synovitis	synovitis	PROPN
iajs-3148	272	13	.	.	PUNCT
iajs-3148	273	1	j.	j.	PROPN
iajs-3148	273	2	immunol	immunol	PROPN
iajs-3148	273	3	.	.	PUNCT
iajs-3148	274	1	today	today	NOUN
iajs-3148	274	2	,	,	PUNCT
iajs-3148	274	3	1998	1998	NUM
iajs-3148	274	4	;	;	PUNCT
iajs-3148	274	5	19	19	NUM
iajs-3148	274	6	,	,	PUNCT
iajs-3148	274	7	2	2	NUM
iajs-3148	274	8	,	,	PUNCT
iajs-3148	274	9	75	75	NUM
iajs-3148	274	10	-	-	SYM
iajs-3148	274	11	79	79	NUM
iajs-3148	274	12	.	.	PUNCT
iajs-3148	275	1	47	47	NUM
iajs-3148	275	2	.	.	PUNCT
iajs-3148	275	3	de	de	PROPN
iajs-3148	275	4	jesús‐gil	jesús‐gil	PROPN
iajs-3148	275	5	,	,	PUNCT
iajs-3148	275	6	c.	c.	PROPN
iajs-3148	275	7	;	;	PUNCT
iajs-3148	275	8	ruiz‐romeu	ruiz‐romeu	NOUN
iajs-3148	275	9	,	,	PUNCT
iajs-3148	275	10	e.	e.	PROPN
iajs-3148	275	11	;	;	PUNCT
iajs-3148	275	12	ferran	ferran	NOUN
iajs-3148	275	13	,	,	PUNCT
iajs-3148	275	14	m.	m.	NOUN
iajs-3148	275	15	;	;	PUNCT
iajs-3148	275	16	sagristà	sagristà	NOUN
iajs-3148	275	17	,	,	PUNCT
iajs-3148	275	18	m.	m.	NOUN
iajs-3148	275	19	;	;	PUNCT
iajs-3148	275	20	chiriac	chiriac	PROPN
iajs-3148	275	21	,	,	PUNCT
iajs-3148	275	22	a.	a.	NOUN
iajs-3148	275	23	;	;	PUNCT
iajs-3148	275	24	garcía	garcía	ADJ
iajs-3148	275	25	,	,	PUNCT
iajs-3148	275	26	p.	p.	NOUN
iajs-3148	275	27	;	;	PUNCT
iajs-3148	275	28	santamaria‐	santamaria‐	PUNCT
iajs-3148	275	29	babí	babí	NOUN
iajs-3148	275	30	,	,	PUNCT
iajs-3148	275	31	l.f	l.f	PROPN
iajs-3148	275	32	.	.	PROPN
iajs-3148	275	33	il‐15	il‐15	PROPN
iajs-3148	275	34	and	and	CCONJ
iajs-3148	275	35	il‐23	il‐23	PROPN
iajs-3148	275	36	synergize	synergize	VERB
iajs-3148	275	37	to	to	AUX
iajs-3148	275	38	trigger	trigger	NOUN
iajs-3148	275	39	th17	th17	NOUN
iajs-3148	275	40	response	response	NOUN
iajs-3148	275	41	by	by	ADP
iajs-3148	275	42	cla+	cla+	NOUN
iajs-3148	275	43	t	t	NOUN
iajs-3148	275	44	cells	cell	NOUN
iajs-3148	275	45	in	in	ADP
iajs-3148	275	46	psoriasis	psoriasis	NOUN
iajs-3148	275	47	.	.	PUNCT
iajs-3148	276	1	exper	exper	NOUN
iajs-3148	276	2	.	.	PUNCT
iajs-3148	277	1	dermatol	dermatol	PROPN
iajs-3148	277	2	.	.	PUNCT
iajs-3148	277	3	,	,	PUNCT
iajs-3148	277	4	2020	2020	NUM
iajs-3148	277	5	;	;	PUNCT
iajs-3148	277	6	29	29	NUM
iajs-3148	277	7	,	,	PUNCT
iajs-3148	277	8	7	7	NUM
iajs-3148	277	9	,	,	PUNCT
iajs-3148	277	10	630	630	NUM
iajs-3148	277	11	-	-	SYM
iajs-3148	277	12	638	638	NUM
iajs-3148	277	13	.	.	PUNCT
iajs-3148	278	1	48	48	NUM
iajs-3148	278	2	.	.	PUNCT
iajs-3148	279	1	yoshihara	yoshihara	PROPN
iajs-3148	279	2	,	,	PUNCT
iajs-3148	279	3	k.	k.	PROPN
iajs-3148	279	4	;	;	PUNCT
iajs-3148	279	5	yamada	yamada	PROPN
iajs-3148	279	6	,	,	PUNCT
iajs-3148	279	7	h.	h.	PROPN
iajs-3148	279	8	;	;	PUNCT
iajs-3148	279	9	hori	hori	PROPN
iajs-3148	279	10	,	,	PUNCT
iajs-3148	279	11	a.	a.	PROPN
iajs-3148	279	12	;	;	PUNCT
iajs-3148	279	13	yajima	yajima	NOUN
iajs-3148	279	14	,	,	PUNCT
iajs-3148	279	15	t.	t.	PROPN
iajs-3148	279	16	;	;	PUNCT
iajs-3148	279	17	kubo	kubo	PROPN
iajs-3148	279	18	,	,	PUNCT
iajs-3148	279	19	c.	c.	PROPN
iajs-3148	279	20	;	;	PUNCT
iajs-3148	279	21	yoshikai	yoshikai	ADV
iajs-3148	279	22	,	,	PUNCT
iajs-3148	279	23	y.	y.	PROPN
iajs-3148	279	24	il‐15	il‐15	PROPN
iajs-3148	279	25	exacerbates	exacerbate	VERB
iajs-3148	279	26	collagen‐induced	collagen‐induce	VERB
iajs-3148	279	27	arthritis	arthritis	NOUN
iajs-3148	279	28	with	with	ADP
iajs-3148	279	29	an	an	DET
iajs-3148	279	30	enhanced	enhanced	ADJ
iajs-3148	279	31	cd4	cd4	PROPN
iajs-3148	279	32	+	+	PROPN
iajs-3148	279	33	t	t	NOUN
iajs-3148	279	34	cell	cell	NOUN
iajs-3148	279	35	response	response	NOUN
iajs-3148	279	36	to	to	PART
iajs-3148	279	37	produce	produce	VERB
iajs-3148	279	38	il‐17	il‐17	NOUN
iajs-3148	279	39	.	.	PUNCT
iajs-3148	280	1	europ	europ	NOUN
iajs-3148	280	2	.	.	PUNCT
iajs-3148	281	1	j.	j.	PROPN
iajs-3148	281	2	immunol	immunol	PROPN
iajs-3148	281	3	.	.	PROPN
iajs-3148	281	4	,	,	PUNCT
iajs-3148	281	5	2007	2007	NUM
iajs-3148	281	6	;	;	PUNCT
iajs-3148	281	7	37	37	NUM
iajs-3148	281	8	,	,	PUNCT
iajs-3148	281	9	10	10	NUM
iajs-3148	281	10	,	,	PUNCT
iajs-3148	281	11	2744	2744	NUM
iajs-3148	281	12	-	-	SYM
iajs-3148	281	13	2752	2752	NUM
iajs-3148	281	14	.	.	PUNCT
iajs-3148	282	1	49	49	NUM
iajs-3148	282	2	.	.	PUNCT
iajs-3148	283	1	de	de	PROPN
iajs-3148	283	2	jesús‐gil	jesús‐gil	PROPN
iajs-3148	283	3	,	,	PUNCT
iajs-3148	283	4	c.	c.	PROPN
iajs-3148	283	5	;	;	PUNCT
iajs-3148	283	6	ruiz‐romeu	ruiz‐romeu	NOUN
iajs-3148	283	7	,	,	PUNCT
iajs-3148	283	8	e.	e.	PROPN
iajs-3148	283	9	;	;	PUNCT
iajs-3148	283	10	ferran	ferran	NOUN
iajs-3148	283	11	,	,	PUNCT
iajs-3148	283	12	m.	m.	NOUN
iajs-3148	283	13	;	;	PUNCT
iajs-3148	283	14	sagristà	sagristà	NOUN
iajs-3148	283	15	,	,	PUNCT
iajs-3148	283	16	m.	m.	NOUN
iajs-3148	283	17	;	;	PUNCT
iajs-3148	283	18	chiriac	chiriac	PROPN
iajs-3148	283	19	,	,	PUNCT
iajs-3148	283	20	a.	a.	NOUN
iajs-3148	283	21	;	;	PUNCT
iajs-3148	283	22	garcía	garcía	ADJ
iajs-3148	283	23	,	,	PUNCT
iajs-3148	283	24	p	p	X
iajs-3148	283	25	,	,	PUNCT
iajs-3148	283	26	;	;	PUNCT
iajs-3148	283	27	santamaria‐	santamaria‐	PUNCT
iajs-3148	283	28	babí	babí	NOUN
iajs-3148	283	29	,	,	PUNCT
iajs-3148	283	30	l.f	l.f	PROPN
iajs-3148	283	31	.	.	PROPN
iajs-3148	283	32	il‐15	il‐15	PROPN
iajs-3148	283	33	and	and	CCONJ
iajs-3148	283	34	il‐23	il‐23	PROPN
iajs-3148	283	35	synergize	synergize	VERB
iajs-3148	283	36	to	to	AUX
iajs-3148	283	37	trigger	trigger	NOUN
iajs-3148	283	38	th17	th17	NOUN
iajs-3148	283	39	response	response	NOUN
iajs-3148	283	40	by	by	ADP
iajs-3148	283	41	cla+	cla+	NOUN
iajs-3148	283	42	t	t	NOUN
iajs-3148	283	43	cells	cell	NOUN
iajs-3148	283	44	in	in	ADP
iajs-3148	283	45	psoriasis	psoriasis	NOUN
iajs-3148	283	46	.	.	PUNCT
iajs-3148	284	1	j.	j.	PROPN
iajs-3148	284	2	exper	exper	PROPN
iajs-3148	284	3	.	.	PUNCT
iajs-3148	285	1	dermatol	dermatol	PROPN
iajs-3148	285	2	.	.	PUNCT
iajs-3148	285	3	,	,	PUNCT
iajs-3148	285	4	2020	2020	NUM
iajs-3148	285	5	;	;	PUNCT
iajs-3148	285	6	29	29	NUM
iajs-3148	285	7	,	,	PUNCT
iajs-3148	285	8	7	7	NUM
iajs-3148	285	9	,	,	PUNCT
iajs-3148	285	10	630	630	NUM
iajs-3148	285	11	-	-	SYM
iajs-3148	285	12	638	638	NUM
iajs-3148	285	13	.	.	PUNCT
iajs-3148	286	1	ihjpas	ihjpas	PROPN
iajs-3148	286	2	.	.	PUNCT
iajs-3148	287	1	37	37	NUM
iajs-3148	287	2	(	(	PUNCT
iajs-3148	287	3	1	1	NUM
iajs-3148	287	4	)	)	PUNCT
iajs-3148	287	5	2024	2024	NUM
iajs-3148	287	6	85	85	NUM
iajs-3148	287	7	50	50	NUM
iajs-3148	287	8	.	.	PUNCT
iajs-3148	288	1	celis	celis	PROPN
iajs-3148	288	2	,	,	PUNCT
iajs-3148	288	3	r.	r.	PROPN
iajs-3148	288	4	;	;	PUNCT
iajs-3148	288	5	planell	planell	PROPN
iajs-3148	288	6	,	,	PUNCT
iajs-3148	288	7	n.	n.	NOUN
iajs-3148	288	8	;	;	PUNCT
iajs-3148	288	9	fernández	fernández	PROPN
iajs-3148	288	10	-	-	PUNCT
iajs-3148	288	11	sueiro	sueiro	PROPN
iajs-3148	288	12	,	,	PUNCT
iajs-3148	288	13	j.l	j.l	PROPN
iajs-3148	288	14	.	.	PROPN
iajs-3148	288	15	;	;	PUNCT
iajs-3148	288	16	sanmartí	sanmartí	PROPN
iajs-3148	288	17	,	,	PUNCT
iajs-3148	288	18	r.	r.	PROPN
iajs-3148	288	19	;	;	PUNCT
iajs-3148	288	20	ramírez	ramírez	NOUN
iajs-3148	288	21	,	,	PUNCT
iajs-3148	288	22	j.	j.	PROPN
iajs-3148	288	23	;	;	PUNCT
iajs-3148	288	24	gonzález	gonzález	PROPN
iajs-3148	288	25	-	-	PUNCT
iajs-3148	288	26	álvaro	álvaro	PROPN
iajs-3148	288	27	,	,	PUNCT
iajs-3148	288	28	i.	i.	NOUN
iajs-3148	288	29	;	;	PUNCT
iajs-3148	288	30	cañete	cañete	PROPN
iajs-3148	288	31	,	,	PUNCT
iajs-3148	288	32	j.d	j.d	PROPN
iajs-3148	288	33	;	;	PUNCT
iajs-3148	288	34	synovial	synovial	ADJ
iajs-3148	288	35	cytokine	cytokine	NOUN
iajs-3148	288	36	expression	expression	NOUN
iajs-3148	288	37	in	in	ADP
iajs-3148	288	38	psoriatic	psoriatic	ADJ
iajs-3148	288	39	arthritis	arthritis	NOUN
iajs-3148	288	40	and	and	CCONJ
iajs-3148	288	41	associations	association	NOUN
iajs-3148	288	42	with	with	ADP
iajs-3148	288	43	lymphoid	lymphoid	ADJ
iajs-3148	288	44	neogenesis	neogenesis	NOUN
iajs-3148	288	45	and	and	CCONJ
iajs-3148	288	46	clinical	clinical	ADJ
iajs-3148	288	47	features	feature	NOUN
iajs-3148	288	48	.	.	PUNCT
iajs-3148	289	1	j.	j.	PROPN
iajs-3148	289	2	arthritis	arthritis	PROPN
iajs-3148	289	3	res	re	NOUN
iajs-3148	289	4	.	.	PUNCT
iajs-3148	290	1	therapy	therapy	NOUN
iajs-3148	290	2	,	,	PUNCT
iajs-3148	290	3	2012	2012	NUM
iajs-3148	290	4	;	;	PUNCT
iajs-3148	290	5	14	14	NUM
iajs-3148	290	6	,	,	PUNCT
iajs-3148	290	7	2	2	NUM
iajs-3148	290	8	,	,	PUNCT
iajs-3148	290	9	1	1	NUM
iajs-3148	290	10	-	-	SYM
iajs-3148	290	11	9	9	NUM
iajs-3148	290	12	.	.	NUM
iajs-3148	290	13	51	51	NUM
iajs-3148	290	14	.	.	PUNCT
iajs-3148	290	15	waldmann	waldmann	PROPN
iajs-3148	290	16	,	,	PUNCT
iajs-3148	290	17	t.a	t.a	PROPN
iajs-3148	290	18	.	.	PROPN
iajs-3148	290	19	targeting	target	VERB
iajs-3148	290	20	the	the	DET
iajs-3148	290	21	interleukin-15	interleukin-15	PROPN
iajs-3148	290	22	/	/	SYM
iajs-3148	290	23	interleukin-15	interleukin-15	NOUN
iajs-3148	290	24	receptor	receptor	NOUN
iajs-3148	290	25	system	system	NOUN
iajs-3148	290	26	in	in	ADP
iajs-3148	290	27	inflammatory	inflammatory	ADJ
iajs-3148	290	28	autoimmune	autoimmune	ADJ
iajs-3148	290	29	diseases	disease	NOUN
iajs-3148	290	30	.	.	PUNCT
iajs-3148	291	1	arthritis	arthritis	NOUN
iajs-3148	291	2	res	re	NOUN
iajs-3148	291	3	.	.	PUNCT
iajs-3148	292	1	ther	ther	PROPN
iajs-3148	292	2	,	,	PUNCT
iajs-3148	292	3	2004	2004	NUM
iajs-3148	292	4	;	;	PUNCT
iajs-3148	292	5	6	6	NUM
iajs-3148	292	6	,	,	PUNCT
iajs-3148	292	7	4,174–177	4,174–177	NUM
iajs-3148	292	8	.	.	PUNCT
iajs-3148	293	1	52	52	NUM
iajs-3148	293	2	.	.	PUNCT
iajs-3148	294	1	fraga	fraga	NOUN
iajs-3148	294	2	,	,	PUNCT
iajs-3148	294	3	n.a.d.a	n.a.d.a	PROPN
iajs-3148	294	4	.	.	PROPN
iajs-3148	294	5	;	;	PUNCT
iajs-3148	294	6	oliveira	oliveira	PROPN
iajs-3148	294	7	,	,	PUNCT
iajs-3148	294	8	m.d.f.p.d	m.d.f.p.d	NOUN
iajs-3148	294	9	.	.	PUNCT
iajs-3148	294	10	;	;	PUNCT
iajs-3148	294	11	follador	follador	PROPN
iajs-3148	294	12	,	,	PUNCT
iajs-3148	294	13	i.	i.	PROPN
iajs-3148	294	14	;	;	PUNCT
iajs-3148	294	15	rocha	rocha	PROPN
iajs-3148	294	16	,	,	PUNCT
iajs-3148	294	17	b.d.o	b.d.o	NOUN
iajs-3148	294	18	.	.	PUNCT
iajs-3148	294	19	;	;	PUNCT
iajs-3148	294	20	rêgo	rêgo	NOUN
iajs-3148	294	21	,	,	PUNCT
iajs-3148	294	22	v.r	v.r	NOUN
iajs-3148	294	23	.	.	NOUN
iajs-3148	294	24	psoriasis	psoriasis	NOUN
iajs-3148	294	25	and	and	CCONJ
iajs-3148	294	26	uveitis	uveitis	NOUN
iajs-3148	294	27	:	:	PUNCT
iajs-3148	294	28	a	a	DET
iajs-3148	294	29	literature	literature	NOUN
iajs-3148	294	30	review	review	NOUN
iajs-3148	294	31	.	.	PUNCT
iajs-3148	295	1	j.	j.	PROPN
iajs-3148	295	2	anais	anais	PROPN
iajs-3148	295	3	brasileiros	brasileiros	PROPN
iajs-3148	295	4	de	de	PROPN
iajs-3148	295	5	dermatologia	dermatologia	PROPN
iajs-3148	295	6	,	,	PUNCT
iajs-3148	295	7	2012	2012	NUM
iajs-3148	295	8	;	;	PUNCT
iajs-3148	295	9	87	87	NUM
iajs-3148	295	10	,	,	PUNCT
iajs-3148	295	11	877	877	NUM
iajs-3148	295	12	-	-	SYM
iajs-3148	295	13	883	883	NUM
iajs-3148	295	14	.	.	PUNCT